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Dissertation	  Abstract	  
 
Bisphenol A (BPA) is a high-production chemical found in the food supply that 
has been the subject of public health concerns over the last decade. Government agencies, 
public health and environmental organizations, industry interest groups and the media 
have presented conflicting information and conclusions about BPA’s safety. This topic 
provided a rich context to explore risk communication on a politicized and scientifically 
complex issue with implications for effective risk management and regulatory decision-
making. This case study of BPA risk communication includes a qualitative review of 
stakeholder website documents using the risk assessment framework, a quantitative news 
media content analysis and an analysis of semi-structured key stakeholder interviews. 
Findings confirmed that mixed messages were prevalent in the news media. Key 
stakeholders disagreed on the public health impacts of BPA. Secondly, distrust among 
stakeholders and perceived lacks of objectivity were highlighted as key challenges in 
conveying risks to the public. Third, risk management of BPA lacked focus on 
comprehensive solutions.  
The success of risk management efforts depends on the ability of public health 
professionals to translate data and communicate about complex scientific issues. 
Although BPA is just one example of the many common chemical exposures people face, 
it is emblematic of environmental policy and risk assessment in the U.S., with its history 
of controversy, conflicting messages and complicated regulatory structure. BPA and 
other environmental chemicals present emerging challenges to public health professionals 
in different capacities as researchers, advocates, and regulators. This research fills a gap 
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in the literature on risk communication and news media coverage of a major risk issue of 
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Chapter	  1.	  Introduction	  
	  
Bisphenol A (BPA) is a common industrial chemical often found in food and 
beverage containers.1 The two most common food-related sources are polycarbonate 
plastics and canned goods. BPA is used as a building block in polycarbonate plastics, a 
type of hard, clear plastic in some reusable water bottles and baby bottles. Epoxy resins, 
which line metal food and beverage cans to prevent corrosion, are also commonly made 
with BPA.2 While BPA is not a new compound—it was first synthesized in 18913—its 
production and uses in everyday consumer products has grown tremendously. In 1964, 
nearly 84,000 pounds of BPA were produced in the U.S. annually; by 2003 that figure 
was more than 2 billion pounds.4 In 2011, worldwide BPA production was estimated at 
more than 8 billion pounds per year,5 making it one of the highest volume chemicals in 
use.6   Other commonly used products containing BPA include thermal receipt paper, 
power plugs, car parts, dental sealants, flame-retardants, eyeglasses, toys, compact discs 
(CDs), kitchen appliances and medical equipment.7-9 
Public	  Health	  Significance	  
Over the past decade, BPA has been the source of public health concerns in light 
of its definition as an endocrine disrupting compound (EDC).10,11 Endocrine disruptors 
are defined by the World Health Organization as “an exogenous substance or mixture that 
alters function(s) of the endocrine system and consequently causes adverse health effects 
in an intact organism, or its progeny or (sub)populations.”10 EDCs may mimic or block 
the effects of natural hormone functions. Endocrine disruptors are of particular concern 
on a global level due to what is known about the widespread presence of manmade 
chemicals that affect human and wildlife development. Pesticides, plasticizers and flame-
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retardants are common products containing EDCs.12 Other endocrine disruptors include: 
polychlorinated biphenyls (PCBs), a group of persistent industrial chemicals banned for 
most uses since 1979; polybrominated diphenyl ethers (PBDEs) which are flame 
retardants used in furniture, electronics and other consumer products; phthalates used in 
plastic products; and dichlorodiphenyltrichloroethane (DDT), a pesticide that is banned in 
most countries.13 
Health effects that have been associated with endocrine disruption include 
reproductive dysfunctions, preterm birth and low birth weight, behavioral disorders, 
endocrine-related cancers (breast, endometrial, ovarian, prostate, testicular, and thyroid), 
obesity and Type II diabetes.13 Fetal and early life are particularly sensitive time periods 
in development and of higher concern with regard to EDCs. Epidemiological trends over 
recent decades indicate increases in endocrine-related disorders that are occurring too 
quickly to be explained by genetic changes alone.10 
  Data from animals and humans has linked BPA with a range of adverse health 
effects, including cardiovascular effects, sexual dysfunction, infertility, obesity, early 
puberty, prostate and mammary gland cancers, behavior changes and diabetes.7,8 BPA is 
often described as a weak estrogen, meaning it is not as potent as other compounds with 
similar properties such as estradiol and diethylstilbestrol (DES).14 In animal tests, BPA 
has been shown to be a “reproductive, developmental and system toxicant,” according to 
the Environmental Protection Agency (EPA).15 The estrogenic properties of BPA are of 
concern because EDCs can mimic naturally occurring hormones and result in biological 
changes.16 In the mid-1930s, BPA was used as an estrogen replacement prior to use of 
DES. DES is a carcinogen to daughters of women treated with the chemical while 
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pregnant.12 While causal links to human disease are difficult to establish in light of 
multiple simultaneous chemical exposures, uncertainty of low dose effects and other 
factors, BPA exposure has been associated with a variety of health conditions.  
The issue of low doses relevant to human exposure levels—and whether they pose 
health risks—is the subject of ongoing debate. Despite the large body of literature on 
BPA, uncertainties remain about the risks of human health effects of BPA at current 
exposure levels, particularly in sensitive populations such as infants and young children.9 
There are also weaknesses in the tools scientists have at their disposal to estimate low 
dose effects.23 Further, there is discord among stakeholders about risk management 
solutions from the individual consumer level to the national policy level.17  
BPA	  and	  Risk	  Communication	  
The WHO defines risk communication as “an interactive process of exchange of 
information and opinion on risk among risk assessors, risk managers, and other interested 
parties.”18 The definition used by the U.S. Food and Drug Administration (FDA) in a 
2011 guidance document reflects the broader reach to the general public: “Risk 
communication is the term of art used for situations when people need good information 
to make sound choices.”19 A dilemma for public health practitioners is how to 
communicate about BPA risks when the science is imperfect (as it will always be) and 
causal links to disease may be impossible to prove. This is important because risk 
communication is an essential component of effective risk management.20  
The media play an important role in conveying the messages from stakeholders as 
well as influencing the public and policymakers. The majority of Americans get health 
information from the media.21 The topics covered in the news convey to the public what 
is new and worthy of attention. At the same time, controversial stories may be of special 
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interest to reporters and their readers/viewers, but could lead to conflicts or ambiguity in 
the overall message.21 How issues are framed in the media may influence opinions on 
who is responsible for addressing the problem and the range of potential solutions.22  
In the case of BPA, there have been conflicting conclusions from key 
stakeholders, the news media and in the scientific literature itself about the risks posed by 
BPA. Given the important roles of key stakeholders and the news media in informing 
consumers about risks and setting a policy agenda, BPA presents a relevant and timely 
case study on the risk communication of a complex public health concern.  
Study	  Aims	  and	  Approach	  
 The success of risk management efforts depends in part on the ability of public 
health professionals to translate data and communicate about complex scientific issues. 
Although BPA is just one example of the many common chemical exposures people face, 
it is emblematic of environmental policy and risk assessment in the U.S., with its history 
of controversy, conflicting messages and complicated regulatory structure. There is very 
limited research on the communication of risks relating to food contaminants and EDCs 
in general. BPA and EDCs in general present emerging challenges to public health 
professionals in different capacities as researchers, advocates, and regulators. Thus, the 
intent of this research is to shed light on U.S. based risk communication and news media 
coverage of BPA—a major public health concern of national and worldwide importance 
and with implications for current and future generations. Regardless of any ultimate 
determination on BPA safety, this work provides insights and recommendations for 
public health practitioners faced with translating complex science and uncertain health 
risks.  
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A case study approach was chosen to examine the issue of BPA risk 
communication in the United States. The topic of BPA provides a rich context to explore 
risk communication on a politicized and scientifically challenging issue with implications 
for effective risk management and regulatory decision-making. Within a case study 
framework, this dissertation combines mixed methods including document review, 
quantitative news media content analysis and in-depth key stakeholder interviews. The 
three specific aims of the research are as follows: 
Aim 1/Manuscript 1: Using the risk assessment framework, evaluate BPA-related 
communication from key stakeholders, including main messages about risks, use of 
scientific evidence and policy goals. 
 
Aim 2/Manuscript 2: Analyze the volume and content of national news media coverage 
of BPA. 
 
Aim 3/Manuscript 3: Characterize key stakeholders’ perceptions of BPA risk 
communication challenges. 
Overview	  of	  Chapters	  
 This dissertation consists of seven chapters. Chapter 2 reviews the scientific 
literature on BPA and human health, as well as provides an overview of U.S. regulatory 
and policy action to date. Chapter 3 details the methodological approach to this research. 
Chapter 4 presents the first manuscript, entitled Stakeholder Communications on BPA: A 
Qualitative Analysis Using the Risk Assessment Framework. This manuscript 
characterizes risk messaging from key stakeholder groups’ websites using the risk 
assessment framework. Chapter 5 presents a quantitative news media content analysis, 
entitled U.S. News Media Framing of Bisphenol A (BPA) from 2006-2012. This study 
describes television and print news framing of BPA and health, including how risk and 
scientific evidence are presented, what products are mentioned, and the discussion of 
sensitive populations, health endpoints, policy solutions and replacements. Chapter 6 is 
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the third and final manuscript, “A Poster Child of Endocrine Disruption”: The 
Challenges of Risk Communication on BPA. This chapter presents findings from semi-
structured interviews with key stakeholders on challenges to effective risk 
communication about BPA and approaches for improving messaging on complex and 
uncertain public health issues. Chapter 7 discusses overall findings and implications of 
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Chapter	  2.	  Literature	  Review	  
	  
This chapter summarizes current evidence related to potential health impacts of 
BPA. First, sources and routes of exposure are outlined. Next, population exposures and 
research on health associations are reviewed. A brief overview of risk assessment and 
risk communication is also provided to provide context and grounding in those fields, as 
they were critical in the development, conduct and interpretation of this thesis. Finally, 
this section also provides an overview of U.S. and international policy actions and the 
key stakeholders involved in research, advocacy and communication to the public about 
BPA. 
Exposure	  Assessment	  
Ingestion is the main route of exposure to BPA, especially in children, who in 
addition to exposure from food and drink may experience hand-to-mouth and direct oral 
contact with BPA-containing items.7,9 Dermal absorption is also a route under evaluation, 
particularly in regard to use in thermal paper receipts (a type of paper used in cash 
registers that is coated with BPA). People may inhale BPA as well, especially in 
occupational settings, however current research suggests BPA inhalation is a small 
proportion of total exposure in the general population.7,23 Some dental fillings and 
sealants contain BPA, and exposure from this source appears to be variable and uncertain 
for relevant populations.24 Leaching from dental work may vary depending on the 
manufacturer, and more research is needed on this source of exposure.25 While these non-
food related sources of BPA are important for understanding cumulative exposure and 
environmental and wildlife impacts, they are believed to comprise a much smaller portion 
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of human exposure. In their review, Geens et al. reported that non-food exposures to BPA 
are typically at least one order of magnitude lower than food-related exposures.3  
It is well established that BPA is present in the U.S. food supply. While the EPA 
notes that food and drink containers comprise only five percent of BPA uses in the U.S., 
these sources nonetheless provide the largest portion of human exposure.15 Diet is the 
main route of exposure to people when BPA leaches from food containers into the food 
itself.8  
BPA has been measured in canned food and drinks around the world.3,7 Canned 
foods are believed to be the largest contributor to total exposure of the general public 
based on human intervention studies.3 During processing and storage of canned foods, 
BPA concentrations in the parts per billion (PPB) range can come in contact with the 
can’s contents.26 In a review of studies from the U.S., Canada, Japan, Korea, Belgium, 
Spain and Portugal, the majority of canned food and beverage samples contained BPA 
(59-100%).3 A 2011 study which tested concentrations in popular canned foods detected 
BPA in 71 of 78 canned samples, but not in frozen (non-canned) food samples. While 
BPA was found in the majority of samples, concentrations were wide-ranging both 
between products of the same type and between different batches of the same product (as 
much as a 100-fold difference was observed in peas).26 Variations in BPA levels by 
product type and even among the same product was confirmed in other studies as well.4 
Variations in different products are believed to be due primarily to differences in the 
compositions of the epoxy resins used by various manufacturers for various products.26 
Variations within the same foods are not well understood. High temperatures, and acidic 
or basic foods may also increase leaching of BPA from can linings or plastics.6 The range 
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of BPA levels identified in beverage cans is narrower than for canned food products, and 
the concentrations are generally lower.3   
Traces of BPA have been measured in foods that are not canned as well. Glass 
jars with metal lids may contain BPA, as do other foods packaged with epoxy resins or 
plastic parts (such as cheese, bread, cereals and fast foods).3 A 2010 study, which 
measured BPA in 63 out of 105 samples of fresh meats, plastic wrapped food, canned 
food and pet food, found that BPA level was associated with pH level of the food but not 
type of food or type of food packaging.7 Overall, the evidence suggests that non-canned 
foods make up a small percentage of exposure to BPA.27 While it is clear from existing 
evidence that the food supply is a major contributor to human BPA exposure, more 
representative sampling of foods is needed to determine types of food with higher BPA 
levels.  
Toxicology	  and	  Metabolism	  	  
BPA is commonly measured in urine to determine recent exposures. As BPA is 
considered non-persistent, with a half-life of a few hours, it is quickly excreted from the 
body. BPA levels in blood decrease quickly as it is almost completely excreted in the 
urine.28 As such, urine is the standard metric to evaluate both the total amount of BPA 
and its conjugates from all exposure sources.6,9 Importantly, while BPA is non-persistent 
and quickly excreted, its presence has been described as “pseudo-persistent” because 
exposure is continuous.29 
For oral exposures, BPA is quickly conjugated to a non-active version in the 
intestine and liver.3 The half-life has been reported as less than 6 hours,30 and even less 
than 2 hours.31 Only the unconjugated form, “free BPA” is associated with estrogenic 
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activity.3 Inhalation and dermal exposures are not subject to first-pass metabolism and are 
thus eliminated more slowly.3 
Biomonitoring	  
As BPA is present in the U.S. food supply, it is likewise found in the bodies of the 
vast majority of Americans. BPA has been detected in the populations of other developed 
countries, although there is little information available on BPA levels is less developed 
nations.25 While there is discord on the health significance of BPA exposure, the fact that 
BPA is measurable in blood, urine, semen and other biological samples is not disputed in 
the literature.6 Research has also highlighted the presence of BPA during pregnancy and 
early development. BPA can be found in breast milk, placental tissue, amniotic fluid and 
umbilical cord blood, indicating that the chemical can cross the placental barrier.25   
Biomonitoring data show nearly ubiquitous BPA exposure in Americans. National 
Health and Nutrition Examination Survey (NHANES) data from the Centers for Disease 
Control and Prevention (CDC) in their Fourth National Report on Human Exposure to 
Environmental Chemicals showed 94 percent of a nationally representative sample had 
detectable BPA in urine samples.9 Slightly higher concentrations for children and non-
Hispanic blacks were also observed in data, although in all years reported BPA was 
prevalent in all groups.9 People with lower household income were also found to have 
higher BPA concentrations.32   
 There is some preliminary evidence that there may be a relationship between 
length of residency for immigrants and BPA levels (suggesting that some ethnic diets 
with less packaged foods may be lower in BPA than the typical American diet). In a 
study of immigrant Mexican-American women in California, researchers found higher 
BPA levels in women who had lived in the U.S. their entire lives versus women who had 
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been in the U.S. one year or less. Overall, BPA levels in this group were lower than in 
women of the same age group in the NHANES nationally representative sample.33 
Internationally, the evidence also points to widespread exposures. A summary of small to 
medium scale urinary biomonitoring studies in North America, Europe and Asia shows 
fairly comparable concentrations between countries, and in nearly all the studies the vast 
majority of participants had detectable BPA in their urine.2  
Health	  Effects	  
As previously mentioned, there has been a significant amount of interest and 
research on BPA, particularly in the past decade. Despite this, there is still uncertainty 
about the potential human health effects of BPA, for a variety of reasons. Ongoing 
controversies in the field include the potential non-monotonic dose-response curve, low-
dose effects, and the importance of critical stages of development.34 There is also debate 
about the appropriateness of animal models and extrapolating effects to humans, critiques 
of various experimental approaches, the mechanisms of BPA action and its metabolism, 
levels of human exposure, effects on animals, carcinogenicity and concerns about 
insufficient replicability of some studies.34,35  
Simultaneous exposures to multiple other chemicals, as well as ethical 
considerations of conducting controlled human experiments also pose challenges in 
understanding the role of BPA in human health. According to the World Health 
Organization, there has been a global failure in addressing and preventing environmental 
causes of endocrine-related diseases and disorders. Of the more than 800 known EDCs, 
very few have been adequately tested.10 However, there are several examples of effective 
government actions to reduce harmful environmental exposures, including lead, PCBs 
and some persistent organic pollutants.10 The following section will briefly review 
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existing evidence on health impacts from animal and human studies on BPA, as well as 
sensitive populations and low dose effects. 
Animal	  Studies	  	  
A 2008 report from the U.S. National Toxicology Program (NTP) evaluated the 
weight of evidence on BPA and adverse effects in laboratory animals. The NTP is an 
interagency program housed at the U.S. National Institute for Environmental Health 
Sciences (NIEHS).  NTP concluded there is “clear evidence of adverse effects” (their 
highest point on a 7-point scale with the lowest point being “clear evidence of no adverse 
effects”) for developmental toxicity at high doses (at least 50 mg/kg/day).35 This 
determination was based on studies showing reduced survival in animal fetuses or 
newborns, reduced fetal/birth weight or early life growth, and delayed puberty. NTP 
reported “some evidence of adverse effects” (the second highest point on the scale) with 
regard to developmental effects based on potential lower fertility, changes to estrous 
cycling, and cellular effects on male rat testis.35 “Limited evidence of adverse effects” 
(the third highest point) was the determination on low-dose developmental toxicity, based 
on early puberty onset, neural and behavior changes, altered prostate and urinary tract 
development, and potentially pre-cancerous prostate and mammary lesions.35 These low-
dose studies are more comparable to human exposure levels. While NTP noted that these 
findings are inconclusive with regard to human effects because the impacts on animals 
occur at doses orders of magnitude larger than estimated human exposures, they 
expressed “some concern” for fetuses, infants and children.35 
In a review by Hengsler et al, the authors criticized existing evidence on BPA as 
flawed and insufficient in light of “large and well-designed” studies with negative 
outcomes (no significant effects).31 They recommended baseline requirements for study 
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design addressing sample size, endpoints, statistical procedures, routes of exposure and 
transparency.31 NTP reported that many of the animal studies they reviewed had flawed 
designs, technical shortcomings or failed to provide adequate details, all of which 
factored into their weight-of-evidence determination.35 Despite the concerns, the volume 
of evidence on adverse effects in animals from hundreds of studies in the 1990s and early 
2000s led the NIEHS to convene a targeted research program to increase knowledge on 
the human effects.8 
Human	  Studies	  
The human evidence on BPA is by all accounts somewhat limited. Some studies 
have found associations between health endpoints of interest and BPA levels. Using the 
2003-2004 NHANES data, Lang et al found higher urinary concentrations of BPA to be 
associated with diabetes, cardiovascular disease and liver abnormalities.36 In women, 
BPA levels in blood have been associated with obesity, endometrial hyperplasia, 
recurrent miscarriages, and polycystic ovarian syndrome.25 The NTP found three human 
studies that suggest hormonal effects of BPA exposure in adults.14 They include an 
occupational study of male epoxy resin sprayers,37 a study of women with ovarian 
dysfunctions and obesity,38 and an investigation of serum BPA levels and gender 
differences.39 
However, epidemiological studies of BPA and health effects are methodologically 
difficult and unlikely to present causal evidence. Hengstler et al.’s critique pointed out 
some limitations to cross-sectional epidemiologic studies in that they often use a single 
urinary BPA measurement to link to health outcomes.31 A urinary measurement only 
estimates exposure in recent days and sensitivity to BPA may be dependent on stage of 
development.2 Further, self-reported health outcomes with long latency periods make the 
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results (and any causal implications) difficult to interpret.31 Small sample sizes and cross-
sectional designs with potential confounding factors are also limiting factors.25 As Geens 
et al. note, BPA is just one of the EDCs that people are routinely exposed to, and an 
epidemiologic study cannot separate out these effects in the absence of a control 
population.2 
Sensitive	  Populations	  
Evidence on effects in fetuses, infants and children, while of great interest, is also 
insufficient.35 There is some evidence of a relationship between gestational BPA 
exposure and behavioral and emotional effects, especially among girls.40 Altered 
neurodevelopment, early puberty, and obesity are also of concern during fetal growth.41 
Endocrine disruptors are of the greatest concern at sensitive developmental periods, 
namely during prenatal development, infancy and early childhood. The “fetal basis of 
adult disease” and “developmental origins of health and disease” are terms coined by 
researchers to describe the differential impact of an EDC during development that may 
set the stage for disease later in life.42 
During development, it is feasible that low doses of EDCs could produce effects 
long after the actual exposure and not manifest until later in life. Even very slight 
exposure to chemicals with hormone-like activity—at levels much lower than would be 
harmful in an adult—can hinder normal development in prenatal through adolescent 
periods of endocrine system maturation.42 This concept was conveyed in NTP’s 
assessment that BPA exposures to fetuses, infants and children were of “some concern.”35 
Low-­‐dose	  effects	  and	  non-­‐monotonic	  dose-­‐response	  relationships	  
The effect of BPA at lower doses relevant to human exposure levels has also been 
debated in the literature. Like natural hormones, EDCs can work at extremely low doses 
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and stray from typical dose-response curves.42 Low doses may have more impact than 
higher doses for certain endpoints.42 As such, traditional models which first extrapolate 
high to low doses based on a No Observed Adverse Effects Level (NOAEL) or Lowest 
Observed Adverse Effects Level (LOAEL) and then apply safety factors may not be 
appropriate for chemicals like BPA.16  
While critics argue that exposures showing effects in animal studies are far higher 
than realistic human exposures, others maintain that adverse effects have been shown at 
levels close to human concentrations.25,43 A 2006 review by vom Saal reported more than 
100 studies with effects at low doses, and 40 studies with effects below the EPA and 
FDA’s safe dose of 50 mg/kg/day.44 While the evidence is still emerging on low dose 
effects, it is important to keep in mind complicating factors such as potential interactions 
with other environmental exposures and variability in the doses that may affect different 
endpoints.16   
 Another complication of toxicological risk assessments is the possibility of non-
monotonic dose-response relationships, in which the relationship is non-linear and the 
slope of the curve changes signs. In these cases, high dose effects cannot be used to 
predict low dose effects.16 In 2012, Vandenberg et al discussed the biological plausibility 
of non-monotonic relationships and determined that while they are controversial in the 
regulatory setting, they are common in the EDC literature for both manmade chemicals 
and natural hormones.16 They found several BPA studies with a non-monotonic effect, 
and while the health impact is unknown, the authors argue that low dose and non-
monotonic relationships should be considered in regulatory science for the benefit of 
public health. 
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Risk	  Assessment	  and	  Risk	  Communication	  Overview	  
Risk assessments are an important tool for government agencies, industry and 
academia seeking to understand public health and environmental hazards, and inform 
public policy decisions.20 Risk assessments are conducted to help understand and make 
decisions about hazards that may threaten the environment and public health. Following 
the four-step process of hazard identification, dose-response assessment, exposure 
assessment and risk characterization detailed in the foundational 1983 National 
Academies report Risk Assessment in the Federal Government: Managing the Process 
(also known as the Red Book), risk assessors take this scientific information into 
consideration along with political, social, economic and engineering factors in what is 
known as risk management.45 When new information about a hazard becomes available, 
risk management decisions can evolve and agencies may take steps to reduce or eliminate 
the production of the hazard, reduce exposures to the hazard, and/or change perceptions 
about the hazard in order to be protective of public health.31  
The risk communication literature is also a critical field of research underpinning 
this thesis. The National Research Council (NRC) describes risk communication as “an 
interactive process of exchange of information and opinion among individuals, groups 
and institutions. It often involves multiple messages about the nature of risk or expressing 
concerns, opinions or reactions to risk messages or to legal and institutional arrangements 
for risk management.”46 Risk communication is important because it is an integral and 
essential component of effective risk management.20 In other words, a key aspect of 
addressing risks in society involves responsible parties relaying information about the 
risk assessment findings and risk management solutions. Much inquiry has focused on 
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best practices for risk communication, but it is difficult to provide clear and concise 
recommendations applicable for all situations.46  
Another important factor to consider with regard to risk assessment and risk 
communication is risk perception—in other words, how experts and the public come to 
conclusions about risks and benefits. Sandman makes the distinction between hazard—an 
expert’s assessment of risk, and outrage—the public perception of risk.47 Some risks may 
be a high hazard with low outrage—such as traffic accidents. Other risks may be a low 
hazard but have a high degree of outrage and fear associated with them—for example, 
nuclear accidents.48 According to the risk perception literature, some characteristics 
contribute to elevated fears, including: man-made risks, involuntary exposures, new or 
unfamiliar risks, widespread media coverage, lack of trust in communicators, and 
potential effects on children.47-50	   
U.S.	  Risk	  Assessments,	  Regulation	  and	  Policy	  Actions	  
Agencies in the U.S. and around the world have evaluated the risks of BPA.  
In 1993, the EPA’s Integrated Risk Information System (IRIS) determined the LOAEL 
for BPA to be 50 mg/kg/day in animal studies. After dividing the LOAEL by an 
uncertainty factor of 1000 (10 for animal to human data, 10 for sensitive human 
populations and 10 for uncertainty regarding chronic to sub-chronic doses), the reference 
dose (RfD) for oral exposure was set at .05 mg/kg/day. In this case, the RfD—defined as 
an estimate of a dose believed to be unlikely to cause adverse human health effects51—is 
based on the critical effect of reduced mean body weight.52 This figure has been criticized 
given that this LOAEL— from a traditional toxicology study in 1982—has not been 
adjusted given the concern over low-dose EDC effects.43 The EPA’s Action Plan 
Summary on BPA states that the agency is considering several actions. Under its Toxic 
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Substances Control Act (TSCA) authority, EPA added BPA to their chemicals of concern 
list due to potential risks to the environment and aquatic life. Also under TSCA, EPA 
may develop more data on environmental impacts. With their Design for the 
Environment Program, EPA has assessed alternatives to BPA in thermal receipt paper 
and other uses. Notably, the agency is not planning any action on BPA in response to 
concerns about human health risks.15 
 The U.S. Food and Drug Administration (FDA) is responsible for regulating BPA 
as an indirect food additive or food contact substance. The FDA’s stance on the overall 
safety of BPA exposure is that current low-level human exposures are safe based on 
standard toxicity testing, but the agency (along with NIEHS and NTP) has some concerns 
about effects on fetuses, infants and young children and are continuing to support 
research to clarify uncertainties.1 
In 2008, FDA’s Draft Assessment of Bisphenol A For Use In Food Contact 
Applications used a NOAEL of 5 mg/kg/day for systemic toxicity, based on two 
multigenerational rodent studies.53 In their report, FDA estimated a margin of safety 
(MOS) of 2,000 for infants, and 27,000 for adults based on food-related exposures.53 
FDA determined this was an adequate difference between an established No Observed 
Adverse Effects Level (NOAEL) and human exposure levels—as a 1,000-fold difference 
for children and a 100-fold difference for adults are typically considered the lower limits 
of an adequate MOS. While acknowledging complete certainty of safety is impossible to 
prove, FDA defines safe in this context as “reasonable certainty in the minds of 
competent scientists that the substance is not harmful under the intended conditions of 
use.”53 In the years following release of this report, FDA became increasingly concerned 
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about BPA exposure in the food supply. In July 2012, FDA officially banned the use of 
BPA in baby bottles and children’s’ cups.54 By the time the agency took this action, many 
manufacturers had already ceased using BPA in these products and this move was seen as 
mostly a symbolic response because the American Chemistry Council requested this 
measure to boost consumer confidence.54 
Over the past decade, NIEHS has invested $30 million in BPA research55 to 
address gaps in knowledge that still existed despite the 800 published studies on BPA 
health effects prior to the research program’s establishment.8 The NTP has also been 
heavily involved in this research program. The CDC has been an important source of data 
on human exposures to BPA with their National Biomonitoring Program. All of these 
agencies, with the exception of EPA, are housed under the umbrella of the U.S. 
Department of Health and Human Services (HHS). 
BPA has been approved for its current uses in food packaging in the U.S. since 
the 1960s. Manufacturers may use approved food additives without providing details on 
the specific formulations used or their characteristics. FDA estimates hundreds of 
different types of BPA epoxy linings in production, and modifying the approval of any of 
these uses would involve a complex rulemaking process.1 Policy efforts thus far have 
focused on elimination of BPA from polycarbonate bottles and largely ignored uses in 
metal can linings, with the possible exception of infant formula cans. 
On the state and local level, proposals to limit BPA began as early as 2005. That 
year, Maryland, California and Minnesota proposed legislation to restrict BPA in toys 
and products for children less than three years, but none of the bills passed. Another 
attempt in California in 2008 to ban BPA in children’s food containers and formula cans 
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was also defeated. Besides California, six other states proposed action on BPA in 
children’s products between 2007-2008: Connecticut, Hawaii, Maryland, Massachusetts, 
Minnesota, and New York.43 While these initiatives were also not successful, Suffolk 
County, New York became the first jurisdiction to ban BPA use in baby bottles and 
“sippy” cups in 2009.56 In 2012, they followed up with a ban of BPA in thermal receipt 
paper.57 
In 2009, Chicago and Minnesota also both passed laws to remove BPA from baby 
bottles and children’s cups (cans of formula and baby food were not affected).58,59 By this 
time, these actions were seen as mostly symbolic because BPA had been voluntarily 
removed from baby bottles and sippy cups by many manufacturers and retailers including 
Wal-mart, Toys R Us and CVS.59 That same year, Connecticut went even farther, 
becoming the first state to ban all reusable food and drink containers with BPA (not just 
children’s products), as well as in infant food and drinks in BPA-laden containers. In 
2011, Connecticut also banned BPA in thermal receipt paper, which will go into effect in 
2013, or 2015 if a safe alternative is not available prior to the former date.60 
Besides Connecticut and Minnesota, other states that eventually implemented 
some restrictions on BPA include California, Delaware, Maine, Maryland, 
Massachusetts, New York, Vermont, Washington, Wisconsin, and the District of 
Columbia. Of these policies, those in Washington State, the District of Columbia, 
Vermont and Connecticut extend to cover non-children’s items as well, but none address 
metal food containers (not counting formula cans).60 
The U.S. Congress responded to concerns about childhood BPA exposure with 
the BPA-Free Kids Act of 2008. 61 The bill was introduced in the Senate, but was quickly 
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referred to committee and died. The proposed legislation aimed to limit exposure to 
children by banning the use of BPA in food and beverage containers intended for children 
aged three and younger, with the exception of metal cans. It was reintroduced in 2009 in 
both the House and Senate and again died in committee.62 
Some state and city legislative bodies did not want to wait for federal action, and 
took matters into their own hands to limit exposures. A legislative approach was 
successful in some areas, but it was not the only strategy. Richard Blumenthal, the 
attorney general of Connecticut in 2008 wrote letters urging baby bottle manufacturers 
and formula companies to stop using BPA in their products. The attorneys general in 
New Jersey and Delaware also joined in the letter. Blumenthal also urged the FDA to 
restrict BPA in baby products. The letter from the attorneys general may have been 
influential, as it came before many companies and retailers decided to stop using BPA.63 
International	  Risk	  Assessments	  and	  Policies	  
Countries around the world are continuing to investigate the health impacts of 
BPA, while cautiously assuring the population that current exposure levels are not 
expected to pose health risks, particularly to adults. In some cases, governments have 
been inconsistent. In 2008, Health Canada’s risk assessment concluded BPA in food 
packaging is safe (and set a provisional tolerable daily intake of .025 mg/kg/day), but in 
light of emerging evidence on sensitive points of development and the limitations of 
available studies, supported an approach to limit BPA in infant and children’s products to 
“as low as reasonably achievable.”64 In 2010, Canada became the first country to act on 
BPA, by banning the compound from baby bottles and declaring it toxic.65 However, in 
2012, Health Canada’s updated assessment concluded that current exposures to BPA are 
not expected to pose a health risk, including to infants and young children.65,66 
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In the European Union, the European Food Safety Authority (EFSA) completed 
its risk assessment of BPA in 2006, setting a NOAEL of 5 mg/kg/day and an uncertainty 
factor of 100. Thus, the Tolerable Daily Intake (TDI) was set at .05 mg/kg/day.67 This 
level was reconsidered in light of emerging evidence in 2008 and 2010, but the TDI was 
not changed. In 2011, the European Union banned BPA use in baby bottles, and like all 
materials that come in contact with plastic food materials in the EU, BPA is subject to 
limits on the migration of the compound into food and drink.2 In 2012, EFSA announced 
plans to reevaluate the human health risks of BPA, which will take into account potential 
low-dose effects and total exposures (including non-dietary sources) and is expected to be 
completed by the end of 2014.67    
France banned use in baby bottles in 2010, the year before the EU at large and 
went further by banning the compound in food containers of any type in 2014, making it 
the first country to approve an outright ban in food packages.68 In 2010, Danish officials 
instituted a national ban on BPA-containing cups, bottles and food packaging for children 
under three unless future studies show low doses do not impact development, the nervous 
system or behavior of rats.31 China and Malaysia also banned BPA in infant bottles in 
2011.69 Australia and New Zealand found the scientific evidence does not point to human 
health risk, but is supporting a voluntary phaseout.70 Japan’s risk assessment from 2007 
found that human and environmental risks are below levels of concern,31 but as early as 
1998, manufacturers in Japan began voluntarily reducing BPA use.71 
Stakeholder	  Overview	  
The public interpret risks with the help of  “amplification stations” including the 
media, scientists, government agencies and advocacy groups. These groups may increase 
or decrease the amount of information about a topic and influence whether concern about 
	   23	  
an issue is amplified or attenuated.72 Beyond communication directly from government 
officials charged with conducting research and ensuring the safety of BPA, other 
stakeholders including public health and environmental advocacy groups and industry 
trade associations have weighed in on the debate. 
Stakeholders can also play a role in informing policy and regulatory decisions. 
According to the National Academies’ 2009 report Science and Decisions: Advancing 
Risk Assessment, stakeholder involvement is important throughout the process of 
assessing and managing risks.20 To improve the outcome and utility of risk assessments 
and ensuing regulatory and policy decisions, stakeholders should be involved in the 
process and play a role in identifying important questions and potential solutions. 
Stakeholder groups have come to very different conclusions about safety of BPA 
exposure.73 This section introduces three main categories of stakeholders that have 
communicated to the public about BPA (government, health and environmental groups, 
and industry groups). Actions of retailers and consumers are also briefly outlined, 
although these groups are not key groups of interest in this research.  
Federal	  Government	  Agencies	  
 As previously discussed, the EPA and several branches of HHS (FDA, NIEHS, 
NTP, and CDC) have been involved in research, risk assessment and regulation of BPA. 
These agencies represent the official voice of the government, and as such, are frequently 
the go-to source for safety information. The various agencies have communicated their 
findings and positions on BPA to the public regularly through media interviews, publicly 
available reports, published research and consumer updates on their website. They also 
have solicited comments from stakeholders and the public through the Federal Register, 
provided research funding and convened meetings with experts.1,8,15   
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Environment,	  Public	  Health	  and	  Consumer	  Groups	  	  
Several health and environmental-focused non-governmental organizations 
(NGOs) have been vocal in the BPA debate. Consumers Union, the nonprofit publisher of 
Consumer Reports, has conducted their own tests of BPA-containing products, advised 
the public on ways to lower their exposure and called on the FDA to ban its use in food 
and beverage containers and children’s products.74 Environmental Working Group, 
Environmental Defense Fund, and Breast Cancer Fund, national research and advocacy 
organizations, have urged stricter limitations on BPA, supported state policies and 
provided information to the public.75-77 Likewise, the Natural Resources Defense 
Council’s “Fix the FDA” campaign speaks out about BPA and other contaminants in 
food, beverages and household products.78 The American Public Health Association has 
supported a cautionary approach to reducing exposures to endocrine disruptors like 
BPA.70 
 Some professional medical associations have also made public statements on 
BPA. In 2011, the American Medical Association (AMA) spoke out in favor of banning 
BPA in baby products and recommended the labeling of BPA containing products. They 
also supported the development of alternatives to BPA and a “more robust, science-
based, and transparent federal regulatory framework for oversight of bisphenol A.”79 The 
American Academy of Pediatrics favors reducing exposures, and the American Nurses 
Association and the Endocrine Society have also advocated for tighter BPA restrictions 
and criticized the FDA’s stance as flawed and weak.80-82  
Industry	  Groups	  and	  Manufacturers	  
Companies including Bayer, Dow Chemical, Sunoco and General Electric Plastics 
make a reported $1 million per day in profits from BPA production.43 The American 
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Chemistry Council (ACC), a trade group that represents the chemical industry, including 
major BPA producers, has been outspoken in criticism of scientific studies showing 
health effects. The ACC has campaigned against BPA legislation and criticized EPA’s 
IRIS process.43,83 The ACC also publishes websites that promote the safety of BPA, 
including bisphenol-a.org and factsaboutbpa.org.84,85 They maintain that legislation 
banning BPA use is reactionary and unnecessarily alarms the public.63 The Grocery 
Manufacturers Association, the American Beverage Association, and the North American 
Alliance for Metal Packaging, which each represent companies using BPA, are also 
industry interest groups who have opposed BPA restrictions.86-88 
 At times, producers have broke with the stances of trade groups. Sunoco 
announced in 2008 they would no longer sell BPA to its customers without confirmation 
that it would not be used in food and beverage containers aimed at children younger than 
three years.89 Other manufacturers also acknowledged public concern, and discontinued 
BPA use. Nalgene, the water bottle company, started phasing out production of their 
popular line of bottles with BPA in 2008. Playtex, Tupperware, Gerber, Evenflow, Avent 
America, Dr. Brown’s and Disney First Years also stopped using BPA.43,63 
Retailers	  	  
Even in the absence of scientific consensus, the public concern about BPA in 
children’s products was enough to convince major retailers to pull BPA-containing 
products from the shelves. Wal-mart and Toys R Us were among the major retailers who 
decided not to sell polycarbonate bottles and other BPA-containing plastic products.43   
Nationally, Whole Foods has perhaps done the most to cut down on BPA use in its 
merchandise. First, in 2006, they stopped selling baby bottles and sippy cups with BPA 
(the first national retailer to do so, according to the grocer’s website).90  They also do not 
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use receipt paper with BPA, and have been working with suppliers to find alternatives to 
BPA use in can liners and other types of packaging. For store brands, they are no longer 
accepting new canned items with BPA and encouraging transitions to “safe” 
alternatives.90  
Consumers	  	  
Consumers have had an important voice in the BPA case. There have been several 
reports of consumers filing lawsuits against companies using BPA in their products.43 
Concern from consumers, particularly mothers of young children, was widely reported 
and perhaps played a role in the decision of retailers and manufacturers to discontinue 
BPA use as a public relations advantage. Blogs like MomsRising,91 Mommyish92 and 
groups such as Mom to Mom of Maine93 and the Moms Clean Air Force94 have spoken 
out against BPA. However, there has been some amount of backlash to these concerns 
from mothers. As Sarah Vogel describes in her book Is It Safe? BPA and the Struggle to 
Define the Safety of Chemicals, worried mothers have been portrayed as “hysterical, 
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Chapter	  3.	  Methods	  
	  
This research used a case study approach96 with both qualitative and quantitative 
aspects to address three research aims on risk communication about BPA in the United 
States. This chapter details the research questions of interest, methodological approaches 




The purpose of this study was to better understand how key stakeholders in the 
United States—including government agencies, industry trade groups, health and 
environment-focused non-governmental organizations and researchers have 
communicated to the public about BPA. Additionally, we examined the role of the news 
media in framing potential risks of BPA. The specific research aims and questions were 
as follows: 
Aim 1: Evaluate stakeholders’ messaging on BPA in public documents using the 
risk assessment framework.  
 
 RQ1: What are the key stakeholders’ main messages to the public about the safety of 
BPA? 
RQ2: How do government agencies, industry groups, and health and environment 
focused non-governmental organizations compare in their risk communication messages? 
 
Aim 2: Describe the content of national news media coverage of BPA over a 7-year 
time span.  
RQ3: How has the news media framed BPA risks?  
RQ4: What sources, exposure routes, sensitive populations, health endpoints and 
solutions are discussed in the news media coverage? 
 
Aim 3: Characterize key stakeholders’ perceptions of BPA risk communication 
challenges.  
RQ5: What are the challenges inherent in risk communication on BPA?    
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RQ6: How do stakeholders define effective risk communication and what 
recommendations do they offer for improved public health messaging? 
 
Case	  Study	  Approach	  
 
A case study approach using mixed methods was chosen because it allowed for 
rich, in-depth exploration of the issue of BPA risk communication in the United States. 
Case study research refers to studying a topic within the context of a specific and defined 
“bounded system.”97 This type of research focuses on understanding why and how a 
particular phenomenon occurs, while also considering the context in which the 
phenomenon is observed.96 While some scholars characterize case studies as the topic of 
study and not a research method, others argue it is a methodological approach in which a 
case or cases are examined “over time through detailed, in-depth data collection 
involving multiple sources of information.”97 The data sources used in a case study are 
often qualitative, however quantitative components can also be useful and appropriate. In 
fact, using multiple methods, including both quantitative and qualitative components, 
adds value and context to case study research projects.98 The use of multiple data sources 
and qualitative techniques allows for triangulation and contextual factors to shape 
understanding of the case.99 Given the research questions of interest, a case study 
framework was used to analyze BPA risk communication. 
Defining the boundaries of a case study and identifying the specific case(s) of 
interest is very important in case study research.97 The type of case study used is best 
described as an instrumental case study—“aimed at providing insight into an issue or 
problem or to refine a theory.”100,101 This research was focused on two specific aspects of 
the case.96,97 The first aspect is the role of stakeholders in communicating to the public 
about potential risks from BPA. Stakeholders were defined as national, U.S. based groups 
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who have authority over the risk assessment and risk management of BPA, or will be 
affected by the risk itself or efforts to manage the risk. We identified three main 
“domains”, or types of stakeholder organizations who communicated to the public about 
BPA: 1) government agencies, 2) industry associations, and 3) health and environment-
focused non-governmental organizations (NGOs). In the semi-structured interviews 
presented in Manuscript 3, researchers and news media representatives were also 
included due to their roles in communicating about BPA and in-depth knowledge about 
BPA. The second aspect of the analysis includes the news media framing of BPA risks. 
The news media were identified as an important social institution due to their role in 
delivering information, framing issues, and influencing public perception.102,103 Further, 
the news media play a key role in setting policy agendas and influencing which issues are 
viewed as important and worthy of action within the public sphere.103 Thus, the three 
manuscripts analyze these two aspects of the case—stakeholder and news media roles in 
communicating BPA risks. Manuscript 1 focuses on stakeholder risk communication 
from organizations’ websites, Manuscripts 2 assesses news media content, and 
Manuscript 3 includes analysis of stakeholder perceptions on BPA risk communication. 
Chapter 7 integrates the findings of the research. 
Theory	  and	  Conceptual	  Frameworks	  
 
Theories and conceptual frameworks relevant to the scientific basis of the 
research should inform the design of mixed methods research.104 Given the focus on a 
common, well-publicized chemical regulated by the federal government, the risk 
assessment and risk communication literatures were very influential in the development 
of this research and provided conceptual grounding (See Chapter 2). Other concepts that 
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were influential in the development of this research included Kingdon’s windows of 
opportunity theory and Downs’ description of the issue attention cycle. Kingdon 
describes how three “streams”—a problem stream, a politics stream and a policy stream, 
which come together to create “windows of opportunity” for advocates to push for their 
preferred solutions.105 In the issue attention cycle described by Downs, attention peaks 
for a relatively short period, after which the costs of solving the problem are realized and 
interest fades—often before the problem that originally attracted media attention has been 
resolved.106 In light of these concepts, this research sought to explore how stakeholders 
and the media harnessed attention on this issue and communicated about BPA risks. This 
has relevance and implications for risk management of environmental chemicals and the 
specific solutions that were implemented with regard to BPA—including voluntary 
industry actions, regulatory actions, and legislative actions.  
Ethical	  Review	  	  	  	  
 
The Johns Hopkins Bloomberg School of Public Health Institutional Review 
Board (IRB) reviewed the dissertation research in October 2013 and determined that the 
research was not human subjects research and thus did not require IRB oversight 
(Appendix A). This determination was made because research involves publicly available 
data from organizations’ websites, news media content, and interviews with key 
informants in the context of their professional capacities (rather than about the 
participants as individuals). While the research was declared exempt from review, several 
efforts were made to ensure the privacy and protection of the research participants, as 
described below in the description of Aim 3 procedures.  
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Data	  Collection	  and	  Analysis	  
This section describes how data were collected and analyzed in the three research 
studies comprising this dissertation. Within the case study, Aim 1 involved document 
review of stakeholder website content; Aim 2 was a quantitative news media content 
analysis; and Aim 3 consisted of semi-structured interviews with key stakeholders. Aims 
1 and 3 utilized a qualitative approach. Qualitative methods are often used to produce in-
depth knowledge and explore a topic using open-ended research questions and textual 
data.107 Qualitative methods are warranted when research questions are not conducive to 
quantitative methods and statistical analysis. A qualitative approach allows for a 
systematic yet flexible design that is able to incorporate new and emerging information as 
appropriate.107 In order to conduct a news media content analysis that helps triangulate an 
overall case study, the research questions in Aim 2 were achieved using a quantitative 
approach. Quantitative content analysis as a research method is defined as “the 
systematic assignment of communication content to categories according to rules, and the 
analysis of relationships involving those categories using statistical methods.”108 The 
advantage of such an approach with the news media content analysis is the methodology 
emphasizes reliability, objectivity and replicability.108  
Aim	  1:	  Document	  Review	  
 
Sampling and Data Collection  
This study used the NRC’s risk assessment framework to qualitatively examine how key 
stakeholders communicated about BPA through publicly available documents on their 
websites. Thus, key stakeholders were defined as national, U.S. based groups who have 
authority over the risk assessment and risk management of BPA, or will be affected by 
the risk itself or efforts to manage the risk. The three included “domains”, or types of 
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stakeholder organizations were: 1) government agencies, 2) industry associations, and 3) 
health or environment-focused NGOs. Thirteen organizations and agencies from the three 
domains were purposefully selected for analysis due to their roles in research, 
communications, and/or advocacy regarding BPA. Organizations were identified and 
selected from background research, news media content and/or references from in-depth 
stakeholder interviews.  
Four U.S. federal government agencies with regulatory authority over BPA and/or 
involved in funding or conducting research related to BPA were included in the analysis: 
Centers for Disease Control and Prevention (CDC), Environmental Protection Agency 
(EPA), Food and Drug Administration (FDA), and National Institute of Environmental 
Health Sciences (NIEHS). Five national industry trade associations representing the 
major food-related producers and users of BPA in plastic products and metal food cans 
were included: American Beverage Association (ABA), American Chemistry Council 
(ACC), Grocery Manufacturers Association (GMA), International Bottled Water 
Association (IBWA) and North American Metal Packaging Alliance (NAMPA). In the 
case of the ACC, both the organization’s primary website and their BPA-specific website 
(factsaboutbpa.org) were included. Four NGOs concerned with public health, the 
environment and consumer advocacy were also selected for analysis: Breast Cancer Fund 
(BCF), Consumers Union (CU), Environmental Working Group (EWG) and the Natural 
Resources Defense Council (NRDC). Several additional organizations besides these 13 
were considered for analysis, but excluded due to lack of website documents focused on 
BPA. 
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Documents were obtained directly from the 13 organizations’ websites in June 
2014 using the website’s search function (All data, such as webpages and press releases, 
are referred to here as “documents”). Search terms were pilot tested and refined in order 
determine the most inclusive set of search terms for obtaining relevant documents, while 
omitting documents without a primary focus on BPA. Initial searches intended to 
maximize inclusiveness (such as searching simply “BPA” or “Bisphenol A”) resulted in a 
significant number of hits, but captured many documents that were not related to BPA 
risk communication. In order to increase precision, and reduce the number of “false 
positives,”109 the final search strategy entailed searching each stakeholder website using 
the following terms: BPA or Bisphenol A in the document title and at least one of the 
following words: risk, health or safe. Including only documents with BPA or Bisphenol 
A in the title ensured that BPA was the main subject of the document. Refining the search 
by “risk or health or safe” was broad enough to capture stakeholders’ risk 
communications on BPA while specific enough to omit documents that were not focused 
on potential health risks or safety of BPA. Using these search terms, a total of 308 
documents were identified from the 13 organizations. Due to the intended focus on risk 
messages geared to consumers and the scope of the study, the following documents were 
excluded: reports, official testimony and comment letters, meeting presentations, and 
outlines of specific research projects. Blog posts were excluded due to feasibility and the 
possibility that blog posts did not reflect the official position of the organization. 
Duplicates, documents less than 150 words and links or reprints from other parties were 
also excluded. After applying exclusions, 146 documents (47 percent) remained for 
analysis (Figure 1).  
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Figure 1: Schematic of Document Review Search Criteria 
 
All relevant documents posted during data collection were eligible for inclusion 
and not restricted by date of publication. Details on search results and proportion of 
documents retained is available in Appendix B. Documents remaining in the sample 
consisted of BPA-dedicated web pages, report briefs, fact sheets and press releases. For 
government documents, research project summaries and documents without a primary 
focus on BPA comprised the majority of exclusions. Industry documents were 
predominantly web pages focused on BPA and press releases, and as such this category 
had the lowest exclusion rate of the three domains. The majority of the NGO exclusions 
were blog posts. 
Analysis 
A coding extraction instrument was developed to pull relevant information from 
website documents (Appendix C). The instrument development was guided by a literature 
review (Chapter 2) and structured around the stages of risk assessment and risk 
management.20,45 First, basic descriptive information was collected from each document, 
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including the title, organization, domain, date of publication and/or date of last update, 
document type and document purpose. The first substantive section of the instrument 
coded information on hazard identification. Specifically, information on the language 
used to describe BPA was collected, for example: chemical, toxic, estrogen, or hormone. 
Next, BPA-containing products or sources were coded (i.e., in food and drink containers, 
receipt paper, consumer goods and the environment). The second section coded 
discussion of dose-response assessment—in other words, the quantitative risk estimates 
or points of departure used to quantify risk (i.e. a reference dose of 5 micrograms per 
kilogram body weight per day). The third section covered exposure assessment, or how 
the documents described people’s exposure to BPA. Information was extracted from the 
documents on populations exposed, sensitive populations, and route(s) of exposure. The 
fourth section coded for risk characterization messages, comprising the documents’ main 
messages on BPA safety or risk. Finally, the fifth section of the instrument extracted any 
risk management discussion in the documents, for example the type of solutions 
described and discussion of potential BPA replacements. For each substantive item in the 
instrument, multiple-choice responses as well as text extraction were collected. 
Extraction of relevant portions of text was done to aid in analysis and allowed for 
contextualization and use of quotes.  
Data were collected using the Qualtrics online survey tool.110 Documents were 
coded and analyzed by a single author (PT). After coding the 146 documents, the 
database was examined and checked for errors and missing data. Using Qualtrics 
reporting features, several reports were run to sort data and run descriptive statistics (for 
example, the number of NGOs that described children as a sensitive population in their 
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documents). The unit of analysis used was the individual stakeholder organization. This 
level of analysis was chosen because the intent was to understand the overall messaging 
coming from each organization through their website, as opposed to the content of an 
individual document, i.e. a single web page or press release. To facilitate comparisons 
within and between domains, data were analyzed both at the organization level, and at the 
domain level (government, industry and NGO). Thus, a unique report for each 
organization, summarizing all document data was created. Reports were also created for 
each of the three domains (government, industry and NGO), which summarized all data 
and organized it by coding instrument item. Using the reports, Microsoft Excel 
spreadsheets were created for each domain to further summarize for comparisons. The 
spreadsheets and reports were analyzed for each step of the risk assessment and risk 
management process. 
Aim	  2:	  News	  Media	  Content	  Analysis	  
	  
Sampling and Data Collection  
Aim 2 consisted of a quantitative news media content analysis to understand how 
BPA was framed in print and television news coverage. News media content analysis is a 
method for systematically examining and categorizing content of news coverage. The 
effect of news media content on readers is dependent on a variety of factors and 
conditions, but conducting a content analysis is an important tool for understanding the 
nature of those effects.108 This approach has been described as “a formal system for doing 
something we all do informally rather frequently—draw conclusions from observations 
of content.”111	  The sample included twenty-two U.S. newspaper, news magazine and 
television news sources. The time frame of 2006 to 2012 was chosen to correspond with a 
period of increasing attention on BPA in the form of scientific research, government 
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reports, and public policy. Preliminary database searches confirmed that this 7-year 
period was inclusive of the majority of news coverage on BPA; coverage prior to 2006 
was negligible. Searches were conducted in mid-2013, so an end date of 2012 was chosen 
to include the last full year of news media coverage. 
In order to analyze the news coverage reaching the most Americans, the top three 
U.S. daily newspapers by circulation were selected, as well as three top circulation papers 
from each of the four Census regions based on circulation rates from the Alliance for 
Audited Media for 2006, 2009 and 2012 (corresponding to the beginning, middle and end 
of the sampling period).112 All included newspapers were among the top 25 for national 
circulation rates at least two of those three years. The top three national newspapers in the 
sample were The New York Times, USA Today and The Wall Street Journal. The 12 
regional papers were The Boston Globe, The Philadelphia Inquirer, The Washington 
Post, Chicago Tribune, Minneapolis Star Tribune, Milwaukee Journal Sentinel, Houston 
Chronicle, Atlanta Journal Constitution, Tampa Bay Times, Los Angeles Times, The 
Oregonian and The Denver Post. Time and Newsweek, the top two circulation news 
magazines, were also included in the sample.113 Television news coverage was based on 
viewership rates and included three major networks (ABC, CBS, and NBC) as well as 
cable news channels CNN and Fox News.114 
Lexis Nexis Academic and ProQuest Central were used to collect newspaper and 
news magazine articles and television transcripts in September and October 2013 using a 
single search term, “Bisphenol A.” This search term was chosen in order to be inclusive 
of all news content mentioning the chemical. This was feasible because Bisphenol A is a 
fairly specific topic as opposed to study topics with more common language such as trans 
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fat, childhood obesity or food safety,115-117 which required more complex search strings. 
The database searches identified 926 news stories. A total of 448 articles, or 48 percent of 
articles were included. News stories were included in the final dataset if they had a 
substantial focus on BPA. Substantial focus was defined as at least 100 words of text 
specifically related to BPA (assessed using Microsoft Word’s word count feature). This 
allowed for capturing content on BPA within larger news stories on a related topic (for 
example, chemicals in food in general). In those cases, word counts reflect only the 
portion of the news story on BPA. The following types of content were excluded: letters 
to the editor, corrections, duplicates and news stories less than 100 words. A 50 percent 
random sample of included articles (n=224) was chosen for content analysis due to 
feasibility, and achieved using a random number generator in Microsoft Excel. While 22 
sources were sampled, a total of 20 sources are represented in the analysis. One television 
source, Fox News, had no identified television news stories on BPA during the time 
period of interest. The Tampa Bay Times had one article that was eligible for analysis, 
however it was not included in the 50 percent random sample chosen for content analysis. 
Appendix D provides details on the number of news stories sampled from each source.  
Analysis 
A 38-item instrument was developed to analyze news content (Appendix E). The 
coding instrument was pilot-tested by two authors (P.Truant and E. Donaldson) using 
articles from news sources outside the sample. Items were revised for clarity, and a 
codebook was developed to facilitate reliable coding. The final coding instrument was 
entered into a Qualtrics online survey tool, which was used to code news stories. Kappa 
statistics for inter-rater reliability were calculated using Stata 13.1 statistical software.118 
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Sufficient inter-rater reliability was achieved by double coding a total of 40% of the 
sample (89 articles). 
The coding instrument was organized into four modules. Module 1 covered the 
types of BPA-containing products mentioned in news coverage. Five items assessed 
mentions of food-related products as sources of BPA: any food or drink containers; 
plastic food and drink containers; baby bottles or children’s cups; infant formula or baby 
food containers; and canned food or beverages. Three items assessed mentions of other 
BPA-containing items: any other non-food related products; paper register receipts; and 
dental fillings or sealants.  
Module 2 examined risk framing and health endpoints mentioned, such as 
whether BPA was mentioned as an endocrine disruptor or having hormonal effects. 
Mentions of sensitive populations were also assessed (for example, pregnant women or 
developing fetuses; and infants or young children). Four items further assessed the 
context of the risk discussion: mentions of widespread exposures to BPA; mentions of 
potential adverse effects at low doses of BPA; mentions that BPA does not pose health 
risks or is safe; and mentions that a U.S. government agency has found BPA safe. Eight 
health endpoints were chosen from a review of the scientific literature (See Chapter 2) 
and refined during pilot testing of the coding instrument. Mentions of the following 
health endpoints linked to BPA exposure were quantified: cancer; brain, development or 
neurological effects; immune system or endocrine effects; reproductive or sexual effects; 
diabetes; obesity or weight; behavior; or heart disease.  
Module 3 assessed mentions of solutions discussed to address BPA risks. Five 
items covered the government venues mentioned: any government policy action; local 
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policy; state policy; U.S. federal policy; and foreign policy. Two items captured the type 
of action mentioned: banning BPA; and labeling products with BPA. Mention of a policy 
did not necessarily mean that legislation was introduced or enacted. Rather, mentions of 
policy were interpreted broadly and included policies under consideration or the subject 
of advocacy. Three items focused on voluntary industry actions: mention of any 
voluntary industry action to limit BPA; target population for voluntary action; and type of 
products voluntary action would affect. The final item in this module assessed whether 
news stories mention ways consumers could avoid BPA. The fourth and final module 
captured how BPA replacements and their potential risks were discussed. The three items 
include: mentions of a specific compound which could replace BPA; mentions of 
difficulty in finding replacements; and mentions of replacements in cans. 
Using the news story as the unit of analysis, descriptive statistics on the volume 
and content of news coverage were calculated and reported. Logistic regressions to test 
for shifts in coverage over the study time period, controlling for word count and adjusting 
standard errors for lack of independence among news outlets. Two time periods were 
compared: 2006 to 2008 and 2009 to 2012. The study period was divided into earlier and 
later years to tests for differences in news coverage by time. Differences in print versus 
television coverage, and in “hard” news versus op-eds or editorials were also examined, 
controlling for word count and adjusting for non-independence of news sources.  
Aim	  3:	  Stakeholder	  Interviews	  
 
Sampling and Data Collection 
 Semi-structured key informant interviews were conducted to understand key 
stakeholder perspectives on the goals and challenges of effective risk communication on 
BPA. Interviews are often one of the most important sources of information in case 
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studies.96 Typically, qualitative interviewing is more of a “guided conversation” than a 
rigid set of questioning.96 A semi-structured approach was used to facilitate the collection 
of rich context and detailed perspectives from respondents about BPA risk 
communication.119	  In semi-structured interviews, participants are asked a set of similar 
questions using an interview guide.120 This method was chosen because of its flexibility 
while also retaining the ability to make comparisons across stakeholder organizations. In 
semi-structured interviews, the interviewer can modify question order and probes based 
on the respondent’s answers, and the respondents have some control over the topics and 
focus of the interview.  Yet, because respondents are generally asked the same questions, 
comparisons across interviews are possible.120	  
The selection strategy for the interviews included both stratified purposeful 
sampling and snowball sampling. These selection methods are considered useful in cases 
of in-depth examinations in which representativeness and generalizability are not 
predominant concerns.121 The sample was stratified in order to include the relevant 
groups who have communicated to the public about BPA. This approach facilitates 
comparisons between groups and includes varied perspectives.97 The stratifications 
included:  1) government agency representatives, 2) researchers/academics 3) industry 
groups and consultants, 4) health or environment-focused non-governmental 
organizations, and 5) news media representatives/journalists. Purposeful selection allows 
for individuals to be selected deliberately due to their unique knowledge or perspective 
on the subject.107 Potential participants were identified during background review of the 
scientific literature and news media reports. Snowball sampling was used to identify 
additional experts from the initial set of contacts.97 This allowed for maximizing the 
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diversity of perspectives and including additional relevant organizations and individuals 
involved in risk communication on BPA. 
Contacts with potential respondents were first made by email. The email 
described the purpose of the study and the anticipated interview length (Appendix F). 
Follow-up emails and/or phone calls were used to contact people who did not respond to 
the first email within two weeks. In order to encourage participation and minimize any 
risk to participants, interviewees were advised that their names or organizations would 
not be identified in the study results. Interviewees were read an oral informed consent 
document (Appendix G) and given the opportunity to ask questions prior to the start of 
the interview. Interviews were conducted until reasonable expectations of saturation and 
data sufficiency were achieved.97 Approximately 30 interviews were planned, and a total 
of 39 interviews with 36 organizations were conducted in order to include additional 
respondents referred during snowball sampling and ensure data sufficiency within each 
stratification. Saturation refers to the concept of collecting data until new information 
does not provide new insights or perspectives on the research questions. Data sufficiency 
means having a sample large enough to reflect the variety of perspectives.97    
The interviews covered several topic areas, including 1) background information 
on the individual’s or organization’s efforts related to BPA; 2) BPA communication 
goals, strategies and main messages 3) the state of the scientific evidence and the use of 
scientific information in communications; and 4) the challenges of BPA risk 
communication, evaluation of messaging about BPA and advice for effective risk 
communication. An interview guide was used in each interview to facilitate comparisons. 
Probes were tailored by the researcher based on interviewee’s responses and the 
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interviewees could introduce topics not directly highlighted in the questioning. This 
approach allowed for additional context and understanding of important issues that 
emerged in the interviews.122 In some cases not all questions were applicable to all 
respondents. For example, questions focusing on organizational communication and 
policy goals were not necessarily relevant for media representatives or researchers. Thus, 
the interview guide was tailored to participants’ roles but remained as similar as possible 
to facilitate comparable responses (Appendix H).  
Between December 2013 and March 2014, representatives from 78 organizations 
were contacted for interviews. Of these, 12 groups declined to participate and 27 did not 
respond to interview requests or follow-up contact. Reasons provided for declining 
included time constraints and lack of knowledge or current involvement on the issue. Of 
those who declined to participate, three were from NGOs. Additionally, there were two 
decliners each from industry/consulting, government, research, and the news media. Of 
the 27 groups that did not respond to initial or follow-up contact, nine were from 
industry/consulting, eight were individual researchers, five were from NGOs, three were 
from government, and two were from the news media.  
Thirty-six organizations comprising participants from federal government 
agencies, researchers, industry/consulting, NGOs and the news media were interviewed 
between December 2013 and March 2014. Thirty-nine total interviews were conducted 
with respondents from the 36 organizations. In one case, two individuals from one NGO 
were interviewed separately due to scheduling; and in another case three representatives 
from the same government agency were interviewed separately. In some cases, more than 
one respondent participated in the interview. Four interviews were conducted with two 
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individuals (one interview each with government, researcher, NGO and industry). One 
interview with a government agency was conducted with three representatives. The unit 
of analysis used in this study is the organization (n=36). Interviews lasted an average of 
47 minutes and were conducted primarily by phone. Due to distance and interviewee 
scheduling preferences, the majority of interviews were conducted by phone (34). Four 
interviews were conducted in person, and one interview was conducted via Skype. In 
order to encourage participants to feel comfortable in sharing potentially controversial 
opinions or details about their organization’s risk communication strategies, interviewees 
were granted anonymity and identified only by the type of stakeholder group they 
represented (i.e. government, industry/consultant, NGO, researcher, or news media.  
Interviews were digitally recorded except in one instance where the interviewee 
did not grant permission for audio recording. In that case, the researcher’s (PT) notes 
were analyzed. Audio recording allowed for more natural conversation, as minimal note-
taking was necessary. Audio recordings of interviews and transcription files will be 
deleted after the final defense and publication of dissertation manuscripts. Recording also 
facilitated the use of direct quotations in results. The interviews were transcribed 
verbatim by the lead author using Express Scribe software123 (36) and by D. Anderson (2) 
without software. Following this process, transcripts were reviewed for completeness and 
accuracy. 
Analysis 
Analyzing, representing and drawing meaning from qualitative data is a 
challenging task,97 but critical to the validity of a study. Common data analysis strategies 
in qualitative research include taking notes, identifying codes, reducing codes to themes, 
counting the frequency of codes, noticing patterns, relating categories to theoretical 
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frameworks, and contextualizing and displaying the findings.97 Importantly, in qualitative 
research the steps of data collection, analysis and report writing are often interrelated and 
overlapping steps.97 The analysis process began with the lead author (PT) reading 
through the interview transcripts (and/or notes) several times and creating relevant 
structural and thematic code based on the research questions and interview guides.120  
The transcription process also allowed for increasing familiarity with the data set. After 
reading, re-reading and managing the data set, detailed description and categorization of 
the data into codes is an important step in case study research.97 A codebook was 
developed with definitions of each code and when to apply them (Appendix I). Some 
codes were developed a priori based on knowledge of the questions in the interview 
guide, while others emerged iteratively during review and re-review of transcripts. 
Structural codes, or organizational categories, serve to sort the data for further analysis 
but do not directly answer the research questions.96 An example of an organizational 
category included identification of interviewee’s stakeholder group (i.e., government) or 
denoting a particularly cogent quotation. Substantive categories, or thematic codes, more 
directly describe the content of the statements and facilitate analysis.120 Examples of 
thematic codes included discussion scientific literacy, objectivity and evaluation of the 
news media. During this process, central themes were identified and some codes were 
expanded to include broader concepts, while others were collapsed or eliminated if they 
were too specific or repetitive with other codes.107  
All transcripts were coded using HyperRESEARCH Version 3.5.2 qualitative 
analysis software.124 Due to the quantity of data in and the scope of this study, the coding 
process was focused on topics and themes that directly answered the research questions 
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of interest. This process has been defined as selective or focused coding. Selective coding 
is used to sort large amounts of data on recurring themes, categorize the data precisely 
across interviews and outline the next phase of analysis by generating theory.125 The next 
steps of case study analysis commonly involve classifying codes into themes or patterns, 
interpreting and representing the case using narrative and tables.97 After all the transcripts 
were coded, the interview content was organized by stakeholder domain and theme to 
inform the research questions.97  
Techniques	  to	  Improve	  Study	  Quality	  
Several resources for assessing methodological quality of mixed methods 
resources were used during the development and conduct of this 
research.97,101,104,120,121,126-128 Particularly relevant for evaluating qualitative research are 
the concepts of credibility, confirmability, dependability, transferability, and 
authenticity.97,129 Credibility and confirmability are similar to the quantitative concept of 
internal validity, and can be enhanced by triangulation.97 Triangulation refers to the use 
of multiple data sources to inform research inquiry.101 Dependability requires the research 
process is documented. Transferability is similar to external validity refers to whether the 
findings are applicable to other contexts.126 Whether case findings are transferable to 
other situations is often determined by the person wanting to apply the findings elsewhere 
and this process is aided by the researcher fully detailing the study methods. Authenticity 
is concerned with the value of the research to society and its impact on participants.130 
While the utility of these concepts has been debated in the literature and various scholars 
favor different descriptions of valid qualitative research,97 they provide guidance to 
researchers in rigorous conduct of qualitative and mixed methods research. 
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 Specific strategies to address these quality standards were implemented in this 
case study research (Table 1). First, the use of three separate methodologies of document 
analysis, quantitative news media content analysis and semi-structured interviewing with 
distinct data sets serves to triangulate the data. Within the framework of a case study, this 
approach allowed for analysis of BPA risk communication from key stakeholders and the 
media. Further, the structure and grounding of a case study approach helped to orient the 
research. Chapter 7 provides synthesis of the case study.  
Another technique that added to the quality of this research was the inclusion of 
diverse perspectives via the selection of stakeholders for interview and document 
analysis. This is particularly important on a topic like BPA, where there is disagreement 
among stakeholders and public policy debates.131 Also, advice from senior researchers 
was an important component of the quality assurance of this project. Advice from thesis 
committee members and other senior researchers was incorporated into the research 
during each stage—including designing, collecting data, analyzing and reporting this 
work. This process improved and increased the rigor of this dissertation. 
 Finally, acknowledging and discussing the role of the researcher in qualitative 
work is necessary and important for accountability and quality of qualitative research.  
In qualitative research, the researcher is considered the research instrument and should 
discuss their perspective in order to reduce any effects it many have on the study.127 As a 
researcher, I considered my role and perspectives that influenced my understanding and 
interpretation of the case study. As a public health researcher with a background in 
journalism and environmental health policy, I was primarily interested in the BPA case as 
an interesting scientific and communications issue and was not concerned with 
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determining whether BPA is safe, or not. Despite this, I am based within a discipline that 
emphasizes the precautionary principle and may have more support for advocacy than 
industry perspectives. I addressed researcher bias and my role as a research instrument 
with the use of reflexivity tools such as taking notes and reflecting on interviews. Further, 
transparency in the discussion of methods and the reporting of limitations is important for 
accountability and minimizing biases. Thus, as the original researcher, I took efforts to 
increase transparency and provide detailed descriptions of data and methods in order to 
address this limitation. Additionally, training in research ethics and qualitative research 
methodologies, the use of quotations, the inclusion of diverse perspectives, and the use of 
qualitative software were all used in an effort to be transparent and reduce any 
inappropriate researcher influences on the study findings. The overall strengths and 
limitations of this research are discussed in Chapter 7.  
Table 1: Practices Used to Enhance Case Study Research Quality (Adapted from J. 
Fry, 2012)132 
Quality Concept Practices Used 
Credibility (internal 
validity) 
• Detailed description of data analysis 
• Triangulation from multiple data sources 
• Use of quotations in results  
• Use of inter-rater reliability statistics  
Confirmability 
(objectivity/neutrality) 
• Description of multiple views/stakeholder stratifications 
• Discussion of reflexivity 
• Triangulation from multiple data sources 
• Use of quotations in results 
Dependability (reliability) • Detailed description of data analysis 
• Triangulation from multiple data sources 
Authenticity (fairness) • Description of multiple views/stakeholder stratifications 
• Detailed description of data analysis 
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Bisphenol A (BPA) is a high-volume industrial chemical found in the food supply 
and consumer goods. It is well established that diet is the primary route of exposure, and 
the vast majority of Americans are exposed to BPA. BPA has been found to have 
endocrine-disrupting properties, and hundreds of studies have researched its potential 
health effects. Despite the vast literature on BPA, scientists and regulatory bodies have 
disagreed on whether BPA poses risks to public health. This study used a qualitative 
approach to understand how federal government agencies, industry trade groups and non-
governmental organizations communicated BPA risks to the public. We used the National 
Research Council’s risk assessment paradigm to analyze stakeholders’ risk 
communication, and found very different risk characterizations and risk management 
approaches across the three domains. Industry groups uniformly concluded that BPA is 
safe for use; while non-governmental organizations uniformly concluded that BPA poses 
threats to public health, particularly for sensitive populations such as developing fetuses 
and young children. Risk communication from the federal government was mixed – with 
agencies presenting contradictory conclusions to the public. Further, the Food and Drug 
Administration, which regulates BPA as a food contact substance, has offered conflicting 
guidance to consumers—both assuring safety of BPA and recommending reducing 
exposures. There is a need for increased collaboration between government agencies to 
present unified risk communication messages, particularly in controversial and high-
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Introduction	  
Bisphenol A (BPA) is a common chemical and endocrine disruptor found in the 
food supply and in the environment. BPA, which is often described as a weak estrogen14, 
has been the subject of increasing research attention and public policy debate in the U.S. 
and worldwide. While a causal connection to human disease is difficult to establish, BPA 
exposure has been associated with a variety of health conditions in animals from cancer 
and obesity to infertility and behavioral effects.7,8,35,40,44,133 A number of other studies 
have concluded that exposures to BPA likely do not pose human health risks.134-137 In the 
midst of conflicting and complex science on BPA, stakeholders played an important role 
in informing the public about BPA and influencing policy and regulatory decisions.  
BPA is used as a building block in polycarbonate, a hard, clear plastic. Epoxy 
resins, which line metal food and beverage cans to prevent corrosion, are also commonly 
made with BPA.1,2 In 2011, worldwide BPA production was estimated at more than 8 
billion pounds per year,5 making it one of the highest volume chemicals in use.6 BPA’s 
market value and use in a variety of consumer product applications, particularly in 
children’s products such as baby bottles, have made the chemical a research priority and 
focus of public attention. 
Despite the hundreds of studies conducted over the past decade, there continues to 
be discord among scientists, regulators, environmental health advocates and industry 
representatives about whether typical BPA exposures pose health risks.17,138 Uncertainties 
remain about the potential for health effects from BPA, particularly in sensitive 
populations such as developing fetuses, infants and young children.8 Further, there are 
weaknesses in the tools scientists have at their disposal to estimate low dose effects.16 
Other controversies have included the appropriateness of animal models and 
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extrapolation to humans, critiques of various experimental approaches and sample sizes, 
the mechanisms of BPA action and its metabolism, true levels of human exposure, and 
concerns about contamination and replicability of some studies.34,134  
The Risk Assessment Framework 
 
Over the past 30 years, the risk assessment process has been an important tool for 
government agencies, industry and academia seeking to understand public health and 
environmental hazards, and inform public policy decisions.20 Risk assessments are 
conducted to help understand and make decisions about hazards that may threaten the 
environment and public health.  The National Research Council’s Risk Assessment in the 
Federal Government: Managing the Process established the four-step process of hazard 
identification, dose-response assessment, exposure assessment and risk characterization, 
which is used by regulatory agencies to assess environmental contaminants.45 Following 
the risk assessment, decision makers take this scientific information into consideration 
along with political, social, economic and engineering factors in what is known as risk 
management.45 As shown in Figure 2, available research informs the steps of the risk 
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Figure 2: National Research Council Risk Assessment and Risk Management 
Paradigm20  
 
While the science of risk assessment has advanced over the past three decades, 
uncertainties often remain and may lead to varying interpretations by stakeholders. The 
disconnects between available data and desired information impede decision-making.20 In 
2009, a National Research Council panel identified improved characterizations of 
uncertainty and variability as a top priority in advancing risk assessments. They 
recommended a “coherent, consistent and transparent process that would provide risk 
assessments that are relevant to the problems and decisions at hand and that would be 
sufficiently comprehensive to ensure that the best available options for managing risks 
were considered.”20  
U.S. Risk Assessments of BPA 
 Federal agencies have conducted risk assessments of BPA. In 1993, the EPA’s 
Integrated Risk Information System (IRIS) determined the Lowest Observed Adverse 
Effects Level (LOAEL) for BPA to be 50 mg/kg/day in animal studies. After dividing the 
	   53	  
LOAEL by an uncertainty factor of 1000 (10 for animal to human data, 10 for sensitive 
human populations and 10 for uncertainty regarding chronic to sub-chronic doses), the 
reference dose (RfD) for oral exposure was set at .05 mg/kg/day. In this case, the RfD—
defined as an estimate of a dose believed to be unlikely to cause adverse human health 
effects51—is based on the critical effect of reduced mean body weight.52  
The Food and Drug Administration (FDA) is responsible for regulating BPA as an 
indirect food additive or food contact substance. In 2008, FDA’s Draft Assessment of 
Bisphenol A For Use In Food Contact Applications used a NOAEL of 5 mg/kg/day for 
systemic toxicity, based on two multigenerational rodent studies.53 In its report, FDA 
estimated a margin of safety (MOS) of 2,000 for infants, and 27,000 for adults based on 
food-related exposures.53 A margin of safety represents the ratio between exposure levels 
that can harm lab animals and human exposure levels. A 1,000-fold difference for 
children and a 100-fold difference for adults is typically considered adequate. Thus, FDA 
determined there was a sufficient margin of safety for both children and adults. While 
acknowledging complete certainty of safety is impossible to prove, FDA defines safe in 
this context as “reasonable certainty in the minds of competent scientists that the 
substance is not harmful under the intended conditions of use.”53    
In 2010, the FDA announced that they had some concerns about effects on 
fetuses, infants and young children (based on a report from the National Toxicology 
Program) and were continuing to support research to clarify uncertainties.1 The FDA’s 
current stance on the overall safety of BPA exposure is that current low-level human 
exposures appear safe based on standard toxicity testing.1 
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Other federal agencies have also been involved in researching BPA, albeit not 
necessarily conducting formal risk assessments. Over the past few years, the National 
Institute of Environmental Health Sciences (NIEHS) invested $30 million in BPA 
research55 to address gaps in knowledge that still existed despite the 800 published 
studies on BPA health effects prior to the research program’s establishment.8 The 
National Toxicology Program (NTP), an interagency program housed at NIEHS, has also 
been deeply involved in this research program and has released its own assessments of 
BPA, notably a 2008 report noting “some concern” for effects on the prostate and brain 
and behavioral effects in developing fetuses, infants and children.35 The CDC has been an 
important source of data on human exposures to BPA with their National Biomonitoring 
Program.9   
Stakeholder Risk Messaging 
Stakeholder involvement is critical throughout the process of assessing and 
managing risks.20 According to the Presidential/Congressional Commission on Risk 
Management, stakeholders are “groups that are affected or potentially affected by the 
risk, the risk managers, and groups that will be affected by any efforts to manage the 
source of the risk.”139 To improve the outcome and utility of risk assessments and 
ensuing regulatory and policy decisions, stakeholders should be involved in the process 
and play a role in identifying important questions and potential solutions. Further, the 
public filters and interprets risks with the help of stakeholders via the news media and 
other communication venues. These groups may influence what solutions are considered 
and whether concern about an issue is heightened by the news media and others.72 A 
separate analysis found mixed messages in news media content on BPA in national 
television and newspaper sources between 2006 and 2012 (See Chapter 5).  
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Several health and environment-focused non-governmental organizations (NGOs) 
have been vocal on both the science on BPA and their preferred risk management 
approaches. For example, Consumers Union, the nonprofit publisher of Consumer 
Reports, has conducted its own tests of BPA-containing products, advised the public on 
ways to lower their exposure and called on the FDA to ban its use in food and beverage 
containers and children’s products.74 Other NGOs have likewise urged stricter limitations 
on BPA, supported state policies and provided information to the public.71,140,141 
Industry trade associations have also played an important role in representing the 
voices of BPA manufacturers and users. Companies including Bayer, Dow Chemical, 
Sunoco and General Electric Plastics make a reported $1 million per day in profits from 
BPA production.43 The American Chemistry Council (ACC), a trade group that 
represents the chemical industry, including major BPA producers, has campaigned 
against BPA legislation and criticized EPA’s IRIS process.43,83 The ACC also publishes 
websites that promote the safety of BPA, including factsaboutbpa.org.84,85 Other industry 
associations such have also publicly supported BPA’s safety and opposed restrictions on 
its use.86,87 
Despite the large body of scientific research on BPA from peer-reviewed and 
government sources, this is the first study to analyze how stakeholders communicated to 
the public about BPA. This study applied the risk assessment framework20 as a guide for 
evaluating key stakeholders’ publicly available BPA documents. This study analyzed 
how key stakeholders characterized public health concerns about BPA and discussed risk 
management solutions. While not all stakeholder groups conducted a risk assessment, 
their public statements describe BPA and its properties (hazard identification), how it 
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may affect human health (dose-response assessment), who is exposed, and how (exposure 
assessment), and whether consumer exposures pose health risks (risk characterization). 
Also assessed were stakeholders’ discussion of risk management solutions including 
public policies, voluntary industry actions and replacements for BPA in consumer 
products. Given the important roles of stakeholders in setting regulatory and policy 
agendas and influencing public opinion, it is critical to understand how these groups 
translated scientific data about BPA to the public. 
Methods	  
Sampling and Data Collection 
 The NRC’s risk assessment framework was used to qualitatively examine how 
key stakeholders communicated about BPA through publicly available documents on 
their websites. Thus, key stakeholders were defined as national, U.S. based groups who 
have authority over the risk assessment and risk management of BPA, or will be affected 
by the risk itself or efforts to manage the risk. We identified three “domains”, or types of 
stakeholder organizations: 1) government agencies, 2) industry associations, and 3) health 
or environment-focused NGOs. Thirteen organizations and agencies from the three 
domains were purposefully selected for analysis due to their prominent roles in research, 
communications, and/or advocacy regarding BPA. Organizations were identified and 
selected from background research, news media content and/or references from in-depth 
stakeholder interviews (Manuscript 3).  
Four U.S. federal government agencies with regulatory authority over BPA and/or 
agencies involved in funding or conducting research related to BPA were identified: 
Centers for Disease Control and Prevention (CDC), Environmental Protection Agency 
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(EPA), Food and Drug Administration (FDA), and National Institute of Environmental 
Health Sciences (NIEHS).  
The industry’s perspective on BPA was communicated primarily through industry 
trade associations. Five national industry trade associations representing the major food-
related producers and users of BPA in plastic products and metal food cans were 
included: American Beverage Association (ABA), American Chemistry Council (ACC), 
Grocery Manufacturers Association (GMA), International Bottled Water Association 
(IBWA) and North American Metal Packaging Alliance (NAMPA). In the case of the 
ACC, both the organization’s primary website and their BPA-specific website 
(factsaboutbpa.org) were included. Four NGOs concerned with public health, the 
environment and consumer advocacy were also selected for analysis: Breast Cancer Fund 
(BCF), Consumers Union (CU), Environmental Working Group (EWG) and the Natural 
Resources Defense Council (NRDC). All stakeholder organizations are listed in Table 2. 
Table 2: Included Government, Industry and Non-governmental organizations  
Government Industry Non-governmental 
organizations 
• Centers for Disease 





• Food and Drug 
Administration (FDA) 
• National Institute of 
Environmental Health 
Sciences (NIEHS) 
• American Beverage 
Association (ABA) 
• American Chemistry 
Council (ACC) 
• Grocery Manufacturers 
Association (GMA) 
• International Bottled 
Water Association 
(IBWA) 
• North American Metal 
Packaging Alliance 
(NAMPA)  
• Breast Cancer Fund 
(BCF) 
• Consumers Union (CU) 
• Environmental Working 
Group (EWG) 




Documents from 13 groups were obtained directly from the organizations’ 
websites in June 2014. In order to evaluate the stakeholder’s public messaging about 
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BPA, each stakeholder website was searched with the following terms: BPA or Bisphenol 
A in the document title and at least one of the following words: risk, health or safe.  
From the 13 organizations included, a total of 308 documents were identified. 
Due to the intended focus on risk messages geared to consumers, the following types of 
data were excluded: reports, blog posts, official testimony and comment letters, meeting 
presentations, and outlines of specific research projects. To ensure documents included 
sufficient detail, documents less than 150 words were excluded. To capture the full range 
of relevant documents over time, the documents were not limited by publication date. 
After applying exclusions, 146 documents remained for analysis. The Johns Hopkins 
Bloomberg School of Public Health Institutional Review Board (IRB) exempted this 
study from review, determining it non-human subjects research. 
Data Analysis  
In order to evaluate how stakeholders publicly communicated about BPA, a 
coding instrument was created to extract relevant information from website documents. 
(Appendix C). The instrument development was guided by a preliminary literature review 
and structured around the stages of risk assessment and risk management. The instrument 
was refined during initial review of included documents and finalized prior to document 
coding. First, basic information was collected from each document, including the title, 
organization, domain, date of publication and/or date of last update, document type and 
document purpose. The first substantive section of the coding instrument collected 
information on hazard identification. Specifically, words used to describe BPA were 
coded, for example: chemical, toxic, estrogen, or hormone. Next, BPA-containing 
products or locations were coded (i.e. food and drink containers, receipt paper, consumer 
goods and the environment). The second part of the coding instrument collected data on 
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dose-response assessment —in other words, the risk estimates or points of departure used 
to quantify risk. The third section, covering exposure assessment, collected data on how 
the documents described people’s exposure to BPA. Information was extracted from the 
documents on populations exposed, sensitive populations, and route(s) of exposure. 
Fourth was the assessment of risk characterization, comprising the documents’ main 
messages on BPA safety or risk. Finally, the fifth section of the instrument coded risk 
management discussion in the documents, for example the type of solutions described 
and discussion of potential BPA replacements. For each document, relevant portions of 
text were also collected to aid in analysis and put results in context.  
Data were collected using the Qualtrics online survey tool110 and analyzed using 
Microsoft Excel and Qualtrics. Data were extracted, coded and analyzed by a single 
author (PT). The unit of analysis used was the individual stakeholder organization. This 
level of analysis was chosen because the intent was to understand the overall messaging 
coming from each organization through their website, as opposed to the content of an 
individual document, i.e. a single web page or press release. To facilitate comparisons, 
data were analyzed both at the organizational level, and at the domain level (government, 
industry and NGO). Beyond basic descriptive information provided about the sample, 
reporting of numerical measures in the results was limited due to the non-
representativeness of the data and to avoid overstating generalizability.128 Further, 
because the unit of analysis was the organization, findings are aggregated to that level as 
opposed to contrasting individual documents. 
The 146 documents included for analysis were categorized by their primary 
purpose: 1) to provide general information about BPA, 2) to release news, 3) to 
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summarize a report, or 4) to describe the organization’s overall position and actions 
related to BPA. Notably, there was some overlap in the purpose of the documents. For 
example, some documents were news releases detailing the organization’s actions related 
to BPA, or summarizing a new report. In these cases, the primary purpose was coded as 
news release.  
Results	  
Eighty documents from NGOs, 48 industry documents and 18 government 
documents comprised the sample. (See Appendix B for the tally of included documents 
by organization). As shown in Table 3, the majority of documents were news releases. 
While most industry and NGO documents were news releases, most government 
documents provided general information about BPA or described the agency’s actions on 
BPA. The range of years observed was 2005 to 2014, with most documents published 
between 2008 and 2012 (85% of the documents identified by year were created or last 
updated in these five years).  
Table 3: Included Documents by Purpose and Stakeholder Domain  
 Government Industry NGO Total 
About BPA 5 10 6 21 
News release  3 34 61 98 
Report brief 2 2 13 17 
Describe organization’s 
stance or actions 
8 2 0 10 
Total 18 48 80 146 
 
  Table 4 summarizes risk messages from each stakeholder group for each of the 
risk assessment and risk management steps. The table displays only the uniform risk 
messages that were prevalent in documents from all organizations within each domain. 
For example, all four of the NGOs described BPA as a chemical, estrogen, toxin and 
hormone-disrupting. When all organizations within a domain did not present consistent 
	   61	  
messages (for example, three out of four government agencies referred to developing 
fetuses and young children as sensitive populations), the item is denoted as “not uniform” 
in Table 4. This approach allows for a summary of the most consistent messaging by 
domain, with more nuanced results presented in subsequent sections. 
Table 4: Uniform Risk Messages by Stakeholder Domain 















Food and drink 
containers, receipts 
Food and drink 
containers 







 Not uniform Cancer, development, 
reproductive, diabetes, 









Current exposure levels 
do not cause health 
effects 
Current exposure levels 






























Route of exposure 
Ingestion of food or drink Not uniform Ingestion of food or drink 
Risk 
Characterization 









Not uniform Not uniform State and federal 
legislation, FDA 
regulation, and voluntary 
industry actions to reduce 
BPA exposure; safer 
alternatives needed 
“Not uniform” denotes that organizations within the domain presented different messages. 
 
Hazard Identification   
	   62	  
First, stakeholders’ hazard identification messages were analyzed. General 
descriptions of BPA were relatively consistent across the three domains, with all groups 
describing BPA as a chemical. Two government agencies also referred to BPA as an 
estrogen (EPA, CDC), and EPA and NIEHS referred to BPA as an endocrine disruptor 
and a toxin. All of the NGOs described BPA as an estrogen, toxin, and hormone-
disrupting. Industry groups typically did not use these terms to describe BPA, although 
one group (NAMPA) used the terms “toxic” and “endocrine disruptor” in 
quotations,142,143 and two organizations indicated BPA is as not a reproductive and 
developmental toxin and not a carcinogen (IBWA and NAMPA). 
All three domains consistently identified food and drink containers as BPA 
sources. All government agencies also mentioned receipt paper as a source of BPA. Two 
agencies (CDC, NIEHS) mentioned dental sealants. Three government agencies (CDC, 
EPA, NIEHS) also mentioned the presence of BPA in the environment. Three NGOs also 
mentioned receipt paper and dental sealants as sources (NRDC, EWG and BCF). Two 
industry groups (ACC, IBWA) and three NGOs (NRDC, EWG and BCF) mentioned 
generally that other consumer goods may contain BPA.  
With regard to health endpoints discussed in the documents, disparities in health 
endpoints linked— or potentially linked— to BPA exposure were observed by domain. 
All four government agencies mentioned potential developmental and reproductive 
effects. Behavioral effects were mentioned by three agencies (FDA, EPA, NIEHS). FDA 
and NIEHS also cited diabetes and heart disease. NIEHS documents referred to several 
additional health endpoints such as cancer, asthma and epigenetic effects. As shown in 
Table 3, the NGOs consistently referenced the most health endpoints. All of the NGOs 
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referred to the following health endpoints: cancer, developmental effects, reproductive 
effects, diabetes, obesity, heart disease and behavior. 
By and large, industry groups did not name specific health conditions. In the 
instances where health endpoints were named, they were routinely presented in the 
context that effects were not proven. For example, an undated NAMPA web page titled 
“Common Misperceptions about BPA,” states “there is no conclusive scientific evidence 
that shows a causal relationship between BPA exposure and human health effects.”144   
Dose-Response Assessment 
Second, dose-response discussion was evaluated. The stakeholder documents 
provided little discussion and quantification of what a safe exposure level would be, or 
what points of departure (such as a Reference Dose or No Observed Adverse Effects 
Level) were used in assessing the dose-response relationship. Among the 13 
organizations, three of the industry groups (ACC, NAMPA, IBWA) and one of the NGOs 
(CU) cited specific safety limits (i.e. a point of departure). Government agency 
documents in the sample did not specify points of departure, although some risk estimates 
reported by industry groups and CU did cite U.S. agency data.	  For example, the IBWA 
cited EPA’s Reference dose (RfD) and NOAEL. Consumers Union referred to FDA’s 
safety limit of .05 mg/kg/day, which is the same as the EPA’s RfD. CU also referred to 
FDA’s cumulative exposure daily intake (CEDI), an estimate of an individual’s exposure. 
Foreign government figures were also cited in some instances. For example, the ACC and 
NAMPA reported Tolerable Daily Intake (TDI) estimates from the European Food Safety 
Authority. 	  
Some patterns were identified by domain in the discussion of dose-response: 
some industry groups reported that unrealistically high daily exposures would be 
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necessary to reach unsafe doses of BPA, while some NGOs reported that a single serving 
could be harmful. In some instances, stakeholders translated risk quantifications into 
more readily understandable language to explain the dose-response relationship. For 
example, IBWA noted that a consumer would have to drink 1,000 gallons of water in a 
day to reach Canada’s TDI.145 A 2009 NAMPA document stated that a 130-pound 
individual would have to consume more than 7,400 twelve-ounce cans in order to exceed 
Canada’s TDI.143 In contrast, the Breast Cancer Fund stated in a report brief that of the 
Thanksgiving foods they tested for BPA, half of the foods contained enough BPA in one 
serving to cause health effects in lab studies.146 Government documents in the sample did 
not describe this relationship or list points of departure used in risk assessments, although 
other government sources (such as publicly available reports not included in the sample) 
do detail dose-response assessment approaches.52,53 
Exposure Assessment 
 The third step of the risk assessment framework evaluated was exposure 
assessment. Government agencies and NGOs consistently identified the general public as 
exposed to BPA, commonly referring to biomonitoring data indicating that the majority 
of Americans have detectable BPA in their urine. Three government agencies (EPA, 
CDC and NIEHS) and all four NGOs also referred to exposures in young children. Two 
NGOs also identified pregnant women and developing fetuses as an exposed group 
(EWG, BCF). EWG additionally mentioned heightened exposures of cashiers from 
handling receipt paper.147  
Industry documents did not consistently describe the general population as 
exposed, but two groups (NAMPA and ACC) did refer to exposures of the general 
population and among children. More commonly, the industry groups referred more 
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generally to typical or average human exposures, without explicitly stating widespread 
exposure, or what groups are commonly exposed. For example, a 2010 ACC press release 
stated: “typical consumer exposure to BPA, from all sources, is more than 1,000 times 
lower than government-established safe intake levels.”148 
Many stakeholder documents characterized routes of exposure to BPA. As 
previously mentioned, food and drink containers were the primary source of BPA 
mentioned, and likewise, ingestion of food and drink was the main exposure route. All 
government agencies and NGOs specified the route of exposure as ingestion of food and 
drink, as well as three of the industry groups (IBWA, ACC and NAMPA).  
 Three government agencies (FDA, EPA and NIEHS) identified developing 
fetuses and young children as sensitive populations. CDC’s documents were focused on 
its biomonitoring efforts of children over six and adults, and thus did not provide 
information on sensitive populations. ACC described workers without sufficient 
occupational safety measures as a sensitive group.148 IBWA noted FDA had determined 
“some concern” for infants and developing fetuses.145 In contrast, all four NGOs 
identified pregnant women or developing fetuses, and young children as sensitive 
populations. BCF also specified that breast cancer patients may be particularly vulnerable 
to BPA exposure due to interference with chemotherapy.149 EWG additionally defined 
adolescents, African Americans, and the poor as sensitive populations.150 
Table 5 presents quotations in italics from key stakeholder documents for hazard 
identification and dose-response items. This table provides context on the type of 
language that was extracted from the documents for each item of interest, but does not 
provide representative samples of the content or convey every finding. Each stakeholder 
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group did not specify information relevant to every item; therefore, the organizations that 
provided more details may appear more frequently in the table. Bolded text was added for 
emphasis of the extracted text. 
Table 5: Hazard Identification, Dose-Response and Exposure Assessment Messaging 
Examples By Stakeholder Domain  




BPA is an endocrine 
disruptor, with estrogenic 
activity, which means that 
it has the potential to 




BPA is one of the most 
thoroughly tested 
chemicals in commerce 
today. 
-ACC 2010152 
BPA is a hormone-
disrupting chemical that 
mimics estrogen the 
female sex hormone 
essential for development 






Humans appear to be 
exposed primarily through 
food packaging 
manufactured using BPA, 
although those products 
account for less than 5 
percent of the BPA used in 
this country. 
-EPA 201488 
The use of bisphenol A 
(BPA)-derived epoxy resins 
to make protective coatings 
for metal food and 
beverage packaging helps 
provide safe, wholesome 
and nutritious food and 
beverages for people 
throughout the world.  
-NAMPA 2008154 
…common products like 
the linings of aluminum 
cans, water bottles, food 
storage containers, eating 
utensils, food cans, and 






Reports from some animal 
studies have raised 
potential concerns that 
BPA exposure may cause 
multiple health problems, 
including reproductive 
disorders, diabetes and 
cardiovascular disease. 	  
-FDA 201377 
Research has shown that 
bisphenol A is not a 
carcinogen, not a 
reproductive or 
developmental hazard, and 
is not bioaccumulative 
because it is rapidly 
metabolized and eliminated 
from the body. 
-IBWA 2005156 
Even miniscule exposures 
increase risks for breast 
cancer, prostate cancer, 
infertility, early puberty, 
metabolic disorders and 
type-2 diabetes. 




Not specified. As noted by Health 
Canada, an adult would 
have to drink 
approximately 1,000 liters 
(or 264 gallons) of water 
from polycarbonate water 
cooler bottles every day to 
approach the science-
based safe intake limit for 
BPA established in 
Canada. –IBWA (date 
unknown)158 
For 1 in 10 cans of all food 
tested, and 1 in 3 cans of 
infant formula, a single 
serving contained enough 
BPA to expose a woman or 
infant to BPA levels more 
than 200 times the 
government's traditional 
safe level of exposure for 






CDC scientists found BPA 
in the urine of nearly all of 
the people tested, which 
indicates widespread 
exposure to BPA in the 
Numerous BPA 
biomonitoring studies have 
been conducted and have 
found measurable levels in 
peoples’ urine.  
CDC found BPA present in 
the urine of 93 percent of 
all Americans over the age 
of six. A groundbreaking 
report released late last 








year by EWG discovered 
the plastics chemical in 9 
of 10 umbilical cord blood 






People are exposed to low 
levels of BPA because, like 
many packaging 
components, very small 
amounts of BPA may 
migrate from the food 
packaging into foods or 
beverages. 
-FDA 2014162 
People are exposed to BPA 
almost entirely through 
food contact materials. 
-NAMPA (date 
unknown)144 
Consumers eating just one 
serving of the canned 
vegetable soup tested by 
Consumer Reports would 
get about double what the 
FDA has considered 







Another reason for 
concern, especially for 
parents, may be because 
some laboratory animal 
studies report subtle 
developmental effects in 
fetuses and newborns 
exposed to low doses of 
BPA. 
-NIEHS 2010151 
What You May Have Read: 
Children are more 
susceptible to harmful 
effects of BPA. What the 
Science Says: Studies have 
shown that infants 
metabolize BPA in a 




But the science is now 
showing that fetal 
exposure to BPA is of even 
greater concern, spurring 
public health advocates to 
refocus on protecting 





Patterns in the overall characterization of BPA risks by stakeholder domain were 
observed. Industry sources were consistent in their messaging that BPA is safe. All 
industry organizations in the sample concluded in their public documents that BPA does 
not pose risks to human health from food-related exposures. Frequently, industry sources 
cited U.S. and international regulatory bodies’ findings that current BPA uses are safe. 
NGOs were also consistent in their messaging, but with the opposite conclusion—that 
BPA does pose human health risks at doses relevant to human exposure. All four NGOs 
in the sample concluded that BPA is a public health concern. Government documents 
were varied in their conclusions and recommendations—even within individual agencies. 
For example, several FDA documents reiterated their finding that BPA is safe at current 
exposure levels. Yet, a FDA webpage created in 2010 and last updated in 2013 advises 
consumers on how to reduce their exposure, explaining, “FDA believes that recent animal 
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studies provide reasons for some concern about the potential effects of BPA on infants 
and children.”165 
Other agencies discuss uncertainty and the need for more research (CDC, EPA 
and NIEHS). For example, the EPA noted that it continues to work with other agencies to 
evaluate BPA.154 NIEHS documents explained and described its finding of “some 
concern” for potential effects on the brain, behavior and prostate gland in fetuses, infants 
and children.151 To illustrate the range of risk characterization messages, Table 6 provides 
messaging examples from each of the 13 organizations. 
Table 6: Risk Characterization Messaging Examples by Stakeholder Organization  
Domain Organi-
zation 
Year Risk Characterization Messages Overall Risk 
Characterization  
FDA 2014	   Is BPA safe? Yes. Based on FDA’s 
ongoing safety review of scientific 
evidence, the available information 
continues to support the safety of BPA for 
the currently approved uses in food 
containers and packaging. 162 
Safe	  
EPA 2014 Studies employing standardized toxicity 
tests used globally for regulatory decision-
making indicate that the levels of BPA in 
humans and the environment are below 
levels of potential concern for adverse 
effects.154 
Safe 
CDC 2013 Human health effects from bisphenol A at 
… biomonitored levels from low 
environmental exposures are unknown.160 
Uncertain Government 
NIEHS 2014 The studies in humans are really 
inadequate to reach any kind of a 
conclusion, but the studies in animals 
have shown a variety of effects at very, 
very low levels….The fact that there are so 
many levels of uncertainty make it very 
difficult for us to make any kind of overall 
recommendations as to how exactly the 
U.S. public should view bisphenol A166 
Uncertain 
ACC 2010 The consensus of government agencies 
across the world is that BPA is safe for 
use in food contact materials.153 
Safe 
NAMPA 2012 BPA-based coatings, when used in food 
packaging, do not pose a health risk to the 




IBWA 2013 The consensus among these regulatory Safe 
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agencies is that the current levels of 




The beverage industry's products and 
containers are safe and pose no public 
health risk, including any alleged risk 
associated with BPA.169 
Safe 
 
GMA 2010 We agree with today’s reaffirmation by 
HHS and FDA that baby bottles, infant 
sipping cups, canned infant formula and 
other foods in cans with linings that utilize 
BPA are safe, and that there is no need for 
consumers to change their consumption 
habits.170 
Safe 
NRDC 2011 As thousands of studies have already 
shown, BPA is a dangerous chemical that 
has no place in the food chain.171 
Risk 
EWG 2012 This latest research implicates BPA in one 
of the most serious public health 
emergencies faced by young Americans.172 
Risk 
CU 2010 The scientific evidence is clear that BPA 
poses serious health risks, especially to 
children and the developing fetus.173 
Risk 
NGO 
BCF 2011 …mounting scientific evidence that 
exposure to even extremely low levels of 
BPA can negatively impact health.174 
Risk 
 
Risk Management  
  The fifth and final aspect of the risk messaging assessed was stakeholders’ 
discussion of risk management. Separate from the four risk assessment steps, 
stakeholders’ discussion of potential solutions and replacements for BPA was evaluated. 
Government agencies’ discussion of appropriate solutions was varied. CDC documents 
did not mention solutions. EPA discussed possible solutions within its jurisdiction (such 
as rulemaking under the Toxic Substances Control Act, or acting on the basis of negative 
environmental impacts of BPA). NIEHS recommended reducing consumer exposures and 
more research.  
FDA documents had the most varied discussion of solutions. FDA recommended 
reducing consumer exposures in some instances, but not for infants, stating: “FDA is not 
recommending that families change the use of infant formula or foods, as the benefit of a 
stable source of good nutrition outweighs the potential risk of BPA exposure.”1 FDA 
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documents explained its regulatory decision-making, such as their denial of a NRDC 
petition to ban BPA175, and the approval of a petition to remove the approved use of BPA 
in formula containers due to industry abandonment.176 FDA documents also supported 
voluntary industry efforts to develop BPA alternatives.165 EPA was the only other agency 
to discuss replacements—as the agency conducted an alternatives assessment for BPA in 
thermal receipt paper.154 
NGO documents had the most extensive focus on solutions of the three domains. 
All the NGOs supported legislation at the state and national levels, FDA regulation, and 
voluntary industry actions to reduce BPA exposure. Three of the NGOs also 
recommended consumers reduce their exposures (BCF, CU, EWG). Some NGO 
documents included discussion of multiple solutions, as demonstrated in the CU 
quotation in Table 7. NGOs also uniformly highlighted the need for safer alternatives. 
Some groups mentioned available alternatives that had been used as replacements in 
other settings. In some cases NGOs cited concern about unnamed replacements, such as 
in this undated Breast Cancer Fund document: 
“Can manufacturers are beginning to use alternative liners to BPA in cans. Any 
alternatives to BPA, however, must be studied for their effects on health—
switching out a chemical we know is harmful for one that's unknown and untested 
is just kicking the can down the road. We're proud to say that many canned food 
makers, including industry leader Campbell's, are phasing out BPA. Problem 
solved? Not exactly. Most of these companies aren't telling us what they're using 
instead of BPA, and we have concerns about the alternatives.”149 
 
The industry discussion of solutions was limited and focused on opposing public 
policies and voluntary measures. One industry group, ABA, did not discuss risk 
management. Of the other four industry groups, two were opposed to consumer actions to 
reduce exposures (IBWA, GMA), and IBWA also cautioned against industry changes 
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that could negatively impact food safety. Two industry groups (NAMPA and GMA) 
stated opposition to policy or regulatory efforts to limit BPA. In terms of replacements, 
all industry groups either cautioned against regrettable substitutions or reported that they 
are not safe and viable BPA replacements.  
Table 7: Risk Management Messaging Examples By Domain 
 Government Industry NGO 
Solutions	   FDA is supporting the 
industry’s actions to stop 
producing BPA-containing 
bottles and infant feeding 
cups for the U.S. market.	  
-FDA 2013165 
Given the serious 
implications on food safety 
from any action to ban 
BPA, we believe FDA is 
pursuing a prudent course 
of action. A ban without 
conclusive scientific 
evidence of risk would 
compromise the safety of 
canned foods and 
beverages enjoyed by 
millions of Americans 
everyday. 
-NAMPA 2012177 
“CU continues to urge 
FDA to act immediately to 
remove BPA from food 
and beverage 
containers…. CU 
continues to advise 
consumers to choose fresh 
or frozen foods whenever 
possible and to lower their 
consumption of canned 
foods…. . CU also urges 
federal action to ban BPA 
in all food and beverage 
containers so that all 
consumers will be 
protected.” 
-CU 2011178 
Replacements	   FDA will support changes 
in food can linings and 
manufacturing to replace 
BPA or minimize BPA 
levels where the changes 
can be accomplished while 
still protecting food safety 
and quality. 
 –FDA 20141	  
“Basing decisions on 
emotions and controversy 
alone risks “regrettable 
substitutions” that 
compromise performance 
and/or safety…For both 
polycarbonate plastic and 
epoxy resins, it is not a 
simple matter to find a 
material that can match 
the attributes and 
performance of these 
materials…Replacement of 
BPA can only be defended 
for alternatives that, in 
fact, deliver better 
performance or are safer 
than BPA.” 
-ACC (date unknown)179 
BPA-free alternatives are 
already available and on 
the market. The FDA has 
no good reason to drag 
their feet on banning 
it…the FDA should act 




Key stakeholders from government, industry and health and environmental NGOs 
agreed on some aspects of BPA risks. The three domains were generally consistent that 
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BPA is a chemical in food and drink containers, and that consumers are exposed through 
their diets. The stakeholders differed on the health endpoints associated with BPA, 
sensitive populations, and whether current exposure levels are potentially harmful. As 
expected, NGO and industry stakeholders disagreed on whether BPA is safe as currently 
used, and what, if anything should be done about it. Government risk communication, 
even within just the FDA, was not consistent. 
 Industry groups consistently presented similar messages on BPA. Industry groups 
noted scientific studies and government assessments that downplayed any public health 
risks from BPA exposure. Industry groups also highlighted BPA’s benefits, cautioned 
against replacing BPA, and opposed legislative and regulatory efforts to reduce 
population exposures. One notable exception to this was the ACC’s 2012 petition to the 
FDA to remove the approved use of BPA in baby bottles, which was not based on safety 
but rather market abandonment.181   
Likewise, risk communication from the four NGOs was uniform. However, 
NGOs came to the opposite conclusions as industry. NGO documents showed concerned 
that human exposure levels could cause health impacts, particularly for sensitive 
populations such as fetuses, infants and children. NGOs linked BPA to a host of diseases 
and advocated for legislation, regulation, and voluntary industry actions to remove the 
compound from food and drink containers. In some cases, NGOs recommended ways 
consumers could reduce their exposure. 
 Risk messaging from government agencies was the most varied of the three 
domains and did not present a unified risk characterization message. It is important to 
note that for government agencies, some inconsistencies are to be expected given the 
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various missions of the agencies analyzed. For example, EPA and CDC, because of 
limited or non-existent jurisdiction over BPA, do not report their own conclusions on risk 
characterization, leaving those statements to the FDA as the regulating body. However, 
inconsistencies in the FDA’s risk communication were noted as well, which 
corresponded with the agency’s pronouncement of “some concern” in 2010 while 
continuously maintaining BPA is safe for approved uses. Notably, FDA reported their 
finding of BPA safety in several documents,162 while another document recommends 
consumers reduce their exposures.165 
It is important to note that the type and purpose of documents varied between 
stakeholder domains, which was expected given the different jurisdictions and missions 
of federal government agencies, industry groups and NGOs. For example, most 
government agency documents were intended to inform the public about BPA and 
summarize what actions their agencies were undertaking, as opposed to issuing press 
releases or providing detailed technical reporting. U.S. agencies have released technical 
reports on BPA, which were outside the scope of this study. Industry groups and NGOs, 
on the other hand, frequently disseminated BPA-related news through press releases. 
In the case of BPA, NGOs consistently cited evidence suggesting harm from 
BPA, while industry groups consistently cited evidence suggesting that BPA poses little 
to no public health risk. While there was much discussion (particularly from NGOs) 
about public policies to remove BPA from consumer products, there was limited 
discussion of replacement compounds for BPA. Further, the existing discussion of 
replacements was fractured—with industry groups mentioning that safe alternatives are 
not available, and NGOs stating that viable replacements are available. 
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Strengths and Limitations 
This study is the first to analyze stakeholder BPA risk communication. As in any 
study, there are limitations. Notably, this study included public documents available on 
stakeholders’ websites in June 2014. Any relevant information removed prior to this time, 
or posted thereafter, is not captured in this study. The changing content of websites and 
potential variability in the completeness of archived documents on stakeholder websites 
could also produce bias that cannot be measured. Document reviews can also be biased 
by the researcher’s selection schema.96 It is possible that a different selection of 
organizations, or restricting the documents to a specific time period of interest could have 
produced different results. The dataset used in this study reflects publicly available 
information that any consumer could theoretically access as of June 2014. While 
documents ranged from 2005 to 2014, newer results would likely be prioritized in web 
search results. In order to capture the full range of stakeholder communications to date, 
inclusion criteria were not limited to any particular time period. 
The documents evaluated were aimed for a general audience and not risk 
assessors or experts. Thus, the documents did not necessarily include all of the critical 
information needed for a risk assessment. It was beyond the scope of this research to 
evaluate the merits of the research cited in the documents; rather the goal was to describe 
key stakeholders’ public risk communication on BPA. However, given the vast array of 
scientific literature on BPA, it is possible to cite published research supporting nearly any 
conclusion about BPA’s safety.  
There are also some key strengths of this study. The documents analyzed were an 
existing source of information; they provided specific and detailed background 
information that did not exist elsewhere.96 The data analyzed represent a unique 
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summation of risk communication geared toward consumers from the major stakeholders 
in the United States. The documents provided messaging directly from each 
organization—and thus represent official statements that were not filtered through the 
media or other avenues. This study is the first to evaluate stakeholder’s risk 
communication using the risk assessment framework. This is also the first study to assess 
how key stakeholders in the United States have characterized human health risks 
associated with BPA.  
Conclusion 
This analysis confirms that there has been conflicting risk communication about 
BPA from government agencies, industry associations and NGOs in the United States. 
Such fractured information about the potential hazards about BPA confuses the public 
and muddies the distinction between risk assessment and risk management. Successful 
risk management depends in part on the ability of public health practitioners to translate 
data and communicate about complex and uncertain scientific issues. BPA presents a 
challenging case due to conflicting research results, advocacy efforts, and different, 
evolving conclusions from government agencies. However, years after the industry 
voluntarily removed the chemical from some products, and legislative bodies passed BPA 
bans, scientists and regulators continue to disagree on the public health implications and a 
clear message on BPA safety is still elusive. Government agencies in particular, given 
their intended roles as impartial arbiters, should work together to ensure that consistent 
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U.S. News Media Framing of Bisphenol A (BPA) from 2006-2012 
Abstract	  
	  
Bisphenol A (BPA), a chemical found in food packaging and other consumer goods, has 
been investigated as a potential public health threat over the past decade. Despite much 
research, stakeholders remain in disagreement about human health risks. This study 
assessed U.S. news media coverage of BPA sources, risk framing and discussion of 
health endpoints, solutions and replacements. A quantitative content analysis was 
conducting using a selection of major newspaper, news magazine and television news 
sources between 2006 and 2012. News coverage focused on food-related exposures and 
peaked in 2008. News stories in the sample (n=224) often mentioned baby bottles or 
children’s cups (80%) and framed infants and young children as a sensitive population 
(61%). The majority of news stories linked BPA to health endpoints (89%), and two-
thirds mentioned BPA as safe. Reproductive conditions, cancer and developmental 
effects were most reported. Solutions were discussed in most news stories (80%), with 
2009 to 2012 news stories and print sources more likely to mention U.S. government 
policies to restrict BPA. Replacements for BPA were rarely mentioned. Opposing risk 
messages were present in much of the news coverage, which is reflective of conflicting 
stakeholder views on BPA’s risks. This study provides insights on news media framing of 
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Introduction	  
Bisphenol A (BPA) is a common chemical found in the food supply and in the 
environment that has been linked to health concerns in the United States and around the 
world. A weakly estrogenic compound, BPA has been associated with a range of adverse 
health effects, including cardiovascular effects, sexual dysfunction, infertility, obesity, 
early puberty, prostate and mammary gland cancers, behavior changes, and diabetes. 7,8,14 
The two most common food-related sources of BPA are polycarbonate plastics 
and canned goods. BPA is used as a building block in polycarbonate plastics, a type of 
hard, clear plastic in some reusable water bottles and baby bottles. Epoxy resins, which 
line metal food and beverage cans to prevent corrosion, are also commonly made with 
BPA.1 Other non-food related sources include dental sealants and cash register receipt 
paper.8 Biomonitoring data show nearly ubiquitous BPA exposure in Americans. The 
Centers for Disease Control and Prevention (CDC) reported 94 percent of a nationally 
representative sample had detectable BPA in urine samples.9 While BPA has a short half-
life and is quickly excreted from the body, its presence has been described as “pseudo-
persistent” because exposure is frequently recurring.29 
Safety concerns first emerged in the late 1990s and early 2000s, when researchers 
began reporting adverse health effects in animals. More widespread awareness from the 
public and policy makers began in the mid-2000s. In 2006, a U.S. National Toxicology 
Program (NTP) advisory panel report concluded that BPA was safe.182,183 Two years 
later, in 2008, the NTP changed course and determined there was reason for “some 
concern” (the midpoint on a 5-point scale) about BPA’s potential impacts on the brain, 
behavior and the prostate gland in fetuses, infants and children.35 Also in 2008, the FDA 
released a draft risk assessment concluding that current BPA exposures are safe for 
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children and adults. Despite the FDA’s safety determination, manufacturers of BPA and 
retailers begin voluntarily phasing out baby bottles with BPA due to advocacy efforts and 
consumer demand.182,183   
In 2009, policymakers responded to continued public concern with a host of 
legislative proposals at the local, state and federal level to restrict BPA use, particularly 
in children’s products. A federal bill, the “BPA-Free Kids Act of 2009,” was introduced 
in the Senate, but later died in committee. In 2010, the FDA announced agreement with 
NTP’s finding of “some concern” and supported reducing consumer exposures. In July 
2012, the FDA approved a request from the American Chemistry Council (ACC) on 
behalf of industry to abandon the approved use of BPA in baby bottles. The ACC noted 
this decision was not based on safety concerns, but rather industry’s desire to clarify that  
BPA was no longer being used in children’s food and drink containers.181 By the end of 
2012, 12 states, the District of Columbia and 2 localities (Chicago and Suffolk County, 
NY) had enacted restrictions on BPA.60 Figure 3 presents a brief timeline of major U.S. 
actions on BPA over the time period from 2006 to 2012. 
Despite a large body of research on BPA, uncertainties remain about whether 
BPA poses risks to human health at current exposure levels.8 In addition, there has been  
discord among government agencies, industry and public health advocates about the level 
of risk and appropriate solutions.17 The news media serve an important function in 
informing and influencing the public and policymakers about important public health 
issues. The topics covered in the news highlight potential safety concerns and convey to 
the public what is worthy of attention. The news media filter and interpret scientific data, 
as well as provide a venue for stakeholders to present their views and preferred 
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solutions.102 In cases of uncertainty about an issue, the role of the news media may be 
particularly influential, as how issues are framed in the news media may influence public 
perceptions of the significance of the problem.103  
Figure 3: Major U.S. Government Actions on BPA, 2006-2012 
No study to date has examined how potential health risks have been framed by the 
news media. In order to fill this research gap, we collected and analyzed U.S. news media 
content from major newspapers, news magazines and television sources. In particular, we 
were interested in assessing the types of products mentioned as sources of BPA, the 
December 2006:  The National Toxicology Program (NTP) releases health assessment on BPA, 
concluding that BPA is safe.  
 
June 2008: California becomes the first state to propose a ban on BPA in children’s products.  
 
August 2008:  FDA releases draft risk assessment concluding that current exposures are well below 
levels of concern in children and adults.  
 
September 2008:  NTP releases report noting “some concern” (the midpoint on a 5-point scale) for 
reproductive, behavioral and brain impacts from fetal and infant BPA exposure.  
 
March 2009: A federal bill to ban BPA in children’s food and drink containers, “The BPA-Free Kids 
Act” is introduced in the Senate, but later died in committee. 
 
March-June 2009:  Minnesota, Connecticut, Suffolk County, NY, and Chicago become the first 
jurisdictions to pass laws restricting BPA. 
 
January 2010:  FDA announces increased concern about BPA and agreement with NTP finding of 
“some concern.” FDA describes ways parents can reduce their children’s exposure to BPA and 
supports “reasonable steps to reduce human exposure to BPA in the food supply.”  
 
March 2010: U.S. Environmental Protection Agency announces plan to assess risks from non-food 
sources of BPA, and evaluate BPA substitutes in register receipts.  
 
2010: Maryland, New York, Vermont, Washington, and Wisconsin pass restrictions on BPA in food 
containers. 
 
2011: California, Delaware, Illinois, Maine, Massachusetts, and Washington D.C. pass legislation 
regarding BPA. Connecticut and Maryland pass further measures affecting BPA in additional products. 
 
July 2012: FDA disallows the approved use of BPA in baby bottles and sippy cups in response to an 
industry request.  
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discussion of BPA exposures and risk, and health endpoints linked to BPA. We also 
assessed discussion of solutions: government actions, voluntary industry measures, and 
individual consumer action. Finally, we examined news media coverage of BPA 
replacements. 
Methods	  
A quantitative news media content analysis was conducted to understand how 
BPA was framed in print and television news coverage. Twenty-two U.S. newspaper, 
news magazine and television news sources were examined. The time frame of 2006 to 
2012 was selected to correspond with a period of increasing attention on BPA in the form 
of scientific research, government reports, and public policy. Preliminary database 
searches confirmed that this 7-year period was inclusive of the majority of news coverage 
on BPA; coverage prior to 2006 was negligible. 
In order to analyze the news coverage reaching the most Americans, the top three 
U.S. daily newspapers by circulation were purposefully selected, as well as three of the 
top circulation papers from each of the four Census regions based on circulation rates 
from the Alliance for Audited Media for the years 2006, 2009 and 2012.112 All included 
newspapers were among the top 25 for national circulation rates at least two of those 
three years. The top three national newspapers in the sample were The New York Times, 
USA Today and The Wall Street Journal. The 12 regional papers were The Boston Globe, 
The Philadelphia Inquirer, The Washington Post, Chicago Tribune, Minneapolis Star 
Tribune, Milwaukee Journal Sentinel, Houston Chronicle, Atlanta Journal Constitution, 
Tampa Bay Times, Los Angeles Times, The Oregonian and The Denver Post. Time and 
Newsweek, the top two circulation news magazines, were also included in the sample.113 
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Television news coverage included three major networks (ABC, CBS, and NBC) as well 
as cable news channels CNN and Fox News. 
News Coverage Selection 
Lexis Nexis Academic and ProQuest Central were used to collect newspaper and 
news magazine articles and television transcripts in September and October 2013 using a 
single search term, “Bisphenol A.” The database searches identified 926 news stories. A 
total of 448 articles, or 48.4% of articles were included. News stories were included in 
our final dataset if they had a substantial focus on BPA. A substantial focus on BPA was 
defined as at least 100 words of text specifically related to BPA. In order to capture 
content on BPA within larger news stories on a related topic (for example, chemicals in 
food in general), news stories were included if at least 100 words focused on BPA. In 
those cases, word counts reflect only the portion of the news story on BPA. News articles 
and op-eds or editorials were included; letters to the editor and corrections were 
excluded. News stories were also excluded if they were less than 100 words or duplicates.  
A 50% random sample of included articles (n=224) was chosen for content 
analysis. While 22 sources were sampled, a total of 20 sources are represented in the 
analysis. One television source, Fox News, had no identified television news stories on 
BPA during the time period of interest. The Tampa Bay Times had one article that was 
eligible for analysis, however it was not included in the 50% random sample chosen for 
content analysis (Appendix D).  
Content Analysis 
To analyze U.S. news media content on BPA, a 38-item coding instrument was 
developed and pilot-tested by two authors (P.Truant and E. Donaldson) using articles 
from news sources outside the sample. Items were revised for clarity, and a codebook 
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was developed to facilitate reliable coding. The final coding instrument was entered into 
a Qualtrics online survey tool, which was used to code news stories. Kappa statistics for 
inter-rater reliability were calculated using Stata 13.1 statistical software. A total of 40% 
of the sample (89 articles) was double coded by the two coders. Raw agreement for each 
item ranged from 81% to 100% (average raw agreement 92%). The per-item kappa 
statistics ranged from 0.61 to 1.00 with an average kappa of 0.81 (Appendix E). A kappa 
statistic of greater than 0.60 can be considered good agreement, and 0.80 or higher is 
excellent agreement.184 
Measures 
The coding instrument was organized into four modules. Module 1 covered the 
types of BPA-containing products mentioned in news coverage. Five items assessed 
mentions of food-related products as sources of BPA: any food or drink containers; 
plastic food and drink containers; baby bottles or children’s cups; infant formula or baby 
food containers; and canned food or beverages. Three items assessed mentions of other 
BPA-containing items: any other non-food related products; paper register receipts; and 
dental fillings or sealants. 
Module 2 examined risk framing and health endpoints mentioned. This module 
assessed whether BPA was mentioned as an endocrine disruptor or having hormonal 
effects. This module also collected data on sensitive populations mentioned: pregnant 
women or developing fetuses; and infants or young children. Four items further assessed 
the context of the risk discussion: mentions widespread exposures to BPA; mentions 
potential adverse effects at low doses of BPA; mentions BPA does not pose health risks 
or is safe; and mentions that a U.S. government agency has found BPA safe. Eight health 
endpoints were chosen from a review of the scientific literature and refined during pilot 
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testing of the coding instrument. Mentions of the following health endpoints linked to 
BPA exposure were assessed: cancer; brain, development or neurological effects; 
immune system or endocrine effects; reproductive or sexual effects; diabetes; obesity or 
weight; behavior; and heart disease.  
Module 3 assessed mentions of solutions discussed to address BPA risks. Five 
items covered the government venues mentioned: any government policy action; local 
policy; state policy; U.S. federal policy; and foreign policy. Two items captured the type 
of action mentioned: banning BPA; and labeling products with BPA. Mention of a policy 
did not necessarily mean that legislation was introduced or enacted. Rather, mentions of 
policy were interpreted broadly and included policies under consideration or the subject 
of advocacy. For example, the statement “And Congress is considering a bill…that would 
ban BPA from baby bottles, sports water bottles, reusable food containers, infant formula 
liners and food can liners,” was coded as U.S. federal government action and policy 
action to ban BPA. Three items focused on voluntary industry actions: mention of any 
voluntary industry action to limit BPA; target population for voluntary action; and type of 
products voluntary action would affect. The final item in this module assessed whether 
news stories mention ways consumers could avoid BPA. 
  Module 4 captured how BPA replacements and their potential risks were 
discussed. The three items include: mentions of a specific compound which could replace 
BPA, mentions of difficulty in finding replacements and mentions of replacements in 
cans. 
Data Analysis 
Using the news story as the unit of analysis, descriptive statistics were calculated 
on the volume and content of news coverage over the seven-year study period. Logistic 
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regressions tested for shifts in coverage over the study time period, controlling for word 
count and adjusting standard errors for lack of independence among news outlets. 
Comparisons of two time periods were conducted: 2006 to 2008 and 2009 to 2012. 
Logistic regressions also tested for differences in news coverage in print versus television 
coverage and “hard” news versus op-eds or editorials, controlling for word count and 
adjusting for non-independence of news sources.  
Results	  
As shown in Table 8, the majority of news coverage analyzed was from print 
sources (79%). Print news stories were slightly longer on average than TV news (631 
versus 536 words).  
Table 8: Descriptive Information on News Stories Focusing on Bisphenol A from 
2006-2012 
Total News Stories, % (n) 100 (224) 
Television  21 (48) 
Print  79 (176) 
Print News Story Type, % (n)  
Newspaper news articles 66 (147) 
Newspaper op-eds or editorials 11 (25) 
News magazines 2 (4) 




Figure 4 illustrates that coverage peaked in 2008 and the majority of news stories 
were published in 2008 or 2009 (57%), with declining coverage in later years for both 




Figure 4: Volume of News Stories Focused on Bisphenol A from 2006-2012 by Story 
Type  
Products Mentioned as Sources of BPA  
Almost all news stories referred to food and drink containers as a source of BPA 
(97%), as shown in Table 9. Baby bottles or children’s cups were mentioned in 80% of 
news stories. Baby bottles or children’s cups were significantly more likely to be 
mentioned during the earlier time period of 2006-2008 than in later years of the study 
period (88% vs. 71%). Canned foods or beverages (72%) and plastic food or drink 
containers (68%) were also mentioned in the majority of news stories, but infant formula 
or baby food containers were mentioned only in a quarter of news stories overall (26%). 
Print news stories were significantly more likely to mention infant formula or baby food 
containers (30% versus 10%). Print news stories were also significantly more likely than 
television news to mention a specific non-food related source of BPA (39% versus 15%). 
Overall, one-fifth of news stories mentioned dental fillings or sealants as sources of BPA 
(21%) and 7% mentioned paper register receipts. Hard news and op-eds/editorials did not 
differ in their mention of BPA sources, except in a single instance. Hard print news 
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stories were significantly more likely to mention plastic food and drink containers as a 
BPA source (69%) compared with op-eds/editorials (44%).  
Table 9: BPA Sources, Risk Framing and Health Endpoints: Overall and in Print 







Products Mentioned As Source of BPA  
Food or drink containers  97 96 100 
Baby bottles/children's cups 80 79 81 
Plastic food or drink containers 68 66 75 
Infant formula/baby food containers 26 30 10* 
Canned foods 72 74 65 
Specific non-food related products  34 39 15* 
Paper register receipts  7 9 2 
Dental fillings/sealants  21 23 10 
Risk Framing of BPA 
Hormone or estrogenic effects 42 47 25 
Mentions BPA is an endocrine disruptor 8 10 NM 
Widespread human exposures to BPA 42 44 33 
BPA may cause effects at low doses 26 28 17 
BPA does not pose risks/is safe 67 66 67 
A U.S. government agency said BPA is safe 50 51 46 
Pregnant women/developing fetuses as sensitive 
populations 44 48 29* 
Infants/young children as sensitive populations 61 60 63 
Health Endpoints Linked to BPA 
Any health condition 89 88 94* 
Cancer 57 57 56 
Development, brain or neurological effects 50 49 54 
Immune or endocrine effects 9 7 19* 
Reproductive effects/sexual dysfunction 60 64 44* 
Diabetes 37 36 40 
Obesity/weight 17 19 10 
Behavioral effects 48 51 40 
Heart disease 25 23 35* 
*p-value <0.05 indicating items in news stories that differ significantly between print and 
television sources controlling for news story word count and adjusting standard errors for non-
independence of news outlets. 
 
Risk Framing of BPA  
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Table 3 also shows how news coverage framed potential risks associated with 
BPA. Relatively few articles (8%) specifically referred to BPA an “endocrine disruptor,” 
but 42% discussed BPA’s hormonal or estrogenic qualities. About two-fifths of news 
stories noted that nearly all Americans are exposed to BPA (42%). A quarter of news 
stories (26%) stated that BPA might cause effects at low doses.  
On the other hand, a large portion of news stories also presented the viewpoint 
that BPA is safe and poses no risk to humans. Two-thirds of news stories (67%) included 
statements that BPA is safe. Half of all news stories mentioned that a U.S. government 
agency has deemed BPA safe. Mentions of BPA safety along with simultaneous mentions 
of potential health risks were used to examine the extent of mixed messages in news 
stories. News stories that mentioned BPA safety were often in the context of quoting 
industry representatives or noting that the Food and Drug Administration (FDA) has 
deemed current uses of BPA in food contact applications safe. Table 10 presents 
proportions of news stories mentioning health risk items among the subset of news stories 
mentioning BPA as safe as an indication of mixed messaging in news stories. Of news 
stories that mention BPA is safe (n= 149), nearly half (46%) also mention that BPA has 
hormonal or estrogenic effects, and 28% mention that BPA may cause negative health 
effects at low doses.  
Table 10: Among News Stories Mentioning BPA As Safe (N=149), Proportion 
Noting Specific Health Risks 
 % (n) 
Mentions hormone/estrogenic effects of BPA 46 (68) 
Mentions BPA may cause negative health effects at low doses 28 (41) 
Mentions infants/young children as sensitive population 66 (99) 
Mentions pregnant women/developing fetuses as sensitive population 48 (72) 
Mentions at least one health endpoint 91 (135) 
 
	   88	  
Many news stories mentioned specific populations of concern with regard to BPA 
exposure. Pregnant women or developing fetuses were mentioned in 44% of articles 
(Table 3). Print news stories were significantly more likely to mention pregnant women 
or developing fetuses as sensitive populations than television sources (48% versus 29%). 
Infants or young children were mentioned as a sensitive population in 61% of news 
stories, with no differences in reporting between print and TV sources. Of news stories 
that mention BPA is safe, two-thirds (66%) refer to infants or young children as a 
sensitive population, and 48% refer to pregnant women or developing fetuses as a 
sensitive population.  
Health Endpoints Linked to BPA 
Overall, 89% of news stories reported at least one health endpoint linked to BPA 
(Table 9). The mean number of conditions reported in news stories was three (SD 1.8). 
Television sources were significantly more likely to report any health condition.  
Reproductive effects were most likely to be mentioned as linked to BPA (60%). 
Cancer (57%) and developmental, brain or neurological effects (50%), were the second 
and third most common health endpoints mentioned. Television sources were more likely 
to report immune or endocrine effects and heart disease compared to print sources (19% 
versus 7%). Print sources were more likely to mention reproductive effects or sexual 
dysfunction (64% versus 44%). Of news stories mentioning BPA is safe, the vast 
majority also list at least one health endpoint linked to BPA (91%), as shown in Table 10.  
Solutions  
Table 11 displays government policy solutions to address BPA risk overall, by 
both print versus TV and comparing earlier (2006 to 2008) and later (2009 to 2012) 
years. Eighty percent of news stories discussed at least one solution (government action, 
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voluntary industry action or individual consumer action)—with news stories in the later 
time period significantly more likely than earlier news stories to mention any solution 
(84% versus 77%). Slightly more than half of news stories mentioned any policy action 
related to BPA (53%). Common examples of policy action discussion included mention 
of proposed or enacted laws to ban BPA in children’s products or mention of advocates 
fighting for such a law. Print news stories were significantly more likely than television 
sources to discuss policy, and news stories published between 2009 and 2012 were more 
likely to discuss policy solutions compared to stories published in earlier years.  
Local, state and federal government actions on BPA were mentioned in 12%, 26% 
and 28% of news stories, respectively. For all three categories, print news stories and 
news stories published in the later period were significantly more likely to mention these 
policies than in earlier years. For example, state government actions were mentioned in 
40% of later news stories as opposed to 14% of news stories from 2006-2008. The most 
common policy item, mentioned in 49% of news stories, was banning BPA. Print news 
stories were significantly more likely than television news to mention banning BPA (54% 
versus 29%, p value <.05). Nearly three-fifths of news stories in the later years of the 
sample mentioned banning BPA (58%) versus 40% of news stories from the earlier time 
period. There was little discussion of policies that would label products with BPA (4% 
overall). Among print news sources, op-eds or editorials (n=25) were more likely than 
hard news to discuss several policy related items: any government policy action (80% 
versus 54%); banning BPA (68% versus 52%) and labeling BPA (12% versus 3%).  
 Table 11 also presents results on news media reporting of voluntary industry 
actions related to BPA. An example of a voluntary action commonly mentioned involved 
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retailers such as Wal-mart and Toys R Us removing children’s products with BPA from 
their shelves. Another type of voluntary action mentioned was the manufacturer (for 
example, Playtex) ceasing to produce baby bottles with BPA. Overall, 40% of news 
stories mentioned any voluntary actions, with no significant differences by news source 
type or by time period. Of news stories discussing voluntary actions (n=90), the majority 
referred to food or drink containers (87%) and restrictions on products for children under 
3 (58%). 
 Nearly 40% of news stories provided information on how consumers could avoid 
BPA exposure. For example, avoiding canned foods or switching to glass bottles instead 
of hard plastic bottles were common recommendations. TV sources were more than twice 
as likely to discuss consumer actions—73% in TV news stories versus 31% in print news 
stories. Op-eds and editorials were also significantly more likely to discuss individual 
consumer actions—34% mentioned things consumers could do to avoid BPA, versus 
12% of hard print news.  
Replacements for BPA 
As shown in Table 11, there were very few mentions of replacements to BPA. For 
the small minority of articles that did discuss replacements, common examples of the 
discussion included mention of the need for replacements or the existence of viable 
replacements. Only 3% of news stories named a specific compound that could replace 
BPA. Discussion of the difficulty in finding replacements occurred in 2% of news stories. 
Some articles also mentioned replacements specifically for canned foods and beverages 
(4%). While there is a trend toward more mentions of replacements in the later years, this 
observation is not statistically significant. 
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Table 11: News Coverage Mentioning Solutions: Policy, Industry and Consumer 





















Policy, Industry and Consumer Actions 
Any action  80 78 90 77 84* 
Any government policy regarding 
BPA  53 58 35* 46 61* 
Local government policy  12 14 4* 2 23* 
State government policy 26 28 17* 14 40* 
U.S. federal government policy 28 32 10* 19 37* 
Foreign government policy 29 32 21 26 33 
Government policy to ban BPA 49 54 29* 40 58* 
Government policy to label BPA  4 5 NM 4 3 
Voluntary industry action to limit BPA 40 42 35 35 46 
Consumer recommendations to avoid 
BPA 40 31 73* 41 38 
Replacements for BPA 
Specific compound to replace BPA 3 3 2 2 4 
Difficulty in finding replacements 2 3 NM 1 4 
Replacements in food or beverage cans 4 5 NM 1 7 
* p-value <0.05 indicating items in news stories that differ significantly between print and 
television sources or earlier and later time periods controlling for news story word count and 
adjusting standard errors for non-independence of news outlets. 
NM= no mentions within news stories 
Discussion	  
Given the influence of the news media in framing which health issues are worthy 
of the public’s attention, and the disagreements related to the nature of health risk 
attributable to BPA exposure, it is important to understand how this issue has been 
discussed in U.S. news coverage. Coverage patterns over the seven-year study period 
indicated that media attention peaked in 2008, and has decreased substantially in more 
recent years. BPA sources mentioned were largely food-related (i.e. baby bottles or food 
and beverage cans). News stories often focused on children’s exposure—most mentioned 
baby bottles or children’s cups as a BPA source, and a majority of news stories framed 
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infants and young children as a sensitive population. Reproductive effects, cancer, and 
developmental effects were the most often cited negative health effects linked to BPA. 
Many articles presented both sides of the issue—mentioning both the potential health 
risks of BPA and that the compound has been deemed safe by some stakeholders. 
Solutions such as government policy, industry and consumer actions to reduce BPA 
exposures were discussed in the majority of news articles, but mentions of replacements 
to BPA were largely absent. Print sources and news stories from the later period of the 
sample (2009 to 2012) were more likely to mention U.S. government policies to restrict 
BPA than stories from earlier years. 
The news coverage spike in 2008, followed by decreasing numbers of news 
stories in the following years is consistent with both the timeline of key U.S. actions 
related to BPA, as well as the issue attention cycle described by Downs.106 In this cycle, 
attention peaks for a relatively short period, after which the costs of solving the problem 
are realized and interest fades—often before the problem that originally attracted media 
attention has been resolved. 
Given the focus of policy efforts on children’s polycarbonate drink containers, the 
widespread news media coverage of baby bottles was expected. However, our findings 
can not inform whether news media coverage drove public concern about baby bottles 
with BPA or vice versa. Canned food and beverages were mentioned in a majority of 
news stories, indicating that this was a commonly reported source of BPA in U.S news 
media coverage between 2006 and 2012. Despite this, most government policies and 
voluntary industry actions have focused on polycarbonate plastic uses. This may be due 
to difficulty in finding suitable replacements for BPA’s use in epoxy resins in can 
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liners.185,186 Food and drink containers are believed to be the primary source of human 
exposures, 25,187 and likewise the news media coverage also focuses on food containers. 
Other non-food related sources, such as cash register receipt paper, received much less 
coverage in our print and television news sources. Current evidence suggests that 
handling cash register receipt paper may contribute to overall human exposure levels, 
especially for people in occupations such as cashiers.188,189 However, more research is 
needed on the dermal absorption of BPA.190,191 During the years of the study period, news 
media coverage focused predominantly on food-related sources and thus for some 
populations, other relevant exposure sources may have been underrepresented. 
Of the top three health endpoints most often linked to BPA, cancer was the only 
condition that was not cited by the NTP in their finding of “some concern” for fetuses, 
infants and children. More than half of news stories (57%) mentioned cancer, which may 
be reflective of advocacy campaigns by health and environmental organizations.77 It is 
also possible that in light of the “fear factor” associated with cancer, research linking 
BPA with cancer was highlighted in the news media.192 	  
 Two-thirds of news stories also included some mention that BPA is safe—and 
half of all articles specified that a U.S. government agency has found BPA safe. This 
indicates that government actions were reported in many news stories at least briefly. 
Many articles mentioning safety also reported on potential health risks. This indicates 
that opposing viewpoints were represented in much of the news media coverage. Notably, 
this does not mean that the news stories were equally balanced. For example, some news 
stories briefly mentioned that FDA considers BPA safe, or quoted an industry 
representative stating that there is no evidence that BPA causes harm, while overall 
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focusing on BPA as a health risk. Conversely, some news stories (particularly op-
ed/editiorials) argued that BPA is safe while dismissing links to health endpoints as 
unproven. 
 Removing BPA from the marketplace and reducing consumer exposures was a 
prime focus of news coverage, but discussion of viable replacements was nearly 
nonexistent. This is an important finding as in recent years there has been increasing 
health concerns about some BPA replacements with similar hormonal activity.193,194 In 
the discussion of BPA and other emerging chemical risk issues, public health advocates 
should work to ensure that, when warranted, safe replacements are an integral part of the 
discussion in order to avoid regrettable substitutions. Researchers have emphasized the 
need for chemical alternatives assessments to distinguish between alternatives and ensure 
that replacements do not pose equal or higher or risk as the original compound. 195,196 
This would help ensure that chemicals like BPA are not quickly replaced with “BPA-
free” alternatives, without sufficient knowledge of the replacement material or its safety.  
This study has several limitations to note. First, as news outlets were chosen for 
their broad reach based on circulation and television viewership rates, the sample did not 
represent the entire landscape of U.S. mainstream media. Secondly, the analysis is limited 
to traditional news media and does not capture content including blogs, special interest 
publications or web-only sources. Further research is needed to understand whether the 
patterns of coverage of BPA in emerging news sources resembled those found in 
traditional news. One newspaper in the sample, the Milwaukee Journal-Sentinel, 
published a special series called “Chemical Fallout” focusing largely BPA during the 
study period, and thus its coverage is not representative of all news sources. Third, it was 
	   95	  
beyond the scope of this research to assess causal relationships related to news media 
coverage and policy or consumer actions. Finally, this study cannot extrapolate any 
findings to the attitudes or knowledge of the general public about BPA. However, this 
study provides the first systematic analysis of news media content on BPA in the United 
States. This study characterized the discussion of key BPA sources, populations of 
concern, health endpoints and solutions. This study demonstrated mixed and conflicting 
risk messages were prevalent in the news media content, and comprehensive discussion 
of solutions was lacking, particularly with regard to BPA replacements. 
Conclusion 
The news media is an important avenue for communicating complex scientific 
and risk information to the public. In the midst of uncertainty, this is an even more 
challenging and critical task. In the case of BPA, mixed messages in news coverage may 
reflect both scientific uncertainties and conflicting opinions and actions of government 
agencies and other stakeholders. Risk communicators and public health practitioners 
should be careful to distinguish scientific uncertainty from disagreement on appropriate 
solutions (risk management), in order to avoid undermining the credibility of the science 
and contributing to further confusion. Future research could address how readers interpret 
news stories with mixed messages, and how news media framing affects behaviors and 
beliefs about BPA and other common environmental health exposures. Additionally, 
future research could study the public’s perception of federal government agency 
decision-making on chemical risk assessment and other environmental health issues. 
These efforts could enhance the understanding and effectiveness of public health risk 
communication.  
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BPA has been at the center of scientific and public policy debate in the U.S. over the last 
decade. Key stakeholders including government agencies, industry groups, health and 
environment-focused non-governmental organizations, researchers and the media have 
been engaged in studying, advocating and communicating about the safety of this 
ubiquitous component of food packaging and other consumer goods. Despite the public 
scrutiny on the chemical’s safety, there is little understanding of the role of stakeholders 
in the debate. Semi-structured interviews with key stakeholders were conducted to 
understand key stakeholder perspectives on the goals and challenges of effective risk 
communication on BPA. This study found that the risk communication was driven by the 
science to some extent, but also characterized by accusations of subjectivity and conflicts 
of interest among communicators. Understanding the health impacts of low-level 
environmental exposures is scientifically challenging, and perhaps an even bigger 
challenge is risk communication in a politicized atmosphere. There is a continued need 
for more clear and comparable scientific reporting, as well as credible messengers who 
can deliver accurate information to the public without overstating knowledge. This study 
provides insights on translating complex scientific information to the public and 
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Introduction	  
 Bisphenol A (BPA) is a common industrial chemical often found in food and 
beverage containers such as hard plastic bottles and canned goods.1 There has been much 
research and public interest in BPA in the U.S. in recent years, due to its definition as an 
endocrine disrupting compound (EDC) with weakly estrogenic properties.10,11,14 
Endocrine disruptors are defined by the World Health Organization as “an exogenous 
substance or mixture that alters function(s) of the endocrine system and consequently 
causes adverse health effects in an intact organism, or its progeny or (sub)populations.”10 
EDCs may mimic or block the effects of natural hormone functions. Data from animals 
and humans has linked BPA with a range of adverse health effects, including 
cardiovascular effects, sexual dysfunction, infertility, obesity, early puberty, prostate and 
mammary gland cancers, behavior changes, and diabetes.7,8 
As documented in prior analyses (Chapters 4 and 5), stakeholders have come to 
opposing conclusions about the safety of BPA and presented conflicting and confusing 
messages to the public through the news media and other venues. As part of a case study 
on BPA risk communication from stakeholders and in the news media, this study sought 
to understand the goals and challenges of communicating about BPA risks from the 
perspective of U.S. experts from government, industry, health or environment-focused 
non-governmental organizations (NGOs), the media, and academic and other research 
organizations. Risk communication has been defined as “the term of art used for 
situations when people need good information to make sound choices.”19 Risk 
communication is an essential component of effective risk management and in particular, 
sound public policymaking.20 A dilemma for public health practitioners is how to 
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communicate about potential health risks when the research is imperfect or uncertain, as 
is often the case in science.  
Much research has focused on best practices for risk communication, but it is 
difficult to provide clear and concise recommendations applicable for all situations.46 
Another important factor to consider with regard to risk communication is risk 
perception—in other words, how experts and the public come to conclusions about risks 
and benefits. The risk communication literature distinguishes between hazard—an 
expert’s assessment of risk, and outrage—the public perception of risk. Some risks may 
be a high hazard with low outrage—such as traffic accidents. Other risks may be a low 
hazard but have a high degree of outrage and fear associated with them—for example, 
nuclear accidents.48 Some characteristics contribute to elevated fears, including: man-
made risks, involuntary exposures, new or unfamiliar risks, widespread media coverage, 
lack of trust in communicators, and potential effects on children.47-50	   
In light of these concepts, this research explored how stakeholders described the 
challenges of researching and communicating about BPA. This work has relevance and 
implications for risk management of environmental chemicals and the specific solutions 
that were implemented with regard to BPA—including voluntary industry actions, 
regulatory actions, and legislative actions. Specific research questions included: 1) How 
do key stakeholders describe the scientific literature and their risk communication 
strategies with regard to BPA? 2) What are the challenges inherent in risk communication 
on BPA? 3) How do stakeholders define effective risk communication?  
Methods	  
Procedures 
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Between December 2013 and March 2014, semi-structured interviews were 
conducted with key stakeholders about the goals and challenges of BPA risk 
communication. The selection strategy for the interviews included both purposeful 
sampling and snowball sampling.107,121 The sample was stratified in order to include the 
relevant groups who have communicated to the public about BPA. This approach 
facilitates comparisons between groups and includes varied perspectives.97 The 
stratifications included: 1) government agency representatives, 2) industry groups and 
consultants, 3) researchers/academics 4) non-governmental organizations, and 5) news 
media representatives/journalists. Potential participants were identified during 
background review of the scientific literature and news media reports. Snowball sampling 
was used to identify additional experts from the initial set of contacts. This allowed for 
maximizing the diversity of perspectives and including additional relevant organizations 
and individuals involved in risk communication on BPA.97 
Potential respondents were contacted by email requesting an interview. The initial 
email described the purpose of the study and the anticipated interview length of one hour 
(Appendix F). Follow-up emails and/or phone calls were used to contact people who did 
not respond to the first email within two weeks. In order to encourage participation and 
minimize any risk to participants, interviewees were advised that their names or 
organizations would not be identified in the study results. Interviewees were read an oral 
informed consent document (Appendix G) and given the opportunity to ask questions 
prior to the start of the interview and skip any questions they did not want to answer. 
Interviews were conducted until theoretical saturation and data sufficiency were 
achieved.97  
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A semi-structured interview guide was used in each interview to facilitate 
comparisons. The interviews covered several domains, including 1) background 
information on the individual’s or organization’s efforts related to BPA; 2) BPA 
communication goals, strategies and main messages 3) the state of the scientific evidence 
and the use of scientific information in communications; and 4) the challenges of BPA 
risk communication, evaluation of messaging about BPA and advice for effective risk 
communication. Probes were tailored by the researcher based on interviewee’s responses 
and the interviewees could introduce topics not directly highlighted in the questioning. 
This approach allowed for additional context and understanding of important issues that 
emerged in the interviews.122 In some cases not all questions were applicable to all 
respondents. For example, questions focusing on organizational communication and 
policy goals were not necessarily relevant for media representatives or researchers. Thus, 
the interview guide was tailored to participants’ roles but remained as similar as possible 
to facilitate comparable responses. Appendix H provides the interview guide.  
In October 2013, the Johns Hopkins Bloomberg School of Public Health 
Institutional Review Board (IRB) determined that this study was not human subjects 
research and thus did not require IRB oversight (Appendix A). Interviews were digitally 
recorded and transcribed verbatim (with the exception of one interviewee who did not 
give consent for recording). 
Data Analysis 
Interview data were analyzed using HyperRESEARCH Version 3.5.2 qualitative 
analysis software.124 The analysis process began with the lead author (PT) reading 
through the interview transcripts (or the researcher’s notes) several times and creating 
relevant structural and thematic codes120 based on the research questions and interview 
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guide. Structural codes, or organizational categories96 included identification of 
interviewee’s stakeholder group (i.e., government) or denoting a particularly cogent 
quotation. Substantive categories, or thematic codes, more directly describe the content of 
the statements and facilitate analysis.120 Examples of thematic codes included discussion 
of scientific literacy, objectivity and evaluation of the news media. Some codes were 
developed a priori based on knowledge of the questions in the interview guide, while 
others emerged iteratively during review and re-review of transcripts. During this 
process, central themes were identified and some codes were expanded to include broader 
concepts, while others were collapsed or eliminated if they were too specific or repetitive 
with other codes.107 The final codebook is provided in Appendix I. 
Results	  
Between December 2013 and March 2014, representatives from 74 organizations 
were contacted to participate in the study. Eleven groups declined to participate. Reasons 
provided for declining included time constraints and lack of knowledge or current 
involvement on the issue. Of those who declined to participate, three were from NGOs. 
Additionally, there were two persons who declined each from industry/consulting, 
research, and the news media, and one decliner from government. Twenty-seven groups 
did not respond to initial or follow-up contact. Of the organizations that did not respond, 
nine were from industry/consulting, eight were individual researchers, five were from 
NGOs, three were from government, and two were from the news media.  
A total of 36 organizations were interviewed in 39 interviews. In two cases, 
individuals from the same organization were interviewed separately (one NGO and one 
government agency). In five cases, two to three respondents from the organization 
respondent participated in the interview. The unit of analysis used in this study is the 
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organization (n=36). Table 12 presents the breakdown of interviews and participants 
within each stakeholder category. Interviews lasted an average of 47 minutes. In-person 
interviews were preferred, however, due to distance and interviewee scheduling 
preferences, the majority of organizations were interviewed by phone (n=31). Four 
interviews were conducted in person, and one interview was conducted via Skype.  
Table 12: Number and Type of Stakeholder Organizations Represented in Semi-
Structured Interviews 
 
 Results were organized into four categories: 1) discussion of the scientific 
evidence on BPA, 2) factors influencing risk perception of BPA, 3) BPA risk 
communication challenges, and 4) risk communication recommendations. 
Scientific Evidence on BPA 
Interviewees were asked to describe the state of the scientific evidence on BPA. 
Many respondents noted the vast number of studies that have been conducted about BPA, 
but some noted that the scientific literature can be confusing and is still lacking in some 
areas. Several respondents, particularly from NGOs, government and research, noted the 
difficulty of keeping abreast of the scientific literature and keeping findings in 
perspective, as illustrated in Table 13. A few respondents also described the multi-
disciplinary perspectives needed to understand the literature—including toxicology and 
endocrinology.  
Organization Type Number of 
Interviews 






Government  6 9 4 
Industry/Consultant 8 9 8 
NGO 11 12 10 
Researcher  9 10 9 
News media 5 5 5 
Total 39 45 36 
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Other respondents reported that the literature is clear and compelling. For 
example, most NGOs and some researchers noted that there is clear cause for concern 
about BPA exposure end enough evidence to warrant precautionary actions. Other 
researchers and most industry respondents noted that the evidence is compelling in the 
other direction—that there is not convincing evidence of harm from BPA exposure. Table 
13 provides examples of the state of the evidence discussion. 
Table 13: Examples of Stakeholders’ Discussion of BPA Literature 
Theme Quote Respondent 
Category 
Sure is difficult when you are talking about all the different endpoints that 
people have published on for BPA…even scientists sometimes have a hard time 
putting all that information together and thinking about it. 
Government 
I think it's definitely confusing to a non-technical audience and it's also hard 
for people to understand the whole field of endocrine disruption being an 
emerging area of research... It is hard even for regulatory agencies to evaluate 





There has been an incredible amount of research done on BPA, but a lot of it 
is not terribly informative. A lot of the earlier research was done with 
methodology that the government has since decided it doesn't think is valid, 
and having to do with the way that BPA was administered to animals and 
things like that…There's not been a lot of good science on the impact on 
people. 
Media 
So while we may not be clear on exactly what level is risky and exactly for who 
and exactly what is the increased risk of various illnesses, it’s very clear that 
there’s a relationship between BPA and high blood pressure, heart disease, 
even when you’re controlling for obesity, and so on…but I don’t really think 
that any unbiased person would say that it’s unclear whether BPA can be 
dangerous. I think industry’s the only people, or the only folks saying that 
there’s no clear evidence that it’s dangerous. 
NGO 
Well, I think there’s a growing body of evidence that makes it very clear that 
endocrine disrupting chemicals in general and BPA in particular have 
risks…We don’t know that much about exactly what impact it has and it’s very 
hard to measure because people are exposed to it all the time and the levels in 
their bodies change from day to day so its, you know, it would be impossible to 
do the perfect study on it but we already have a growing body of evidence that 








The reason BPA has exploded the way it is, and so many people are getting 
grants and the National Institute of Environmental Sciences puts 30 million 
dollars of their funding into just BPA as a model endocrine disruptor is 
because it was absolutely clear, from a scientific perspective, that this was a 
really bad news chemical. I mean, there's no argument about this in the 
scientific community. You can argue about specific details, but not that there's 





Well I think it is far more clear today than in has been in the last couple of 
years… The European Food Safety Authority just recently released its latest 
risk assessment on BPA and came to some significant findings, which basically 
Industry 
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state that the current exposure is safe from basically all of the sources that 
consumers would come from. So the science around it is becoming far more 
conclusive about the safety of the materials at the current use levels. So I 
would say it's becoming very solid. 
Industry 
So I'm fully convinced that the weight of the evidence of Bisphenol A basically 
says that under today's conditions of use…that the current exposures of 
Bisphenol A are well within and well below actually the current levels of 





 The fears are overblown, and are not supported by the preponderance of 
evidence…Of course with any topic you can always find a study to back up any 
view that you may have. But what we should do in the world of science is look 
at all of the evidence available and not cherry pick the data. We need to shake 
the whole tree until all the cherries come down and then mash those together 
and taste that. 
Researcher 
 
Overall, NGOs noted concerns about public health impacts from BPA exposure. 
There was one notable exception, as one NGO stated “there basically are no risks.” The 
majority of respondents from the industry or consulting category cited skepticism that 
human exposures to BPA pose human risks, discussed limitations of existing research 
suggesting harm, and referred to the safety determinations of U.S. and international 
regulatory bodies. Some industry organizations indicated that BPA may produce clear 
effects at high doses, but the evidence doesn’t suggest the need for concern at typical 
consumer level exposure levels. For example, one industry/consulting respondent stated:  
“I am not convinced that the perturbations that have been reported, if in fact they 
are reproducible and real—of which I have some skepticism—produces adverse 
effect. So I acknowledge it has biological activity, in very high amounts... I would 
never as a scientist absolutely close the door… But…in my opinion I'm 
skeptical...that it serves as an...environmental risk.” 
 
Researchers, government agencies and the news media presented varied 
perspectives. Some researchers highlighted concerns about BPA based on their own study 
findings or findings from fellow researchers. Other researchers described study findings 
supporting BPA safety and offered critiques on the existing body of scientific literature. 
Government respondents from relevant federal agencies also presented divergent 
opinions—with some interviewees indicating concerns and lingering questions regarding 
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the health effects of BPA, while others maintained BPA safety based on the weight of the 
evidence. News media respondents were also varied in their discussion of BPA risks and 
description of how the issue has unfolded. While not all media respondents indicated a 
clear stance on BPA risk, some described how they perceived their role in 
communicating about the issue. For example, one media interviewee stated:  
“We have highlighted the absence of critical data from the public debate or the 
mistaken data within the media coverage. And as such, the overwhelming 
conclusion of all of that research is that the public has been misled about the risks 
of BPA and we believe the…risk assessment process conducted by the FDA and 
EFSA has reached a correct conclusion. Again, based on the most rigorous 
methodological research on the subject. “  
 
Another media respondent categorized their role in the following way:  
“So because we're not scientists, we're not equipped to pass judgment on whether 
or not this chemical… is a… hazard of any kind. What our role was is to look at 
how pure or how unadulterated the government's examination of those risks are, 
and so that's why we looked for unholy alliances or any kind of inappropriate 
pressure on government regulators… It was obvious that there was a heck of a lot 
of pressure from the plastics and chemical industry to minimize any kind of 
concern about bisphenol A.” 
	  
Overall, stakeholder organizations agreed that BPA is a challenging topic to 
research for a variety of scientific reasons. In light of the multi-disciplinary nature of the 
research, stakeholder organizations varied in their perceptions of appropriate 
methodological approaches to study BPA. Many organizations highlighted the 
differences between traditional toxicology based approaches (often large studies using 
“good laboratory practices” or a “guideline” approach) and studies designed to explore 
hormonal effects informed by the endocrinology and epidemiology disciplines.  
One government respondent described the disparity between different research 
approaches in the following way: 
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“I think one of the issues is there is very little study repetition that actually goes 
on, or study replications. The settings that the industry tends to rely on are the 
guideline kind of study. On the other side, people tend to look at exposures in 
different models which are not guideline...and it would be very nice if they were 
telling you the same thing, but they are asking very different questions and using 
different models. And I think that is very important to understand. So that, the fact 
that person A finds something and person B doesn't— doesn't necessarily mean 
that either of them is wrong.” 
 
Stakeholder organizations with concerns about the health risks of BPA often 
pointed out that traditional toxicological approaches may not be sensitive enough to 
capture hormonal effects and evaluate potential endocrine disruptors. Stakeholder 
organizations that erred toward BPA safety often mentioned limitations in smaller scale 
“academic” studies and the lack of standardization and reproducibility among some 
studies showing BPA effects. Figure 5 provides a summary of key findings on BPA 
scientific literature from stakeholder organizations. 
Figure 5: Summary of Key Points on BPA Scientific Literature from the Perspective 
of Stakeholder Organization Respondents (n=36) 
Factors Shaping Risk Perceptions of BPA 
 Respondents were asked for their perceptions on why BPA has been the subject of 
public attention and research scrutiny. Overall, respondents agreed that BPA has been the 
focus of much research and public attention. Respondents from government and NGOs 
frequently cited potential effects on children and BPA’s presence in baby bottles as a 
reason for heightened awareness and concern. Another reason mentioned was the 
• There is a large body of research on BPA, which can be difficult to interpret and requires 
understanding of multiple disciplines, including toxicology, endocrinology and risk 
assessment. 
• Some respondents perceive the literature to provide compelling evidence of health effects 
from BPA exposure. 
• Other respondents perceive the literature to provide compelling evidence of the safety of BPA 
at human exposure levels. 
• Respondents identified two distinct types of BPA research—studies using a toxicological 
approach (often large-scale studies using good laboratory practices) or an approach designed 
to assess more subtle hormonal effects (sometimes referred to as academic studies). 
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ubiquity of the chemical in common products and measurable in human bodies. As a high 
volume chemical to which nearly everyone is exposed, respondents also noted BPA’s 
high market value and the fact that it is an “enormous commercial asset” (according to a 
government agency).  
 Others noted factors contributing to heightened risk perception among the public, 
as described in the following response from a news media respondent: 
“Well if you talk to people who study risks, this is one of those things that kind of 
meets the criteria for worrying people. One, it's described as a chemical… and 
people are worried about chemicals. It's described as something that companies 
are putting in, are exposing you to against your will or without your knowledge. 
That tends to make people especially worried, and it's been described as affecting 
infants or developing fetus, and those are groups that we particularly worry about, 
so it's the trifecta of fear, right?  It has all of the elements that most make people 
afraid. It's a chemical that we're being exposed to by companies, and it could 
affect our children.” 
 
 Industry respondents noted reasons such as high levels of research funding and 
BPA emerging as the “chemical du jour” as reasons for public attention. Another theme 
that emerged from some industry respondents (as well as a few research and NGO 
respondents) is the concept of “chemophobia” among the public and an “emotional” 
response that is less influenced by the science and more influenced by distrust of 
industry. According to one industry respondent: 
“I think our society is cancer-phobic. The public confuses endocrine disruption 
with cancer and if a researcher can get the money to investigate that and go up 
against quote—big business and big chemical—and they can force a scary result, 
they'll get more research money and they'll get more notoriety.” 
 
A contrasting message from NGOs and researchers was the issue that the 
government is not adequately protecting them from potentially hazardous exposures, and 
that consumers should not have to worry about whether everyday products are harming 
their family. As one NGO described: 
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“In the space of chemicals, I think it feels really unsafe because nobody is 
manning, no one is watching over us and I think that… when you hear just how 
outdated and antiquated our chemicals management system is, that freaks people 
out too. So this sense that well, I should be able to pick up a receipt or get a baby 
bottle that isn't going to put my child at risk. That message resonates with people 
like ‘Bingo’!  That's why that baby bottle thing was just like whoa, over the top 
messaging. It was like—hit it out of the park, right?” 
 
Interestingly, several others noted that BPA has received heightened attention 
because it is easy to spell and pronounce. A NGO respondent stated: 
“I think it’s no small thing that everybody can pronounce BPA. To this day, I find 
that a lot more people know what BPA is than know what phthalates are, and 
they’re both very similar in their potential risks and both similarly ubiquitous in 
our environment.” 
 
Additionally, many organizations noted that a reason BPA has been the subject of 
much public attention is due to the success of advocacy efforts—including local and state 
bans of BPA and industry abandonment of some uses. A critical theme that emerged from 
all five types of organizations was the identification of BPA as a “poster child of 
endocrine disruption.” Both respondents who described BPA as harmful and respondents 
who described BPA as safe commented that BPA has become a symbol for the 
environmental movement, or a “flagship for endocrine disruptors.” According to a 
research respondent: 
“There's a community of endocrine disruptor scientists who… have really seen 
BPA in some ways as the poster child of endocrine disruption, and that in and of 
itself has elevated it in the scientific discourse….It doesn't mean there's not a lot 
of other chemicals that are just as bad, so in some ways BPA is just a poster child 
of a system.”  
 
Another researcher elaborated on this concept of BPA as a poster child for a 
movement: 
“In the case of BPA, I very strongly feel that it has become the poster child for the 
group of people who are trying to promote, if you will, the idea that endocrine 
disruption and endocrine disrupting compounds are a major new threat to public 
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and environmental health. It's gotten attention because of that, and that's some 
pretty scary stuff and the media reports on it regularly, so they fuel that. It's also 
gotten a tremendous amount of attention I think because remember…toxicologists 
don't get money to study non-toxic things... It’s just, in my opinion it has very 
little to do with BPA anymore, and it has more to do with all these other things. 
And in some ways it has less to do with public health than some of these people 
would be willing to admit I think.” 
 
 Several respondents from research and NGOs indicated concern that BPA’s status 
as a poster child for endocrine disruptors could backfire for advocates if the science does 
not support continued public health concern. For example, one NGO respondent 
explained: 
“It's a problem when the science then starts to undermine possibly the assertion 
that it's a huge public health risk right now to everybody, and it's like it’s 
threatening the whole enterprise, which we don't want, because it's representing 
something that is a real problem.” 
 
Figure 6 presents the main findings discussed by stakeholder organizations with 
regard to the public’s perception of BPA risks. 
Figure 6: Summary of Key Factors Shaping Risk Perceptions from the Perspective 
of Stakeholder Organization Respondents (n=36) 
Risk Communication Challenges 
 Given the complexity of the science and opposing conclusions from various 
stakeholders on the public health implications of BPA, the vast majority of respondents 
described communicating to the public about BPA as challenging. Themes that emerged 
from the interviews on the topic of BPA risk communication challenges are described 
below. 
• BPA is a ubiquitous substance to which nearly everyone is exposed. 
• BPA was present in baby bottles and items for children, who may be sensitive to 
exposure. 
• BPA is a very lucrative, high volume chemical. 
• BPA is easy to pronounce and spell. 
• Public distrust of “big business” and chemicals in general. 
• BPA has become a symbol, or “poster child” for endocrine disruption. 
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Scientific Literacy and Translating Science 
 Many respondents mentioned difficulties in translating complex science and 
explaining the limitations of the research. For example, stakeholder organizations 
mentioned taking care to convey findings in a way that’s relevant to human health. Many 
respondents from government and industry in particular spoke of the limited scientific 
literacy of the public and the media as a challenge of communicating nuanced scientific 
results. According to one government agency:  
“There's literacy issues. There's scientific literacy, which is a big thing with me. 
You know…a lot of people have made up their minds about BPA. I talked to a lot 
of people personally about it and they've made up their minds. There's nothing 
really we can say that will convince them otherwise… There's probably the vast 
majority of people really don't care what's in their food, and as long as it's in the 
grocery store, they feel it's safe you know. And then there's an active group of 
people who feel that BPA is dangerous and anything we say regarding its safety is 
just not to be trusted.” 
 
Further, expertise in multiple realms is needed to fully understand the science, 
prior to conveying the message, as the same government agency explained: 
“This isn't easy stuff because we work at the edges. We work at the edges of 
technology, we work at the edges of safety, we work at the edges of regulations 
and that's three areas that someone has to be an expert in before they can really 
understand what we do and it's very difficult for us to put a message out in that 
environment.” 
 
Other interviewees from multiple sectors also emphasized the difficulty in 
conveying uncertainty in communications. For example, an industry organization noted 
that an important challenge, which is not unique to BPA, is that “the uncertainty that is 
typically attached to results of studies doesn't necessarily get easily translated into 
popular media.” 
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 The complexity of BPA research noted in a prior section was also cited as a 
barrier to clear and effective communication to the public. A news media respondent 
described the difficulty as such: 
“I think it's extremely difficult because it involves a lot of scientific nuance. It 
involves complicated concepts having to do with dose response curves. It involves 
people understanding the difference between different administration routes. It 
involves concepts like clearance from the body. It involves active forms of 
circulating chemical versus ones that have been bound and are going to be 
eliminated from the body. These are all concepts that are really hard for the public 
to get across, and yet they are critical to understanding potential risks from this 
chemical.” 
 
Even when journalists were willing and able to go into technical detail on BPA 
science, venues for such stories are limited in the traditional news media due to the 
complexities of the subject, according to a news media respondent.  
“I actually had an assignment for a major magazine to write about BPA, and the 
magazine ended up killing the story because the science was so complicated. You 
know, what happens is you can get into the weeds really fast with BPA…It's very 
technical and quite dry and boring, but it's also really important in the discussion. 
So if you really want to write about BPA, you kind of have to get into that stuff 
but the fact is that most major news organizations don't want to write that up, it's 
too boring.  
 
A counterpoint to the notion of insufficient scientific literacy among the lay 
public and the press was observed in several interviews—which was that that scientific 
literacy among the public is often underestimated and researchers often have difficulty 
adequately translating their findings. A government agency respondent said: “I think 
sometimes scientists especially tend to underestimate what the public can understand and 
I think scientists often have a problem in communicating their understandings because 
they forget that science is often spoken in a language which is not the same that everyone 
else speaks.” Another researcher echoed the point that scientific translation is difficult for 
journalists and researchers alike:  
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“What we do is very complicated, and a lot of times we see researchers who are 
trying to communicate the results of a recent animal study, and they get pushed to 
go too far with the relevance of that finding to humans. We also see people who 
have really cool fascinating results that downplay them, and the importance of 
those results don't get conveyed appropriately. It's a really difficult job for a 
reporter to explain scientific results. It's also a really difficult job for a scientist to 
appropriately put into context the results of their studies without overhyping it or 
underexplaining what it actually means.” 
 
Misinformation, Sensationalism and Objectivity 
 Other themes that arose in the interviews related to BPA risk communication 
challenges were the issues of misinformation, sensationalism, and a perceived lack of 
objectivity among some stakeholders and communicators. For example, a government 
respondent described BPA’s conflicting and sometimes incorrect messaging: 
“It's kind of got a life of it's own because it's such a hot topic in the press, and I 
think some of the message has been driven by the science, conducted by the 
scientists…but a lot of the policy has been driven by advocacy groups as well. So 
there's just a lot of contention about this chemical. Some of it’s true, some of it's 
not, some of it's unknown, and it gets driven in all sorts of directions because 
there's so many people talking about it.” 
  
 Several researchers and industry representatives mentioned an imbalance in media 
reporting, where negative study findings do not receive sufficient attention. According to 
an industry organization: 
“Well, I guess the right way to talk about the challenges is the reporting from the 
media is all asymmetrical. Negative findings on the dangers of BPA, meaning the 
ones that don't have the ‘skull and crossbones’ appeal, never get published, never 
get circulated—that’s not good news. But if somebody injects a million fold toxic 
dose of BPA into a lab rat, and the lab rat ends up getting ill, then that scientific—
very unscientific research… gets into the popular press.”  
 
As demonstrated in Table 13, respondents’ perceptions of the state of the 
scientific literature varied dramatically—with participants on both ends of the spectrum 
suggesting that those who disagree with their conclusion are inherently biased. Indeed, 
the discussion of objectivity in research and communication emerged as an important 
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theme in the interviews. Interviewees from all sectors noted concerns and distrust of other 
stakeholder groups. For example, one government agency respondent noted:  
“My opinion is that everybody who's working on it has lost their objectivity. So 
I’m hard pressed to find people who have approached the question truly 
objectively. Everyone who is currently investing in BPA research is almost 
entirely doing it because they have a position to fulfill. They have a fait accompli 
that they need to prove….So to me, I don't see an objective arbiter in here 
somewhere. So… if someone asked me to render a decision, I don't know, I would 
have to do a weight of evidence that's based on the studies that are available, but 
somehow I would have to be able to weigh in the known biases.” 
 
Given the existence of many studies on BPA drawing disparate conclusions, many 
stakeholder organizations also discussed the difficulty of determining trustworthy sources 
of information, and the negative impact this has on the public. As one researcher 
described it:  
“Everyone has their own little soapbox that they're standing on and because of the 
plethora of studies that are out there, it's cherry picking. You can always support 
almost any view that you have, and that just leaves the public in a state of 
confusion. They don't know who to believe, because every day there seems to be 
some new toxin du jour, you know.” 
 
Respondents from several sectors including industry, research and government 
also specifically discussed a lack of objectivity among researchers as a concern. While 
many respondents (particularly from NGOs, government, research and media) 
acknowledged that industry has a vested interest in establishing BPA as safe, several 
industry, news media and research respondents said that academic researchers too are 
subject to biases. For example, according to a researcher, academics have “pressing 
financial interests” to publish studies showing harm to attract grant funding and advance 
their own careers. Further, the same respondent stated the incentive structure in research 
promotes publishing “positive” results and “works towards the overemphasis of risks 
posed by chemicals in everyday life.” Another researcher criticized some academics for 
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developing “preconceived ideas” that cause them to become “self-delusional in their 
research” and ignore findings that do not fit their opinion. However, one researcher 
presented a counterpoint to this concept of academics having vested interests in 
demonstrating a chemical’s harm: 
“We've heard industry people say that academic scientists have a conflict of 
interest. We need to publish in order to get tenure, or we need to publish in order 
to get grants. That's true, but the thing is, I don't have to publish that BPA is safe 
or dangerous in order to get tenure. And if I find that a chemical has no effect on 
the endpoint that I'm interested in, I move on to something else. I'm not limited in 
the questions I can ask, and I'm not limited in the scope of what I can do in my 
work. So, it's almost offensive to suggest that somehow academic scientists have 
a reason to lie about the dangerousness of a chemical, because there is always 
going to be a dangerous chemical we can study.” 
 
The motives and interests of NGOs were also questioned, particularly by some 
industry and research organizations that were skeptical that BPA causes any harm to the 
public. Several stakeholder organizations criticized the work of NGOs as “irresponsible” 
and “alarmist.” For example, one media interviewee said:  
“I think a number of advocacy groups have said things about BPA that are really 
scientifically unsupportable, and I also think…it has been a very convenient 
fundraising and you know, political issue for them. It's something that gets a lot of 
attention. And sometimes I think they are more concerned about giving a 
particular message that's going to get headlines than they are about truly telling 
people what risks out in the environment are greatest for them.” 
 
 Despite this, others said the NGOs overall did a good job “sticking to the 
science,” and many respondents from all sectors perceived NGOs as very effective in 
their communications on BPA— whether respondents agreed with their underlying 
conclusions or not. NGOs were described as particularly effective in garnering swift 
changes in the marketplace when manufacturers and retailers stopped selling BPA-laden 
baby bottles. A news media interviewee said the following about the work of prominent 
NGOs on the BPA issue: 
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“I think they really took this substance and ran with it, and I think some of them 
profited tremendously from BPA. They really made this a big rallying cry for the 
work that they do and I think they have very effective campaigns revolving 
around BPA that generated more membership for them and more attention to their 
causes. I think they were fairly brilliant actually, whether you agree with them or 
not.” 
 
As previously alluded to, many respondents indicated that the industry’s primary 
interest is to defend their product. Respondents from multiple sectors including 
government, NGOs, media and research described industry groups as ineffective in their 
communication, in part because they are poor messengers and not trustworthy due to 
economic motivations. Further, interviewees noted that industry communications were 
unwavering and, as one NGOs put it “frustratingly well-financed and consistent.” Several 
media respondents noted industry group’s predictable risk messaging on BPA. As a 
media respondent explained: 
“Well, the industry groups are pretty predictable. They have essentially 
disavowed any risk or even hypothetical risk, and they sometimes have good 
arguments to make, but they are so adamant and absolute in their statements that I 
don't need to call them to know what they are going to say. So I don't think that 
they've been terribly effective in this debate either.” 
 
Regarding BPA risk communication from the federal government, nearly all 
stakeholder organizations criticized the FDA’s communications. While some respondents 
(particularly from industry and research) praised the quality of FDA’s research, most 
agreed that the agency’s risk communication was lacking and inconsistent on this issue. 
As one media respondent explained: 
“I find in general the FDA, in terms of broad strokes, is not very good at risk 
communication. It struck me that they were for a long time just—‘it's safe it's safe 
it's safe’, ‘ok we're banning it in children's in baby bottles and sippy cups’. And 
it's like well, if it's safe, why is it being banned in baby bottles and sippy cups? 
And if it's not safe, why isn't it being banned more broadly? Why isn't it getting 
out of liners and other things?  And it's hard, it's very hard to communicate when 
you have a nuanced response, you know. It's challenging and there's a lot of 
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suspicion around the FDA anyway in terms of how decisions are made and who 
factors into those decisions that there's always skepticism in terms of was this a 
political decision or a science and health-related decision.” 
 
Several other media respondents also indicated that they have found the FDA 
reluctant to be interviewed about BPA. For example, one media respondent explained: 
“I think the FDA's sort of impossible, frankly. From a journalist's perspective, it's 
really hard to feel like you get a straight answer from them. It's really hard to even 
reach people from the agency who will talk to the media. I feel like I have a hard 
time trusting anything they say because they manage the media so tightly. They 
tend to be slow to respond to the substance, and then I felt like they responded 
inadequately. You know, BPA is sort of a big example of what's wrong with the 
FDA.” 
 
However, there was also a disconfirming case from a media organization, where 
the respondent praised the work of the FDA, explaining “I am certainly trying to amplify 
the kind of work the FDA is doing, because you know the FDA is constantly under attack 
in the media and I think it’s really important to know when somebody is doing good 
science.” 
As indicated throughout this section, the issue of distrust of various messengers 
emerged as a key communication challenge in the case of BPA. Interestingly, several 
respondents from government, NGOs and research described the tone of the debate on 
BPA as unusually adversarial compared to other chemical issues. Several interviewees 
from government, media and research commented that the case of BPA was unusual in 
the level of personal attacks, hostility, and a “polarized” and “unhealthy” dynamic. 
According to a NGO: “You know it's rare to see such rancor among scientists but this 
sure did display that on the issue of whether or not BPA is safe and how much is safe. 
And it's just, again because it's a very difficult thing to get to the bottom of.” Figure 7 
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summarizes the main risk communication challenges discussed by stakeholder 
organizations. 
Figure 7: Summary of Key Risk Communication Challenges from the Perspective of 
Stakeholder Organization Respondents (n=36) 
 
Risk Communication Recommendations and Advice for Public Health Practitioners 
 
 Given the noted challenges in communicating about complex and uncertain 
scientific issues, respondents from stakeholder organizations were asked how they would 
define effective risk communication and provide their thoughts on how public health 
practitioners could improve risk communication in general. Overall, respondents from all 
sectors described effective risk communication as clear, factual, concise and using simple 
language. However, some respondents also said risk communication should not 
oversimplify or overstate knowledge, and must explain where there are uncertainties and 
admit limits in understanding. Putting findings in appropriate context for people’s lives 
was also cited as important.  
 Among government respondents, interviewees noted the importance of ensuring 
that risk communication messages are not only delivered, but received and 
comprehended. Industry and media respondents noted that communicators—be they 
public health officials or the media— should adequately understand the science and 
consider whether the messaging will elicit undue alarm. As one media respondent 
explained:   
• Limited understanding of scientific concepts among the public and the media. 
• Difficulty of translating complex and nuanced scientific information. 
• Misleading or incorrect information from the media or various stakeholders. 
• Higher likelihood of positive findings reported in research and the media (publication 
bias). 
• Perceived lack of objectivity among stakeholders.  
• BPA has become an adversarial, politicized issue.  
	   118	  
“Effective risk communication has to anticipate how people are going to hear a 
message. It's not enough to have a caveat included in the text somewhere. You 
actually have to think about what is the tone of my message, because I think 
people are much less sifting through facts in the public health message and much 
more listening for the should I be scared or shouldn't I. So I think … public risk 
communication has to ask the question: Are people going to be scared after they 
hear this or are they not? And if they are going to be scared, is that justifiable, and 
is this something where there's enough reason that we should make people 
afraid?” 
 
Some NGOs challenged the notion that risk communication would incite undue 
fears and stressed the need to inform people of personal actions they can take to reduce 
risks. For example, one NGO said: 
“One of the things that we find really problematic is the stance that … you can't 
tell people about this because you're just going to scare them and there's nothing 
they can do about it…We absolutely have to explain to people the risk of 
chemicals and there are things they can do. There are things they can do, there are 
personal actions they can take to reduce their exposure and then they can also join 
together with others…to make system-wide change. So we really challenge the 
notion that you're just going to scare people and people will be paralyzed by fear. 
We think that there's a way of doing it, talking about BPA responsibly in a 
nuanced manner— that gives people information… We present them with the 
information, they understand the risk, and then they make decisions based on that, 
based on their perception of the risk.” 
 
Many researchers noted the difficulty of effectively communicating risks, 
especially considering that “there is nothing that is zero risk,” according to one 
researcher. Other researchers stated that effective risk communication would highlight 
potential hazards and solutions, but allow people to weigh risks and benefits themselves. 
For example, a researcher described their role in the following way:  
“Our charge has to be to help the public health agencies sort out the difference 
between what chemicals are truly a risk to public health, and which are not. And 
the only way to do that is to stick to the science, not speculate, be objective and 
complete in their reporting, and also put things in a context that's understandable 
for folks that are laypeople. And if there's controversy, to be honest about that 
controversy.” 
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Despite these challenges, stakeholder organizations from all sectors agreed on the 
importance of risk communication. Figure 8 provides a summary of key points from 
stakeholder organizations on the characteristics of effective risk communication. 
Figure 8: Summary of Key Risk Communication Recommendations from the 




 Semi-structured interviews with key stakeholders provided a diverse set of 
perspectives on scientific and communications issues related to BPA, a ubiquitous 
chemical that remains in common consumer goods such as canned food. As expected, the 
majority of industry groups were skeptical of any human health effects from BPA 
exposure, while the majority of NGOs continue to remain concerned about potential 
health impacts. Government agencies, researchers and media respondents included 
perspectives along the entire continuum— from confidence in BPA safety in consumer 
products to citing clear evidence of danger. Overall, respondents from the five sectors 
were in consensus that BPA is a challenging chemical to research and communicate 
about to the public. Many respondents from different sectors pointed out weaknesses and 
complexities in the scientific methodologies used to study BPA. Further, respondents 
noted a variety of risk communication challenges and critiqued the actions and 
motivations of government agencies, industry groups, NGOs, researchers, and the media. 
• Effective risk communication is clear, factual and concise. 
• Risk communication messages should not oversimplified. 
• Risk communication should acknowledge uncertainties. 
• Risk communication should be a dialogue as opposed to a one-way message. 
• Risk communication should put risks in context and consider how the audience will 
perceive messages. 
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Specific findings discussed below provide important context and understanding to the 
complexities of risk communication. 
Scientific Methodology Issues  
 Stakeholder organizations have diverse expectations and divergent criteria for 
reliable, rigorous research on BPA. Respondents noted conflict between a toxicological 
“the dose makes the poison” paradigm and an endocrinology-based paradigm in which 
minute exposures, particularly during critical windows of development, may cause 
negative effects. Among respondents who were skeptical of BPA health effects, some 
noted that BPA—like many other environmental chemicals—has endocrine activity at 
certain levels. In other words, critics did not disagree that extremely high exposures could 
cause effects. The conflict was whether human exposure levels may approach (within 
several orders of magnitude) levels that could impact sensitive human populations. 
 In light of these conflicting perspectives, some efforts are underway to increase 
research comparability. For example, the NIEHS and NTP developed a collaborative 
approach aimed at answering lingering controversies on the effects of chronic low-level 
exposure to endocrine disruptors. The agency convened a consortium of research grantees 
to facilitate communication and data-sharing.8 Additionally, an ongoing comprehensive 
toxicity study facilitated by the NIEHS/NTP and FDA began in 2012. Deemed 
CLARITY-BPA, the program features GLP-compliant protocols as well as data and 
specimen sharing to examine additional disease endpoints not traditionally assessed in 
regulatory assessments.8 While this program is resource-intensive and still ongoing, the 
CLARITY-BPA program represents a unique and potentially valuable approach for 
bridging distinct methodological approaches. 
BPA as a Poster Child 
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 An important theme that emerged from the interviews was the description of BPA 
as a poster child for endocrine disruption. Respondents attributed this to a variety of 
factors that raised the level of concern among advocates, the media and the public. 
According to the risk perception literature, some risk characteristics contribute to 
elevated fears, including: involuntary exposure, little preventive control, and threatening 
future generations.49 These elements were discussed by some stakeholder groups as 
reasons that BPA became the subject of media attention and public concern. Perhaps due 
to the ubiquity of BPA and its combination of risk perception factors, the chemical 
became a prime example for advocates to highlight and explain the threat of endocrine 
disruptors. Several interviewees (NGOs and researchers) pointed out that holding up BPA 
as an example could be detrimental to the field of endocrine disruption if research 
findings do not support continued concern. Despite its status as a symbol, BPA is only 
one of countless environmental exposures occurring simultaneously. Additional research 
and regulatory attention should be focused on understanding health effects of cumulative 
exposures, rather than solely a  “one chemical at a time” approach.  
Risk Communication Challenges 
 The case of BPA includes many elements that make risk communication 
challenging. An important theme that emerged in this case was the profound distrust and 
perceived lack of objectivity among various parties. No stakeholder group was immune 
to accusations of hidden (or not so hidden) conflicts of interest. As described by the 
National Research Council (NRC) in Improving Risk Communication, science may be 
sufficiently uncertain to allow for different interpretations, but experts are often “accused 
of hiding their subjective preferences behind technical jargon and complex, so-called 
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objective analyses.”46 While messaging for non-experts must be simplified and somewhat 
selective, this opens the door for critics to deem it inaccurate or misleading.46 
 This study noted criticism of both the media’s coverage of BPA as well as the 
messaging from scientists in research, government, academia and interest groups. 
However, both the media and scientists need to better understand each other’s roles and 
constraints.46 There was much criticism of government agency actions on BPA, 
particularly the FDA. Respondents largely thought the FDA’s risk communication on 
BPA was lacking and inconsistent – whether or not they considered BPA a public health 
concern. This presents a problem for the credibility of government agencies, which are 
intended to be impartial bodies that prioritize the public good.  
Improving Risk Communication 
 It is important to note that there is no easy solution or quick fix to improve risk 
communication. Even when there is clear messaging and better understanding of an issue, 
this does not always lead to consensus, in part due to the varying priorities and values of 
society. As the NRC noted, “but even though good risk communication cannot always be 
expected to improve a situation, poor risk communication will nearly always make it 
worse.”46 When people are uninformed about an issue, they rely on social trust to make 
judgments.197 In the case of BPA, there were a variety of communicators coming to 
opposite conclusions, and forcing the public to decide whom to trust. When there is a 
breakdown in credibility, the public questions the competency and objectivity of the 
communicator and potentially affects future efficacy in communications.46 This is 
detrimental to society, particularly in regard to government agencies and their ability to 
effectively manage risks. The BPA issue showed that regardless of opinions on the rigor 
of scientific evaluations, poor communication hampers risk management. Although the 
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FDA largely maintained that BPA is safe, these findings were not trusted by advocates 
and legislators who supported BPA bans, and consumers who urged industry to remove 
BPA from their products. While it is true that proving a chemical is safe is more 
challenging than raising concern, replacing BPA is not without its own potential risks. In 
the rush to remove BPA from the marketplace and label baby bottles and other products 
“BPA-free,” little attention was paid to whether replacement compounds were indeed 
safer than BPA. We are now learning more about similar endocrine disrupting properties 
in replacement compounds and similar health questions are being raised.198 Better 
dialogue and contextualization of chemical risks could help reduce future problems with 
regrettable substitutions. 
 This research highlighted both needs and opportunities with regard to better 
dissemination of scientific information to the public. Even though it may sound 
counterintuitive, describing uncertainties, limits in knowledge and the limitations in the 
study design may actually result in more successful risk communication because it 
improves the base of accurate information that people use to make decisions. It is 
unrealistic to think there will always be a clear and compelling determination on public 
health risks. Successful risk communication satisfies people that they are adequately 
informed with the best available knowledge, despite the existence of uncertainties. 
Strengths and Limitations 
This study provides the first qualitative assessment of key stakeholders’ 
perceptions of BPA risk communication challenges. However, there are some limitations 
worth noting. The findings of this study are not based on a representative sample of 
stakeholders. Rather, a purposeful and snowball selection strategy was used to recruit 
experts within key stakeholder organizations with particular knowledge and insight on 
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BPA research and communication. A limitation of these strategies can be key informant 
bias if the respondent’s views are atypical of their group’s experience, and self-selection 
since a number of groups declined to participate.107 Notably, there was a higher 
proportion of respondents from the industry/consulting sector who declined the interview 
or did not respond to interview requests. Despite this, there was a sufficient number of 
interviews across the five categories to achieve saturation and capture a wide range of 
perspectives from high-profile stakeholder groups involved in researching and 
communicating about BPA in the U.S. Other potential limitations of key informant 
interviews include social desirability bias.107 Indeed, it is possible that stakeholders were 
wary of saying anything that would reflect negatively on their organization and thus 
answer the questions in a way they view most flattering and desirable. We sought to 
reduce this bias by granting interviewee anonymity and only identifying quotes by 
stakeholder category. This step was intended reduce the risks to organizations and 
increase the likelihood that participants were candid and honest. While transferability to 
other settings is often best determined by those seeking to apply the findings 
elsewhere199, it is anticipated that risk communication findings are transferable to other 
public health issues, particularly in challenging cases with unclear science, entrenched 
interests and regulatory and policy implications. The format of semi-structured interviews 
with key stakeholder organizations allowed for the collection of rich, contextual data that 
is unavailable through other data collection methods.  
Conclusion 
  This study provides new understanding relevant for public health practitioners 
interested in improving translation of public health risks. In the case of BPA, concerns 
about lack of objectivity were rampant, and respondents described misinformation and 
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sensationalism in stakeholder communications and news media reports. Future research 
should address opportunities for improved translation of scientific information and risk 
communication by government and the news media, as the public relies on these groups 
as objective arbiters of information. Future research should also address best practices for 
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Chapter	  7.	  Discussion	  
	  
The previous chapters provided a background review of the literature, described 
the methods used to conduct the dissertation research, and presented the study findings. 
This chapter summarizes the findings of the three manuscripts, presents public policy 
implications and opportunities for future research, and discusses overall strengths and 
limitations of the case study. 
Summary	  of	  Findings	  
 
This research examined how key stakeholders in the United States communicated 
about potential health risks from BPA exposure. Together, these three studies present a 
compelling case study with important implications for how public health practitioners 
present scientific findings, communicate about uncertain health issues and translate 
science into regulations and public policies. The three main findings are summarized 
below.  
1) Key stakeholders have come to opposing conclusions about the safety of BPA, and 
mixed messages were prevalent in the news media and from government agencies 
and interest groups. 
 
The case of BPA demonstrated the pervasive challenge of conflicting risk 
communication messages. Stakeholders disagreed on whether BPA is safe as currently 
used, and what solutions are appropriate. As described in Manuscripts 1 and 3, health and 
environment-focused NGOs were fairly uniform in their descriptions of BPA risks and 
preferred risk management approaches. NGOs highlighted public health concerns and 
advocated for the removal of BPA in baby bottles and other consumer products. Industry 
groups also provided uniform messaging, but maintained that BPA is safe at typical 
human exposure levels. Industry groups referred to the safety determinations of 
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regulatory bodies and opposed policies to restrict BPA. While NGOs and industry groups 
have been consistent in their messaging, U.S government agencies been conflicting. The 
U.S. Food and Drug Administration has supported the safety of BPA, yet also agreed 
with the National Toxicology Program’s determination of “some concern” and advised 
consumers on how to reduce their exposure. U.S. news media coverage reflected these 
mixed messages from stakeholders.  
Mixed messaging on BPA is partially due to conflicting scientific evidence. Even 
experts in the field consider scientific literature on BPA to be confusing. Existing 
scientific evidence on BPA can be used to support nearly any conclusion about BPA 
risks. Hundreds, if not thousands of scientific studies have examined BPA’s health 
effects, but stakeholders continue to disagree on where the weight of the evidence lies 
and what methodologies are appropriate for assessing the impacts of BPA exposure. 
Stakeholder organizations with concerns about the health risks of BPA often pointed out 
that traditional toxicological approaches may not be sensitive enough to assess potential 
endocrine disruptors. Further, they raised issues about the industry funding of the large-
scale studies following good laboratory practices favored by government regulators. 
Stakeholders who erred on the side of BPA safety discussed the lack of standardization 
and replicability of smaller studies as a problem. Stakeholders perceived mixed messages 
to be the result of both scientific complexity and the politicized nature of the issue.  
2) Mistrust and the perceived lack of objectivity among stakeholders complicates 
risk communication.  
 
It was clear from the stakeholder interviews that lack of trust and accusations of 
bias were major barriers to effective risk communication on BPA. As expected, given 
their financial interest in BPA, industry groups’ motivations were questioned by other 
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stakeholders. Advocates argued that studies supporting BPA safety were predominantly 
funded by industry. However, industry was not the only group accused of bias. Some 
NGOs and researchers were accused of financial and career benefits from raising 
concerns about BPA. Whether or not these criticisms are fair, the acrimony among some 
groups was apparent. This rancor is in some ways a natural product of the democratic 
process, but nonetheless presents an additional challenge in risk communication.  
Establishing trustworthy messengers is a critical aspect of effective risk 
communication. The credibility of a messenger is an important factor in how an audience 
perceives a message. The public relies on experts to frame risks, but because they are not 
privy to all relevant information, they are unable to judge the fairness and accuracy of the 
message by its contents alone. Therefore, the reputation and credibility of the source, as 
perceived by the audience, could add or detract from their trust in the risk communication 
messages.46 In the case of BPA, breakdowns in trust and concerns about the objectivity of 
messengers posed an additional challenge to stakeholders’ risk communication efforts. 
3) Risk management of BPA lacked focus on comprehensive solutions.  
 
 Although there were legislative and regulatory policy changes and voluntary 
industry actions limiting the presence of BPA in some consumer products, responses by 
decision-makers were fractured and reactive. The need for increased focus on 
comprehensive solutions for chemical risk issues was identified, particularly with regard 
to BPA replacements. Decision-making is complicated by uncertainties and the lack of 
short-term feedback about whether the decision was effective; however, risk management 
must consider risk tradeoffs. In stakeholder documents and news media coverage, the 
discussion of viable replacements was extremely limited. In the documents and 
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interviews, discrepancies in availability of appropriate replacements were also noted and 
stakeholders raised concerns about the possibility for regrettable substitutions. This is an 
important finding as in recent years there has been increasing health concerns about some 
BPA replacements with similar hormonal activity.193,194  
Public	  Policy	  Implications	  and	  Recommendations	  
 
This analysis confirms that there has been conflicting risk communication about 
BPA from government agencies, industry associations, NGOs, researchers and the news 
media in the United States. Such fractured information about the potential hazards about 
BPA confuses the public and muddies the distinction between risk assessment and risk 
management. Successful risk management depends in part on the ability of public health 
practitioners to translate data and communicate about complex and uncertain scientific 
issues. BPA presents a challenging case due to conflicting research results, advocacy 
efforts, and different, evolving conclusions from government agencies. However, several 
years after the industry voluntarily removed the chemical from some products and 
legislative bodies passed BPA bans, scientists and regulators continue to disagree on the 
public health implications. Mixed messages undermine the credibility of the science and 
foster distrust of stakeholders tasked with risk management. Government agencies in 
particular, given their intended roles as impartial arbiters, should work together to ensure 
that consistent risk information to the public in spite of their different missions and goals. 
In the case of BPA, mixed messages may reflect both scientific uncertainties and 
competing political interests. Risk communicators and public health practitioners should 
be careful to distinguish scientific uncertainty in risk assessment from disagreement on 
appropriate solutions (risk management), in order to avoid undermining the credibility of 
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science and contributing to further confusion. Further, the issue of “cherry-picking” data 
to support one’s preferred conclusion undermines science and conflates science and 
advocacy. This issue was described in the NRC’s Improving Risk Communication report: 
“The principle of separating science and politics seems to be a cornerstone of 
professional risk management. Many of the antagonisms surrounding risk 
management seem due to the blurring of this distinction, resulting in situations in 
which science is rejected because it is seen as tainted by politics…even technical 
experts may fall prey to partisanship as they advance views on political topics 
beyond their fields of expertise, downplay facts they believe will worry the 
public, or make statements that cannot be verified.”46 
 
This research also identified the need for more comprehensive evaluations of 
potential solutions. Integrative approaches to increase the comparability and transparency 
of research should be pursued, which would also help address the trust and objectivity 
issues highlighted above. However, the goal is not to squash scientific debate and ensure 
that diverse perspectives always agree. Future research should examine opportunities for 
fostering scientific advancements while increasing dialogue and transparency between 
stakeholders. As recommended in Science and Decisions, additional efforts are needed to 
increase the comparability of research and understand effects of cumulative exposures. 
Further, these processes need greater stakeholder involvement in both the design and 
interpretation.20 The years of research and millions of dollars in research funding invested 
in BPA is not feasible to repeat for the thousands of other compounds for which 
knowledge is limited. Research on cumulative effects of typical consumer exposures is 
inadequate, and research and regulatory methodologies need to be strengthened in order 
to move away from a “one chemical at a time” approach to understanding health impacts. 
In the discussion of BPA and other emerging chemical risk issues, public health 
advocates should work to ensure that, when warranted, safe replacements are an integral 
	   131	  
part of the discussion in order to avoid regrettable substitutions. Researchers have 
emphasized the need for chemical alternatives assessments to distinguish between 
alternatives and ensure that replacements do not pose equal or higher or risk as the 
original compound.195,196 This would help ensure that chemicals like BPA are not quickly 
replaced with “BPA-free” alternatives, without sufficient knowledge of the replacement 
material or its safety. Better dialogue about risk tradeoffs could help reduce future 
problems with regrettable substitutions. 
According to interview respondents and the risk communication literature, 
effective risk communication puts risks into context, uses clear language without 
oversimplifying, and acknowledges uncertainties. In reality, there will not always be clear 
answers on public health risks. Successful risk communication provides accurate 
information while acknowledging lingering uncertainties. Improving risk communication 
is no easy task in our modern world. At the same time we are able to measure and 
investigate impacts of minute chemical exposures, it remains difficult to put findings into 
context within a complex world with innumerable risk tradeoffs. Effective risk 
communication requires open dialogue during the risk management process to foster trust 
between stakeholders and the public. 
Strengths	  and	  Limitations	  	  
 
There are some on overarching limitations of a case study. Defining the 
boundaries of a case study and ensuring adequate explanation of methodologies are two 
of the challenges that were discussed in Chapter 3. Like any type of scientific inquiry, 
qualitative and mixed-methods research have methodological challenges that need to be 
disclosed. Limitations for each manuscript were reported in their individual chapters and 
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also summarized here. The document review of stakeholder websites conducted in 
Manuscript 1 presents a snapshot of public documents available in June 2014. As such, 
relevant information removed prior to this time, or posted thereafter, is not captured in 
this study. In light of the potential for changing website content and variability in website 
searches and archives, it was important to outline search strategies and inclusion criteria 
to clearly define the data set. It is possible that modifications such as a different selection 
of organizations, or restricting documents to a specific time period of interest could have 
impacted findings. Manuscript 2 presents a quantitative news media content analysis. 
While efforts were made to sample from high circulation newspapers in each census 
region and national television news sources, the sample may not represent the entire 
landscape of U.S. news media. Smaller media outlets and local news were not included. 
Newer or non-traditional sources of news including blogs, special interest publications 
and social media were also beyond the scope of this study. Further, the study does not 
assess any causal relationships regarding news media coverage and public policy actions 
or public opinion on BPA. The semi-structured interview analysis conducted in 
Manuscript 3 also has some distinct limitations. Purposeful and snowball selection 
strategies were used to recruit experts within key stakeholder organizations. A limitation 
of these strategies can be key informant bias if the respondent’s views are atypical of 
their group’s experience, and self-selection since a number of groups declined to 
participate.107 Notably, there was a higher proportion of respondents from the 
industry/consulting sector who declined the interview or did not respond to interview 
requests. Other potential limitations of key informant interviews include social 
desirability bias.107 Indeed, it is possible that stakeholders were wary of saying anything 
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that would reflect negatively on their organization. We sought to reduce this bias by 
granting interviewee anonymity and only identifying quotes by stakeholder category. 
Despite these limitations, several strategies were used optimize overall study quality, as 
discussed in Chapter 3. 
 This dissertation also has some noteworthy strengths. This case study approach 
using mixed methods and multiple data sources allowed for the collection and analysis of 
rich, contextual data that was not available elsewhere. The three distinct approaches 
provided strength to the overall study by triangulating the data. Triangulation refers to 
collecting data using variety of methods and sources to strengthen conclusions and 
minimize the possibility that systematic biases taint results. The combination of data 
directly from stakeholders in the document review, media reports in the news content 
analysis and key stakeholders interviews help diversify the data and strengthen the 
research design Manuscript 1 is believed to be the first study to evaluate stakeholder’s 
risk communication using the risk assessment framework, and as such presents a novel 
framework for future analyses. This is also the first study to assess how key stakeholders 
in the United States have characterized human health risks associated with BPA. The 
documents consisted of risk communication directly from each organization—and thus 
represent official statements that were not filtered through the media or an individual’s 
perspective. Manuscript 2 provides the first known systematic analysis of news media 
content on BPA in the United States. This study quantified the discussion of key BPA 
sources, populations of concern, health endpoints and solutions in major U.S. news 
sources and demonstrated mixed and conflicting risk messages were prevalent. 
Manuscript 3 presents the first known analysis of key stakeholders’ perspectives on BPA 
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risk communication via semi-structured interviews. The findings of the study were based 
on the perspectives of 36 organizations from five sectors (government, 
industry/consulting, NGO, research and the news media) involved in research and 
communication on BPA. The stratification of different stakeholder groups, as well as the 
range of opinions within these groups reached at saturation enhanced the analysis and 
sought to reduce potential biases. Similar themes emerged both within each strata and 
overall, which supports the internal validity of the results. Together, these three studies 
provide a cohesive picture and unique insights into the challenges of communicating risks 
to the public. While transferability to other settings is often best determined by those 
seeking to apply the findings elsewhere,199 it is anticipated that the findings of this case 
study may be applicable to other public health issues, particularly in challenging cases 
with unclear science, entrenched interests and regulatory and policy implications. In 
summary, a primary strength of this case study research is that it addresses a largely 
unexplored topic of significance and the missing link in the management of public health 
risks: effective risk communication.  
Conclusion	  
 
The success of risk communication and risk management efforts depends on the 
ability of public health professionals to translate scientific information and communicate 
about complex risk issues. This research examined a high stakes, highly prevalent 
chemical and revealed just how divided stakeholders are in their risk perception and 
communication strategies. This study illustrated the challenges communicating about 
nuanced scientific findings and the resulting impact on risk management. Future research 
should address how mixed messages on BPA affected consumer risk perceptions. 
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Additional recommendations include supporting efforts to increase the comparability and 
translation of science, as well as to identify credible messengers who can deliver clear, 
accurate and useful information to the public without overstating knowledge.	  This case 
study is a step forward in understanding the risk communication process in action and 
provides a roadmap for addressing an important public health dilemma. Best practices in 
risk communication and risk management as described by experts over the last 30 years 
have not been adequately implemented.19,20,46,48 There is a need for increased 
collaboration between government agencies to present unified risk communication 
messages, particularly in controversial and high-profile cases such as BPA. We 
undoubtedly need strong science to inform sound decision-making, but just as important 
is ensuring that the science is translated appropriately, and that risk tradeoffs are 
explained by credible and objective messengers. Without skilled risk communication, 
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Appendix	  B:	  Tally	  of	  Included	  Documents	  By	  Stakeholder	  Organization	  
 Number of search results 
Number of documents 
retained for analysis (% 
retained) 
GOVERNMENT 
CDC 5 2 (40) 
EPA 11 3 (27) 
FDA 14 6 (43) 
NIEHS 41 7 (17) 
Total Government 
documents 71 18 (25) 
INDUSTRY 
ABA 3 3 (100) 
ACC 13 12 (92) 
GMA 7 4 (57) 
IBWA 3 3 (100) 
NAMPA 31 26 (84) 
Total Industry documents 57 48 (84) 
NGOs 
BCF 90 28 (31) 
CU 28 21 (75) 
EWG 56 25 (45) 
NRDC 6 6 (100) 
Total NGO documents 180 80 (44) 
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Appendix	  C:	  BPA	  Document	  Coding	  Extraction	  Instrument	  
1. Document Number 
2. Document Title 
3. Stakeholder Organization Type 
 Government 
 Industry 
 Health Environment NGO 
 















5. Primary Purpose of Document 
 About BPA/Q and A/Basic Information/Fact Sheet 
 Release news 
 Information Brief/Report Brief 
 Describe organization's actions/stance on BPA 
 
6. Date created 
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 HAZARD IDENTIFICATION 
 
8. HI1: How is BPA described?  
 Chemical 
 Endocrine Disruptor/Endocrine Disrupting Compound 




 Other ____________________ 
 
9. HI 1: How is BPA described? Specify text. 
 
10. HI2: Where is BPA found? 
 In food or drink containers 
 In receipt paper 
 In dental sealants 
 In other consumer goods (cds, car parts, etc) 
 In the environment (air, water) 
 
10. HI2:  Where is BPA found? Specify text. 
 




 Reproductive/Sexual Dysfunction 
 Diabetes 
 Obesity/Weight 
 Behavioral effects 
 Heart disease/cardiovascular 





18. DR1 What sources of scientific evidence are cited/What sources of information are mentioned? 
 US Government- suggesting risk 
 US Government-suggesting safety 
 US Government- biomonitoring or neutral 
 Foreign gov't - suggesting risk 
 Foreign gov't -suggesting safety 
 Foreign gov't- biomonitoring or neutral 
 Scientific literature- suggesting risk 
 Scientific literature- suggesting safety 
 Scientific literature- neutral 
 Grey literature - suggesting risk 
 Grey literature- suggesting safety 
 Grey literature- neutral 
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19. DR2 Overall State of the Evidence discussion. 




12. EA1: Who is exposed? 
 Everyone/widespread  
 Developing fetuses/Pregnant women 
 Young children 
 Other ____________________ 
 
13. EA1: Who is exposed? Specify text. 
 
 
14. EA2: Who are sensitive populations/populations of concern? 
 Developing fetuses/Pregnant women 
 Young children 
 Other ____________________ 
 
15. EA2:  Who are sensitive populations/populations of concern? Specify text. 
 
16. EA3: What is the route of exposure? 
 Through food/drink (oral) 
 Oral- general 
 Dermal 
 Inhalation 
 Other ____________________ 
 




20. RC1: Does BPA pose risks to human health? 
 No, BPA is safe. 
 Yes, BPA is a concern. 
 "Some concern" (based on NTP language) 
 It's uncertain. 
 Other ____________________ 
 Not discussed 
 
21. RC1: Does BPA pose risks to human health?  Specify text. 
 
22. RC4: Main Messages/ Public Position on Risk/Safety. Specify text. 
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RISK MANAGEMENT 
23. RM1: Solutions Discussed 
 Federal Policy affecting children- PRO 
 Federal Policy affecting children- ANTI 
 Federal policy affecting children- neutral 
 Federal Policy general- PRO 
 Federal Policy general- ANTI 
 Federal policy general - neutral 
 Consumer behavior (reducing exposures)- PRO  
 Consumer behavior (reducing exposures)- - ANTI  
 Consumer behavior (reducing exposures)- - neutral  
 FDA regulation- PRO 
 FDA regulation- ANTI 
 FDA regulation- neutral 
 State policy affecting children- PRO 
 State policy affecting children- ANTI 
 State policy affecting children- neutral 
 State policy general- PRO 
 State policy general- ANTI 
 State policy general- neutral 
 Voluntary industry actions to remove BPA- PRO 
 Voluntary industry actions to remove BPA- ANTI 
 Voluntary industry actions to remove BPA- neutral 
 Other ____________________ 
 
24. RM1: Solutions Discussed. Specify text. 
 
25. RM2: Alternates/Replacements discussed. 
 1 ____________________ 
 2 ____________________ 
 3 ____________________ 
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Appendix	  D:	  News	  Sources	  Used	  in	  Content	  Analysis	  Sample	  
Source Number of articles (%) 
New York Times  13 (5.8) 
USA Today 21 (9.4) 
Wall Street Journal  5 (2.2) 
Los Angeles Times 15 (6.7) 
The Oregonian 7(3.1) 
Denver Post 1 (0.5) 
Washington Post 26 (11.6) 
Philadelphia Inquirer 2 (0.9) 
Boston Globe  10 (4.5) 
Houston Chronicle  9 (4.0) 
Atlanta Journal Constitution 4 (1.8) 
Tampa Bay Times 0 (0) 
Chicago Tribune  20 (8.9) 
Minneapolis Star Tribune 2 (0.9) 
Milwaukee Journal Sentinel 37 (16.5) 
Time Magazine  1 (0.5) 
Newsweek Magazine 3 (1.3) 
CNN  21 (9.4) 
Fox News  0 (0) 
ABC News  9 (4) 
NBC News  11 (4.9) 
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Appendix	  E:	  Coding	  Instrument	  with	  Raw	  Agreement	  and	  Inter-­‐rater	  Reliability	  
Kappa	  statistics	  	  
 
 
Item Kappa Raw 
Agreement (%) 
Module 1: Products 
Food or drink containers mentioned as source of BPA?  1.0 100 
•  If yes, baby bottles or other children’s cups? .82 93 
•  If yes, plastic food or drink containers? .61 83.5 
•  If yes, infant formula or baby food containers? .80 91.8 
•  If yes, canned food or beverages? .67 86.2 
Other non-food related products mentioned as a source of/containing 
BPA? .75 88.8 
• If yes, paper register receipts? 1.0 100 
• If yes, dental fillings? 1.0 100 
Module 2: Health and Risk 
Mentions that BPA has hormone-like effects or mimics the effects of 
estrogen? .82 91.0 
Mentions BPA as an endocrine disruptor? .63 93.3 
Are pregnant women or developing fetuses mentioned as potential 
sensitive groups or populations of concern? .83 91.5 
Are infants or young children mentioned as potential sensitive groups 
or populations of concern?  .75 89.3 
Are any of the following health conditions mentioned as linked, or 
potentially linked to BPA?   
• Cancer? .85 92.9 
• Brain, developmental or neurological effects?  .81 90.4 
• Effects to endocrine system, hormone function, thyroid or 
metabolism? .79 97.6 
• Reproductive effects or sexual dysfunction? .77 89.4 
• Diabetes? .80 91.6 
• Obesity? .87 96.3 
• Behavioral effects? .76 88.2 
• Heart disease? .84 94.7 
Mentions widespread exposure to BPA? 
 .84 91.8 
Mentions BPA (or endocrine disruptors in general) may cause effects at 
very low doses? .81 94.2 
Mentions that BPA does not pose risk to human health or is safe. 
 .77 88.8 
Mentions that a U.S. government agency has found BPA uses safe.  .61 80.6 
Module 3: Policy 
Any mention of government policy action regarding BPA? .75 87.6 
• If yes, any mention of local government policy action?  .93 97.9 
• If yes, any mention of state government policy action? .83 91.5 
• If yes, any mention of federal government policy action? .79 89.4 




















• If yes, any mention of foreign government policy action? .71 85.1 
• If yes, any mention of banning BPA? 
 .64 93.6 
• If yes, any mention of labeling products with BPA? .66 91.5 
Any mention of industry self-regulation/voluntary action to limit 
BPA?  .72 86.5 
• If yes, what target population would the voluntary action 
affect? .79 86.7 
• If yes, what type of BPA-containing products would be 
affected by the voluntary action? .83 93.3 
Mentions ways consumers can avoid BPA. .75 88.8 
Module 4: Replacements 
• Any mention of the specific compound that could replace 
BPA? 1 100 
• Any mention of difficulty in finding replacements? 1 100 
• Refers to replacements in food cans? 1 100 
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Appendix	  F:	  Initial	  Email	  to	  Potential	  Interviewees	  
 
Dear [Name], 
My name is Patti Truant and I am a PhD candidate at Johns Hopkins University. 
 
I am conducting a study on risk communication about Bisphenol A (BPA). The purpose 
of this research project is to better understand risk communication on BPA and the roles 
of researchers, stakeholder organizations and the media in conveying information to the 
public and policymakers. 
I am contacting you to ask if you would be willing to be interviewed for this study.  
The interview will last about an hour, and with your permission it will be audio recorded. 
The questions will be focused on the state of the scientific evidence on BPA, how 
you/your organization communicates to the public about BPA, how you/your 
organization uses scientific evidence in your communications, and the challenges of 
effective risk communication. 
You may skip any questions or stop the interview at any time. Quotes will not be made 
attributable to you or your specific organization in the written results of the study. 
Instead, they will be attributed by the type of stakeholder organization (media, 
government agency, trade association, health or environmental organization, academic 
researcher etc.). 
If you are willing to participate, please let me know when would be a convenient time to 
schedule an interview. 
 Thank you very much. 
 
Patti Truant, MPH, CPH 
Johns Hopkins School of Public Health 
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Appendix	  G:	  Oral	  Informed	  Consent	  Script	  
 
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH 
Oral Informed Consent for Interviewees 
 
Study Title:  Government Agencies, Interest Groups and the Media: An Evaluation of 
Bisphenol A Risk Communication 
Principal Investigator:  Tom Burke, MPH, Ph.D. 
 
Purpose 
You are invited to take part in a research study. The purpose of this study is to better 
understand risk communication on Bisphenol A (BPA) and the roles of scientific studies, 
stakeholder organizations and the media in conveying information to the public and 
policymakers. 
 
Why You Are Being Asked to Participate 
You are being asked to participate because you, or your organization, were identified as a 
stakeholder while conducting background research. 
 
Procedures 
Participating in the study involves one interview, which will last about an hour. With 
your permission, the interview will be audio recorded. 
 
You may skip any questions or stop the interview at any time. In addition, if you would 
like any of your answers to be “off the record,” notify the interviewer and those responses 
will not be reported in the study results. 
 
Risks  
All research studies have some degree of risk or discomfort. Risks from participating in 
this research study are minimal because the topics covered will focus on your 
professional activities. Potential risks include feeling uncomfortable discussing 
communication and policy strategies. 
 
Benefits 
There is no direct benefit to you from participating in this study. Indirect benefits include 
the opportunity to contribute your thoughts and expertise on this topic. Findings from this 
study could result in increased knowledge on BPA risk communication and improved 
public health communications on BPA and similar topics.  
 
Data Confidentiality 
Data collected during this study will be stored on a password-protected computer. Types 
of organizations may be linked to quotes when results of the study are shared. Notify the 
researcher if you do not want certain answers included in the written results of the study. 
 
Voluntary Participation  
You do not have to agree to be in this study, and you may change your mind at any time.  
	   161	  
• Call the principal investigator, Thomas Burke at 410-614-4587 if you have 
questions or complaints about being in this study.  
• If you have any questions about your rights as a research participant, or if you 
think you have not been treated fairly, you may call the Johns Hopkins School of 
Public Health Institutional Review Board (IRB) at 410-955-3193, or 1-888-262-
3242. 
 
Permission to Proceed 
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Could you briefly describe your organization’s mission and your role? 
 
Has your organization communicated a public position concerning risks to the public on 
BPA?  If so, how would you describe that position? 
 
Communication on BPA 
How would you describe your organization’s strategies in communicating to the public 
and policy makers about BPA? 
 
Does your organization have goals with regard to policy interventions related to BPA? 
 
What means of communication does your organization use to disseminate information 
about BPA (i.e. websites, press releases, submitting testimony, social media, news media, 
etc.)? 
 
What are your main messages about BPA risks?  Have these main messages changed 
over time? 
 
Is there a document or reference that provides the best summary of your organization’s 
position and work on BPA? 
 
Scientific Evidence 
How would you describe the state of the scientific evidence on BPA and human health? 
 
How does your organization use scientific information in crafting public communications 
about BPA?    
 
What sources of scientific information or critical studies do you reference? 
 
What sources does your organization rely on for trustworthy scientific information? 
 
Challenges/Effective Risk Communication 
 
How would you describe the challenges of communicating to public about BPA? 
 
How do you define effective risk communication? 
 
Why do you think BPA has gotten a lot of public attention? 
 
How would you describe your organization’s effectiveness in communicating about 
BPA? 
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How do you think the federal government did with regard to their risk communication 
about BPA? 
 
How do you think industry groups did with regard to their risk communication about 
BPA? 
 
How do you think environmental and health organizations did with regard to their risk 
communication about BPA? 
 





Do you work with other groups to communicate or advocate about BPA?  
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Appendix	  I:	  Interview	  Codebook	  
Mnemonic code   Full description of code  
Government Identifies respondents from a government agency. 
Industry Identifies respondents from an industry trade association or a 
consultancy. 
NGO Identifies respondents from a health, environment or consumer-
focused non-government organization. 
Media Identifies respondents from the news media. 
Researcher Identifies respondents who are involved in research and/or 
communication about BPA. 
Great quote Particularly great or well-phrased quote from interview. 
Main Messages Answer to question about main messages about BPA risk/ also 
public position about BPA. Code entire answer to this question 
and other times discussion of main messages comes up, as 
relevant. For example "Our bottom line on BPA is…" 
Public Attention Answer to question as to why BPA has received public attention. 
Code entire answer to this question and other times discussion of 
public attention comes up, as relevant.  
Comm Challenges Answer to question about why communicating about BPA is 
challenging. Code entire answer to this question and other times 
communication challenges come up, as relevant. 
PH Advice Answer to question about advice to public health professionals. 
Code entire answer to this question and other times public health 
advice comes up, as relevant. 
Defining Effective 
Risk Comm 
Answer to question about how would they define effective risk 
communication. Code entire answer to this question and other 
times effective risk communication comes up, as relevant. 
Comm Strategies Answer to question about the respondent' communication 
strategies. Code entire answer to this question and other times 
communication strategies come up, as relevant. 
Lessons Learned Answer to question about lessons we can learn from this case. 
Code entire answer to this question and other times this issue 
comes up, as relevant. 
Research 
challenges 
Discussion of challenges or complexities of BPA research. 
Examples include discussion of research methodologies (GLP, 
endocrinology/academic research, etc), assessing exposure, lack 
of human studies, etc. 
Conflicting 
methodologies 
Discussion of methodologies to study BPA and various 
approaches that may be at odds. Specifically addresses good 
laboratory practices (GLP), a toxicology approach and/or 
endocrinology, hormone, academic focused studies. May discuss 
the differences between different approaches and merits or 
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problems with either.  
Literature-strong In discussion of state of the science, mention of BPA literature 
as strong. Respondent indicates the BPA literature as relatively 
strong, clear, compelling, or building-- in either direction toward 
indicating safety or indicating risk. 
Literature-complex In discussion of state of the science, mention of BPA literature 
as complex or confusing. For example, respondent indicates the 
BPA literature as complicated, confusing, hard to understand, or 
uncertain, in either direction toward indicating safety or 
indicating risk. 
Objectivity Discussion of bias or objectivity in regard to the science on 
BPA. Examples include discussion of the science and 
objectivity, such as industry studies not objective, the discussion 
of academics' objectivity not objective, government objectivity, 
the existence or lack thereof of objective parties, etc.  
Gov eval General discussion about government's efforts regarding BPA. 
Discussion of government's actions or evaluation of their actions 
and/or communications regarding BPA. 
Gov positive Positive comments regarding the government's efforts in general 
or communication. 
Positive discussion of government actions or communications, 
such as stating effectiveness, good research, good 
communication, even if respondent does not agree with 
government. 
Gov negative Negative comments regarding the government's efforts in 
general or communication. Negative discussion of government 
actions or communications, such as stating ineffectiveness, bad 
research, bad communication, even if respondent does not agree 
with government. 
Gov role Discussion of the government's role or the government's 
incentives or goals, for example, the government's role in 
research or communication about BPA. 
Industry eval General discussion about industry's efforts regarding BPA, for 
example, industry's actions or evaluation of their actions and/or 
communications regarding BPA. 
Industry positive Positive comments regarding the industry's efforts in general or 
communication, such as stating effectiveness, good research, 
good communication, etc., even if respondent does not agree 
with industry. 
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Industry negative Negative comments regarding the industry's efforts in general or 
communication, such as stating ineffectiveness, bad research, 
bad communication, even if respondent does not agree with 
industry. 
Industry role Discussion of the industry's role or the industry's incentives or 
goals regarding BPA, role of industry in defending their product, 
etc. 
NGO eval General discussion about NGO's efforts regarding BPA or 
evaluation of their actions and/or communications regarding 
BPA. 
NGO positive Positive comments regarding the NGO's efforts in general or 
communication, such as stating effectiveness, good research, 
good communication, etc., even if respondent does not agree 
with NGOs. 
NGO negative Negative comments regarding NGO efforts in general or 
communication, such as stating effectiveness, bad research, bad 
communication, etc., even if respondent does not agree with 
NGOs. 
NGO role Discussion of NGO role or NGO incentives or goals, for 
example NGO role/mission, incentives to raise money, etc. 
Researcher eval General discussion about researcher efforts regarding BPA or 
evaluation of their actions and/or communications regarding 
BPA. 
Researcher positive Positive comments regarding researcher efforts in general or 
communication, such as stating effectiveness, good research, 




Negative comments regarding researcher efforts in general or 
communication, such as stating ineffectiveness, bad research, 
bad communication, even if respondent does not agree with 
researchers. 
Researcher role Discussion of researcher's role or researchers incentives or goals, 
or researcher's role in studying or communication about BPA, 
discussion of objectivity, etc. 
Media eval General discussion about media's efforts regarding BPA or 
evaluation of their actions and/or communications regarding 
BPA. 
Media positive Positive comments regarding media efforts in general or 
communication, such as stating effectiveness, fair reporting, etc., 
even if respondent does not agree with news media. 
Media negative Negative comments regarding media efforts in general or 
communication, such as stating ineffectiveness, bias, bad 
reporting, etc., even if respondent does not agree with news 
media. 
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Media role Discussion of media role or the industry's incentives/goals, such 
as incentives, objectivity, etc. 
Self evaluation Answer to question about how their organization did with regard 
to BPA communication. 
Scientific literacy Discussion of scientific literacy or understanding of science in 
the public and in the media or public risk perception. May refer 
to high or low science literacy.  
Translating science Discussion of explaining or translating science. May refer to 
ease or difficulty of putting science in understandable terms, or 
researchers speaking in technical language.  
Misinformation Discussion of challenges of misinformation, misleading 
information or counteracting misinformation, bad science, and 
unclear or misleading information among any stakeholder 
groups. 
Sensationalizing Discussion of difficulty communicating in light of 
sensationalized information, for example--- findings of safety 
aren't as interesting, or it's scary, advocacy vs science, special 
interests, role of incentives in sensationalizing.  
Simple Discussion of ease of communication, i.e. it's not that difficult or 
challenging to communicate about BPA. 
Poster Child Discussion of BPA as a poster child, representing endocrine 
disruption or other environmental contaminations, i.e. 
description of BPA as an example chemical. 
Other Captures discussion of other interesting aspects of the risk 
communication challenges, other interesting risk communication 
challenges not expressly identified, such as characterizing good 
vs. evil dynamic. 
Tone of the debate  Discussion of whether the tone or tenor of the debate on BPA is 
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  releases	  and	  blog	  posts	  on	  current	  
environmental	  health	  issues	  including	  antibiotic-­‐resistant	  organisms,	  
biofuels	  and	  concentrated	  animal	  feeding	  operations.	  
• Synthesized	  research	  and	  compiled	  data	  on	  local	  food	  production	  and	  
nutrition	  interventions	  for	  Baltimore	  Food	  Policy	  Task	  Force	  Report	  and	  
Baltimore	  Office	  of	  Sustainability’s	  urban	  agriculture	  initiative.	  
Johns	  Hopkins	  Office	  of	  Public	  Health	  Practice	  and	  Training	  	  
Research	  Assistant,	  2010-­2013	   	  
• Managed	  team	  of	  four	  in	  the	  development	  of	  environmental	  health	  
curriculum	  on	  air	  quality,	  water	  quality	  and	  the	  built	  environment	  for	  
the	  Maryland	  Department	  of	  Health	  and	  Mental	  Hygiene.	  Oversaw	  
program	  budget,	  developed	  partnerships	  with	  environmental	  health	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community	  leaders	  and	  educators.	  Supervised	  videographer	  in	  the	  
filming	  and	  editing	  of	  video	  lessons	  for	  distribution	  throughout	  the	  state.	  
• Developed,	  implemented,	  and	  analyzed	  an	  800-­‐person	  community	  
health	  survey	  as	  part	  of	  a	  health	  and	  environmental	  study	  in	  Spring	  
Valley,	  Washington	  D.C.	  Communicated	  findings	  through	  community	  
presentations	  and	  a	  final	  project	  report.	  
• Led	  interviews	  with	  community	  members	  and	  public	  health	  experts	  as	  
part	  of	  an	  oral	  history	  research	  project	  on	  cancer	  cluster	  investigations.	  
Worked	  with	  team	  in	  Frederick,	  MD	  to	  provide	  insights	  and	  
recommendations	  to	  public	  health	  practitioners,	  local	  government	  and	  
the	  community.	  Wrote	  and	  edited	  content	  for	  a	  website	  with	  video	  
interviews,	  Johns	  Hopkins	  School	  of	  Public	  Health	  Magazine	  article,	  and	  
an	  American	  Journal	  of	  Public	  Health	  article.	  	  
U.S.	  Environmental	  Protection	  Agency,	  Office	  of	  Research	  and	  Development	  
ASPPH	  Public	  Health	  Fellow,	  2009-­2010	  
• Conducted	  research	  and	  presented	  findings	  to	  EPA,	  Department	  of	  
Agriculture,	  and	  Department	  of	  Energy	  leadership	  and	  staff	  on	  the	  
environmental,	  safety	  and	  health	  effects	  of	  biofuels	  use.	  
• Developed	  and	  managed	  the	  selection	  process	  for	  a	  Request	  for	  Proposals	  
on	  interdisciplinary	  biofuels	  research	  for	  several	  million	  dollars	  in	  
research	  grants	  to	  EPA	  laboratories.	  
• Collaborated	  with	  an	  EPA	  team	  to	  produce	  “Biofuels	  and	  the	  
Environment:	  First	  Triennial	  Report	  to	  Congress”	  and	  wrote	  section	  on	  
environmental	  and	  health	  impacts	  of	  biofuels	  throughout	  the	  supply	  
chain.	  
• Represented	  EPA	  on	  interagency	  panels	  overseeing	  the	  implementation	  
and	  evaluation	  of	  federally	  mandated	  biofuels	  programs.	  
Center	  for	  Science	  in	  the	  Public	  Interest	  
Communications	  Coordinator,	  2006-­2008	   	  
• Authored	  and	  distributed	  news	  releases	  on	  food	  issues	  ranging	  from	  
school	  nutrition	  policies	  and	  trans	  fat	  legislation	  to	  foodborne	  disease	  
outbreaks.	  
• Researched	  the	  cost-­‐effectiveness	  of	  100-­‐calorie	  snack	  packs	  and	  
distributed	  findings	  to	  the	  news	  media,	  which	  culminated	  in	  a	  segment	  
on	  ABC's	  Good	  Morning	  America.	  
• Conducted	  targeted	  media	  outreach	  and	  secured	  news	  coverage	  from	  
top	  television	  and	  newspaper	  outlets	  including	  The	  New	  York	  Times,	  The	  
Washington	  Post,	  NBC	  News,	  CBS	  News,	  and	  others.	  	  
• Managed	  the	  organization’s	  website,	  including	  writing	  and	  updating	  
content.	  
• Planned	  and	  executed	  special	  events	  such	  as	  expert	  Congressional	  
testimonies	  and	  press	  conferences	  with	  staff	  members	  and	  high-­‐profile	  
guest	  speakers.	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Temple	  University	  Office	  of	  Communications	  
Staff	  writer,	  2006	   	   	  
• Covered	  university	  news	  and	  events	  for	  university-­‐run	  newspaper,	  the	  
Temple	  Times	  and	  the	  Temple	  alumni	  magazine.	  
• Wrote	  feature	  profiles	  highlighting	  outstanding	  professors,	  staff	  and	  
students.	  
• Participated	  on	  university-­‐wide	  development	  and	  student	  orientation	  
committees.	  
The	  Buffalo	  News	  Washington	  Bureau	  
Research	  Assistant,	  2005	   	   	  
• Conducted	  research	  and	  data	  analysis	  for	  two	  Washington,	  D.C.-­‐based	  
reporters.	  
• Attended	  press	  briefings	  on	  military	  base	  closings	  at	  the	  Pentagon	  and	  
covered	  events	  including	  the	  2005	  Presidential	  Inauguration	  and	  the	  
2005	  State	  of	  the	  Union	  Address.	  
American	  Public	  Health	  Association	  
Communications	  Intern,	  2005	  	   	   	  
• Wrote	  articles	  on	  public	  health	  issues	  including	  postpartum	  depression	  
and	  multi-­‐drug	  resistant	  tuberculosis	  for	  APHA’s	  newspaper,	  The	  Nation’s	  
Health.	  
• Covered	  news	  events	  at	  U.S.	  Department	  of	  Health	  and	  Human	  Services	  
and	  other	  agencies.	  
• In	  2007-­‐2009,	  attended	  APHA’s	  annual	  meetings	  in	  Washington,	  D.C.,	  San	  
Diego	  and	  Philadelphia	  as	  part	  of	  APHA’s	  blog	  team	  covering	  the	  event.	  
TEACHING	  EXPERIENCE	  
Served	  as	  a	  teaching	  assistant	  in	  the	  Department	  of	  Health	  Policy	  and	  Management	  
at	  Johns	  Hopkins	  Bloomberg	  School	  of	  Public	  Health	  from	  Fall	  2010	  to	  Summer	  
2014	  (courses	  listed	  below).	  Responsibilities	  included	  guest	  lecturing,	  collaborating	  
with	  faculty	  on	  course	  development,	  developing	  grading	  rubrics,	  supervising	  class	  
activities,	  managing	  other	  staff,	  organizing	  and	  distributing	  course	  materials,	  
answering	  student	  questions,	  serving	  as	  primary	  liaison	  to	  students	  about	  course	  
requirements	  and	  deadlines,	  and	  course	  grading.	  
	  
Course	  Name	  












Introduction	  to	  the	  Risk	  Sciences	  and	  Public	  
Policy*	  
4	   6	   80	  
Public	  Health	  Practice*	   4	   6	   70	  
Health	  Advocacy	   3	   2	   80	  
Tools	  of	  Public	  Health	  Practice	  and	  Decision	  
Making*	  
1-­‐3	   3	   250	  
Current	  Issues	  in	  Public	  Health	   1	   8	   60	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Role	  of	  Government	  in	  Health	  Policy	   3	   1	   20	  
Public	  Health	  Applications	  for	  Student	  
Experience	  (PHASE)	  Internship	  Course*	  
1-­‐3	   6	   10	  
	   	  
HONORS	  AND	  AWARDS	  	  
2010-­‐2014	  	   Center	  for	  a	  Livable	  Future-­‐	  Lerner	  Fellowship	  
Johns	  Hopkins	  Bloomberg	  School	  of	  Public	  Health	  
	  
2009	   	   Reed	  Frost	  Scholarship	  
	   	   Johns	  Hopkins	  Bloomberg	  School	  of	  Public	  Health	  
	  
2005	   	   President’s	  Scholarship	  and	  Archibald	  Scholarship	  
	   	   	   	   University	  of	  Maryland,	  College	  Park	  
	  
2004	   	   University	  Honors	  Program	  Citation	  
	   	   	   	   University	  of	  Maryland,	  College	  Park	  
	  
PUBLICATIONS	  AND	  PRESENTATIONS	  
Journal	  Articles	  	  
Simpson,	  BW;	  Truant,	  PL;	  Resnick	  BA	  (2014).	  Stop	  and	  Listen	  to	  the	  People:	  An	  Enhanced	  




Truant,	  PL;	  Neff,	  RA	  (Forthcoming	  2014).	  The	  Food	  Environment.	  In	  Roni	  A.	  Neff	  (Ed.),	  
Introduction	  to	  the	  U.S.	  Food	  System:	  	  Public	  health,	  environment,	  equity.	  San	  Francisco,	  CA:	  
Jossey	  Bass.	  
	  
Reports	  and	  Non-­Peer	  Reviewed	  Articles	  
Kim,	  BF;	  Laestadius,	  LI;	  Lawrence,	  RS;	  Martin,	  RP;	  McKenzie,	  SE;	  Nachman,	  KE;	  	  Smith,	  TJS;	  
Truant,	  PL	  (2013).	  Industrial	  Food	  Animal	  Production	  in	  America:	  Examining	  the	  Impact	  of	  
the	  Pew	  Commission’s	  Priority	  Recommendations.	  Johns	  Hopkins	  Center	  for	  a	  Livable	  Future.	  
Baltimore,	  MD.	  
	  
Fox,	  M;	  Resnick,	  B;	  Nachman,	  K;	  Truant,	  P;	  McGinty,	  M;	  Le,	  Jennifer;	  Burke,	  T.	  (2013).	  
Follow-­Up	  On	  Spring	  Valley	  Health	  Study.	  Johns	  Hopkins	  Office	  of	  Public	  Health	  Practice	  and	  
Training.	  Baltimore,	  MD.	  
	  
Simpson,	  B;	  Resnick	  B;	  Truant	  P	  (2013).	  It	  would	  break	  your	  heart:	  	  science	  vs.	  experience	  
in	  a	  cancer	  cluster	  investigation.	  Johns	  Hopkins	  Public	  Health	  Magazine.	  Baltimore,	  MD.	  
	  
Professional	  Presentations	  
Truant,	  PL	  (2013,	  November).	  Environmental	  Health	  Tracking	  Programs	  in	  Middle	  and	  
High	  School	  Curricula:	  Lessons	  from	  Maryland.	  Annual	  meeting	  of	  the	  American	  Public	  
Health	  Association.	  Lecture	  conducted	  from	  Boston,	  MA..	  
	  
Truant,	  PL	  (2013,	  February).	  8th	  Grade	  Curriculum	  Development	  on	  Environmental	  Health	  
Topics:	  Using	  Technology	  and	  Tracking	  Programs.	  Annual	  meeting	  of	  the	  Maryland	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Association	  of	  Environmental	  and	  Outdoor	  Educators.	  Lecture	  conducted	  from	  Ocean	  City,	  
MD.	  	  
	  
Truant,	  PL	  (2012,	  August).	  Arsenic	  and	  Pharmaceuticals	  in	  Poultry	  Feather	  Meal:	  Recent	  
Research	  and	  Implications.	  2012	  Indiana	  CAFO	  Watch	  Conference	  sponsored	  by	  the	  Socially	  
Responsible	  Agriculture	  Project.	  Lecture	  conducted	  from	  Chesterfield,	  IN.	  	  
	  
Truant,	  PL	  (2012,	  July).	  Spring	  Valley:	  Analyzing	  Community	  Health.	  Johns	  Hopkins	  
Environmental	  and	  Community	  Assessments.	  Annual	  meeting	  of	  the	  Chemical	  Stockpile	  
Emergency	  Preparedness	  Program.	  Lecture	  conducted	  from	  Pueblo,	  CO.	  	  
	  
PROFESSIONAL	  MEMBERSHIPS	  AND	  CERTIFICATIONS	  
2013	   Certification	  in	  Public	  Health	  (CPH)	  from	  the	  National	  Board	  of	  Public	  Health	  
Examiners	  	  
	  
2012-­‐2014	   Member,	  American	  Public	  Health	  Association	  
	  
2013-­‐2014	  	   Member,	  Society	  for	  Risk	  Analysis	  
	  
2011	   Certificate	  in	  Risk	  Sciences	  and	  Public	  Policy,	  Johns	  Hopkins	  Bloomberg	  
School	  of	  Public	  Health	  
	  
OTHER	  UNIVERSITY	  SERVICE	  
2013-­‐2014	   Served	  as	  student	  representative	  on	  Johns	  Hopkins	  Bloomberg	  School	  of	  
Public	  Health	  Plagiarism	  Task	  Force	  
	  
2012-­‐2013	  	   Fellowship	  Journal	  Club	  Coordinator	  
Johns	  Hopkins	  Center	  for	  a	  Livable	  Future	  
Johns	  Hopkins	  Bloomberg	  School	  of	  Public	  Health	  
	  
2011-­‐2012	   Public	  Health	  Practice	  Committee	  Student	  Representative	  
Department	  of	  Health	  Policy	  and	  Management	  
Johns	  Hopkins	  Bloomberg	  School	  of	  Public	  Health	  
 
 
 
 
 
 
 
